data_2mkx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mkx _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.0 m120 . . . . . 0 CA--C 1.519 -0.217 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.631 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 54.8 m -109.29 84.98 2.01 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 46' ' ' ILE . 2.1 p90 -85.02 123.4 30.52 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.579 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.423 ' CE2' ' HA ' ' A' ' 8' ' ' VAL . 1.0 OUTLIER -117.89 135.82 53.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.117 -167.308 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.429 HG22 ' HD3' ' A' ' 44' ' ' LYS . 1.1 p -80.92 126.21 31.09 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 173.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.752 HG22 HG22 ' A' ' 39' ' ' ILE . 34.0 t -57.14 120.28 3.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.073 -176.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -175.32 2.73 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.35 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.2 t -41.72 114.67 0.55 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.531 0.681 . . . . 0.0 110.122 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.616 ' O ' HG21 ' A' ' 17' ' ' ILE . . . 124.35 31.54 0.9 Allowed Glycine 0 C--O 1.221 -0.718 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -164.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 39' ' ' ILE . 6.1 p-10 -52.93 -3.34 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -170.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.901 ' HB ' ' HD3' ' A' ' 16' ' ' LYS . 7.1 m -112.92 143.68 43.78 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 121.389 -0.819 . . . . 0.0 108.92 -173.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.451 ' CD1' HD13 ' A' ' 28' ' ' LEU . 54.8 tp -56.52 -47.26 79.73 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 123.569 0.543 . . . . 0.0 112.053 -166.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -65.86 -31.02 71.73 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.415 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.901 ' HD3' ' HB ' ' A' ' 13' ' ' THR . 36.0 mtpt -71.43 -47.39 56.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.286 -178.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.616 HG21 ' O ' ' A' ' 11' ' ' GLY . 1.8 pt -74.09 -37.96 47.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.56 0.219 . . . . 0.0 111.533 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.22 -50.01 74.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.031 0.443 . . . . 0.0 110.862 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.43 -22.5 60.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.654 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.535 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 30.7 tt0 -67.28 -47.8 69.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.371 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.583 ' HH ' HD11 ' A' ' 45' ' ' LEU . 3.5 p90 -107.56 13.27 26.91 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.56 49.62 6.55 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.604 -0.808 . . . . 0.0 114.635 167.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.2 p -133.36 143.91 37.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 173.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.498 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 47.0 t -70.38 147.26 49.75 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.526 0.679 . . . . 0.0 110.498 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 36.5 t -57.88 -33.01 44.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.039 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.49 -48.6 64.04 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -174.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.498 ' OD1' ' HB3' ' A' ' 24' ' ' SER . 9.2 p-10 -75.9 -40.46 54.33 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.379 -0.528 . . . . 0.0 112.248 -175.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.843 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -68.98 -31.6 70.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 118.378 -1.329 . . . . 0.0 109.442 -178.37 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -65.04 -35.17 80.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.012 171.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 66.1 m -64.25 -43.96 93.27 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -174.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.843 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.9 OUTLIER -88.33 -2.6 58.69 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.117 -0.633 . . . . 0.0 112.682 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 . . . . . 0 N--CA 1.467 0.387 0 O-C-N 122.1 -0.375 . . . . 0.0 111.472 175.775 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.752 HG22 HG22 ' A' ' 8' ' ' VAL . 22.3 mt . . . . . 0 N--CA 1.445 -0.681 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -149.95 158.17 43.9 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 89.5 t -59.51 126.93 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 123.247 0.342 . . . . 0.0 110.77 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.45 -21.01 35.98 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.529 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.54 ' NE2' ' HA ' ' A' ' 39' ' ' ILE . 6.5 tt0 -65.33 134.71 54.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.429 ' HD3' HG22 ' A' ' 7' ' ' THR . 13.7 tptm -92.31 107.72 19.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.917 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.583 HD11 ' HH ' ' A' ' 21' ' ' TYR . 2.8 pp -119.82 139.34 52.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.061 0.458 . . . . 0.0 110.517 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 46' ' ' ILE . 2.8 mp -76.3 137.45 22.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.148 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.631 ' O ' ' HB ' ' A' ' 4' ' ' THR . 11.2 p -144.6 115.78 2.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.748 0.785 . . . . 0.0 109.378 166.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.546 ' HD2' ' O ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.8 0 O-C-N 121.535 -0.728 . . . . 0.0 112.578 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.949 0.404 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.676 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 96.4 m -112.91 154.12 26.88 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.606 ' HB3' HD11 ' A' ' 46' ' ' ILE . 1.8 p90 -130.84 145.66 52.05 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 169.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -116.84 132.67 56.64 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.86 -173.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.41 116.24 19.52 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 168.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.776 HG23 HG23 ' A' ' 39' ' ' ILE . 59.7 t -58.12 125.37 14.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.388 -177.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.513 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 25.0 mmtt -103.83 -174.22 2.49 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.06 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.5 m -42.25 -26.6 0.11 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -173.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.447 ' O ' HG23 ' A' ' 17' ' ' ILE . . . -76.67 66.81 2.68 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 168.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.455 ' O ' HG21 ' A' ' 39' ' ' ILE . 3.5 p30 -63.32 -3.1 1.73 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -168.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.486 ' O ' HG12 ' A' ' 17' ' ' ILE . 1.9 m -113.59 143.48 44.49 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 119.064 -1.055 . . . . 0.0 110.067 -167.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.599 HD11 HD12 ' A' ' 28' ' ' LEU . 14.3 tp -55.91 -46.0 78.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.803 -169.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -61.48 -35.85 78.82 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.398 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -71.67 -47.34 54.91 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.815 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 13' ' ' THR . 4.5 pt -74.09 -37.33 46.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.776 -177.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 23' ' ' VAL . . . -57.1 -49.34 76.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.106 0.479 . . . . 0.0 110.834 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.58 -21.8 61.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.723 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -65.17 -47.22 77.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.064 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.464 ' HH ' ' HB ' ' A' ' 17' ' ' ILE . 0.5 OUTLIER -106.71 7.88 30.7 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 179.534 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.63 49.33 6.67 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 120.517 -0.849 . . . . 0.0 114.348 169.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.431 HG11 ' HD1' ' A' ' 21' ' ' TYR . 6.4 p -132.52 143.82 38.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 172.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.503 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 45.1 t -70.03 148.37 48.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.456 0.646 . . . . 0.0 110.603 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.552 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 78.8 t -52.84 -40.97 37.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.439 174.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.404 ' HA ' ' NE ' ' A' ' 29' ' ' ARG . . . -63.35 -49.07 75.35 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -171.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.503 ' OD1' ' HB3' ' A' ' 24' ' ' SER . 5.2 p-10 -76.51 -35.75 58.16 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 120.443 -0.503 . . . . 0.0 112.29 -175.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.792 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -72.76 -32.77 65.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 119.121 -1.031 . . . . 0.0 110.432 -177.026 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.552 ' HG2' ' O ' ' A' ' 25' ' ' VAL . 40.5 ptt85 -72.78 -31.47 64.89 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 121.506 -0.746 . . . . 0.0 111.053 174.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 72.5 m -64.98 -45.25 86.41 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -176.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.792 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -78.28 -2.84 39.87 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.527 179.734 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.851 174.563 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.776 HG23 HG23 ' A' ' 8' ' ' VAL . 9.5 mt . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.492 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 55.0 p90 -131.34 159.72 37.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.636 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 51.7 t -64.16 131.07 29.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.695 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.46 -13.3 64.43 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.2 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.663 HE22 HG12 ' A' ' 39' ' ' ILE . 28.7 tt0 -70.34 128.64 36.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.97 0.414 . . . . 0.0 111.162 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -81.65 109.12 15.78 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.55 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.426 ' C ' HD21 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -121.93 138.16 54.51 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 175.216 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 5' ' ' TYR . 45.4 mm -65.45 138.08 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.15 0.5 . . . . 0.0 111.435 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.676 ' O ' ' HB ' ' A' ' 4' ' ' THR . 10.0 p -155.18 130.99 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.95 172.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.3 pttt . . . . . 0 C--N 1.304 -1.404 0 O-C-N 121.232 -0.918 . . . . 0.0 111.375 169.094 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.521 ' HA ' ' HB3' ' A' ' 48' ' ' LYS . 4.5 p-10 . . . . . 0 CA--C 1.52 -0.207 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.595 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 97.9 m -132.32 158.94 40.58 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -130.65 146.69 52.2 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.058 0.456 . . . . 0.0 110.311 171.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -117.73 126.1 51.85 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.189 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.79 119.76 15.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.285 174.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.577 HG22 HD22 ' A' ' 45' ' ' LEU . 97.2 t -57.13 116.66 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.088 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.799 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 10.5 mmpt? -102.34 -173.47 2.34 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.221 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.1 m -44.04 -18.35 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 178.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 17' ' ' ILE . . . -70.71 60.39 0.93 Allowed Glycine 0 C--O 1.223 -0.562 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 166.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -68.27 -3.39 10.7 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 123.698 0.799 . . . . 0.0 113.148 -172.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.487 ' O ' HG12 ' A' ' 17' ' ' ILE . 25.6 m -116.81 143.76 45.3 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.571 -0.452 . . . . 0.0 109.83 -173.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.784 ' HB3' HG12 ' A' ' 25' ' ' VAL . 3.5 mm? -55.19 -47.42 75.28 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.739 0.649 . . . . 0.0 111.21 -172.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -67.23 -31.11 71.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.281 -175.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.423 ' HE2' ' HB ' ' A' ' 13' ' ' THR . 54.8 mtmt -72.0 -47.88 48.81 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.988 0.423 . . . . 0.0 110.763 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.538 HD11 HD11 ' A' ' 39' ' ' ILE . 4.3 pt -74.74 -38.13 44.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.921 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.424 ' HB2' HD22 ' A' ' 28' ' ' LEU . . . -57.3 -48.42 78.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.088 0.47 . . . . 0.0 110.865 177.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.2 -24.45 64.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.756 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -60.35 -47.45 86.02 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.508 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -104.88 12.99 31.88 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.911 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.13 48.78 37.37 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.701 170.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.408 HG21 ' OD1' ' A' ' 27' ' ' ASN . 1.3 p -131.61 171.25 18.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.46 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 48.0 t -88.1 145.33 26.0 Favored 'General case' 0 C--O 1.251 1.159 0 CA-C-O 122.433 1.111 . . . . 0.0 111.662 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.784 HG12 ' HB3' ' A' ' 14' ' ' LEU . 21.1 t -61.3 -32.28 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 114.141 -1.391 . . . . 0.0 109.679 175.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.89 -46.77 83.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.761 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.46 ' OD1' ' HB3' ' A' ' 24' ' ' SER . 1.8 p-10 -67.13 -46.3 74.55 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.48 -177.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.816 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 2.3 pp -70.61 -31.18 68.06 Favored 'General case' 0 C--O 1.228 -0.067 0 C-N-CA 118.514 -1.274 . . . . 0.0 112.197 -177.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.491 ' HD3' HG13 ' A' ' 25' ' ' VAL . 25.6 mtp-105 -64.66 -36.45 84.29 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 122.137 -0.352 . . . . 0.0 111.144 173.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.1 t -73.22 -46.55 49.63 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -171.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.816 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -83.56 -5.49 59.19 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.721 -176.184 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 . . . . . 0 C--N 1.326 -0.438 0 CA-C-O 120.9 0.381 . . . . 0.0 110.205 172.865 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.538 HD11 HD11 ' A' ' 17' ' ' ILE . 1.5 mt . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -127.26 151.3 48.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.373 -173.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 57.3 t -59.81 139.7 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.552 -175.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.96 -21.64 44.98 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.43 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.425 ' O ' HG21 ' A' ' 8' ' ' VAL . 21.5 tt0 -73.03 127.35 32.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.603 0.239 . . . . 0.0 110.734 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -85.86 106.47 17.09 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 171.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.577 HD22 HG22 ' A' ' 8' ' ' VAL . 4.6 pp -101.42 140.35 35.83 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.491 ' HB ' ' CD1' ' A' ' 31' ' ' TRP . 50.3 mm -63.71 135.21 28.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.413 0.625 . . . . 0.0 110.817 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.595 ' O ' ' HB ' ' A' ' 4' ' ' THR . 7.6 p -149.44 120.76 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.351 171.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.521 ' HB3' ' HA ' ' A' ' 3' ' ' ASN . 51.9 pttt . . . . . 0 C--N 1.308 -1.219 0 O-C-N 121.872 -0.517 . . . . 0.0 111.617 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.6 m120 . . . . . 0 CA--C 1.516 -0.333 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.733 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 92.4 m -107.1 154.63 20.87 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 173.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -130.26 145.38 51.75 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.293 172.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -117.68 115.59 25.37 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.205 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.03 117.29 8.16 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 169.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.568 HG23 HD23 ' A' ' 45' ' ' LEU . 74.7 t -56.75 118.28 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.568 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.802 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 10.1 mmpt? -99.85 -173.21 2.39 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.035 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.1 t -42.82 -17.77 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.897 ' HA2' ' HE3' ' A' ' 16' ' ' LYS . . . -74.18 61.88 2.2 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 167.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -66.4 -3.56 6.32 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -173.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.551 ' O ' HG12 ' A' ' 17' ' ' ILE . 2.8 m -115.8 143.89 44.76 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.002 -170.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.65 ' HB3' HG11 ' A' ' 25' ' ' VAL . 4.0 mm? -55.52 -50.02 71.08 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.228 -171.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -69.47 -29.9 67.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.904 -175.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.897 ' HE3' ' HA2' ' A' ' 11' ' ' GLY . 32.2 ttpt -72.34 -47.48 49.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.956 -176.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 13' ' ' THR . 5.1 pt -74.68 -39.57 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.813 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.02 -49.0 77.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.002 0.43 . . . . 0.0 110.864 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.27 -22.17 61.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.74 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -64.96 -47.7 76.67 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.65 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.415 ' CE1' HG21 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -108.03 11.32 27.85 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -178.64 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.4 48.62 7.28 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.282 169.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.402 HG21 ' N ' ' A' ' 24' ' ' SER . 14.8 p -134.7 160.21 41.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 172.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.572 ' HB2' ' OD1' ' A' ' 27' ' ' ASN . 66.8 m -90.66 149.15 22.2 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.782 0.801 . . . . 0.0 111.083 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' A' ' 14' ' ' LEU . 14.5 t -59.08 -36.4 62.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.626 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.66 -48.07 82.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.902 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.572 ' OD1' ' HB2' ' A' ' 24' ' ' SER . 0.3 OUTLIER -75.37 -36.0 61.01 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -176.601 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.885 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 3.0 pp -71.14 -30.65 66.74 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 118.046 -1.462 . . . . 0.0 111.607 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.404 ' N ' HD13 ' A' ' 28' ' ' LEU . 77.8 mtt180 -59.71 -44.78 93.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.819 0.342 . . . . 0.0 110.906 171.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 64.8 m -69.8 -43.94 71.05 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -171.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.885 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -82.18 -4.05 56.22 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.533 -178.477 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 . . . . . 0 C--N 1.326 -0.419 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.677 174.108 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.477 HD13 HD11 ' A' ' 17' ' ' ILE . 3.0 mt . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.223 0.535 . . . . 0.0 109.967 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.458 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 19.5 p90 -134.63 154.81 51.33 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.406 -175.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 41.8 t -63.08 132.31 28.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.272 -173.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.7 -20.93 40.18 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.419 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.41 ' O ' HG22 ' A' ' 8' ' ' VAL . 23.0 tt0 -71.27 127.19 31.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.441 0.162 . . . . 0.0 110.572 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -81.9 107.37 14.57 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 171.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.568 HD23 HG23 ' A' ' 8' ' ' VAL . 4.2 pp -105.47 134.36 48.7 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 175.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.459 ' N ' HD13 ' A' ' 46' ' ' ILE . 1.9 mp -62.45 136.58 25.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.733 ' O ' ' HB ' ' A' ' 4' ' ' THR . 7.7 p -145.59 125.94 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.502 ' HE3' ' CE3' ' A' ' 31' ' ' TRP . 36.6 pttt . . . . . 0 C--N 1.301 -1.506 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.091 175.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.735 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 47.7 m -114.01 151.3 32.61 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.496 ' HB3' HD12 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -132.11 153.95 49.96 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 121.772 -0.58 . . . . 0.0 110.296 174.177 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.48 ' OH ' ' HB2' ' A' ' 9' ' ' LYS . 1.4 t80 -145.94 142.41 28.69 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.045 -173.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.39 121.27 28.71 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 174.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.521 HG22 HG22 ' A' ' 39' ' ' ILE . 95.0 t -56.91 125.47 12.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.556 -175.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.628 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -92.15 -173.81 3.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.955 176.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.6 m -43.87 -17.69 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.711 ' HA2' ' HE2' ' A' ' 16' ' ' LYS . . . -75.26 52.59 2.62 Favored Glycine 0 C--O 1.222 -0.622 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 168.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -57.58 -3.43 0.19 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -169.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.9 m -114.77 149.36 37.06 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 121.301 -0.875 . . . . 0.0 109.236 -173.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.682 HD12 HG11 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -53.92 -47.27 71.36 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.605 0.566 . . . . 0.0 110.612 -171.821 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -69.23 -29.18 67.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.056 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.711 ' HE2' ' HA2' ' A' ' 11' ' ' GLY . 60.0 mtpt -71.06 -48.7 51.13 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.522 -178.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.686 HG23 ' O ' ' A' ' 11' ' ' GLY . 4.9 pt -74.31 -41.63 50.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.66 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.23 -49.36 76.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 0.0 111.146 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.38 -22.56 60.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.743 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.509 ' HA ' ' OE1' ' A' ' 20' ' ' GLN . 5.7 tp60 -68.13 -47.26 68.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.478 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.558 ' HE1' HG12 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -100.93 2.79 41.12 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.765 178.664 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.33 48.92 7.1 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.92 -0.657 . . . . 0.0 114.479 169.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.575 HG23 ' OD1' ' A' ' 27' ' ' ASN . 3.0 p -122.74 162.83 22.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 170.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.0 t -74.94 146.5 41.72 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.853 0.835 . . . . 0.0 111.241 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.682 HG11 HD12 ' A' ' 14' ' ' LEU . 91.2 t -58.91 -35.76 58.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.169 172.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.47 -46.61 69.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.233 -175.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.575 ' OD1' HG23 ' A' ' 23' ' ' VAL . 6.9 p30 -74.87 -43.58 53.64 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.491 -174.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.785 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -68.43 -31.99 71.7 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.834 -178.004 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.615 ' HE ' ' HG ' ' A' ' 14' ' ' LEU . 96.5 mtt180 -66.99 -35.81 80.78 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.887 172.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.6 t -64.38 -45.26 88.48 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -172.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.785 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER -89.02 -2.12 58.43 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.148 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 . . . . . 0 C--N 1.327 -0.379 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.29 176.188 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.521 HG22 HG22 ' A' ' 8' ' ' VAL . 14.1 mt . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -142.28 171.04 14.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.011 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 61.0 t -64.74 128.63 27.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.59 -10.27 60.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.005 -177.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -61.47 127.99 34.13 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 122.44 0.296 . . . . 0.0 110.427 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -92.73 107.21 19.04 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.743 HD21 HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -124.17 140.61 52.8 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.16 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.496 HD12 ' HB3' ' A' ' 5' ' ' TYR . 49.6 mm -70.3 131.51 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.198 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.735 ' O ' ' HB ' ' A' ' 4' ' ' THR . 11.3 p -136.95 123.49 29.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 122.46 1.124 . . . . 0.0 109.36 173.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.8 tttp . . . . . 0 C--N 1.297 -1.675 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.705 175.711 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.402 ' OD1' ' HD3' ' A' ' 48' ' ' LYS . 24.9 t30 . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.695 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 83.6 m -99.31 157.27 16.51 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -127.42 150.91 49.42 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.621 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CE2' ' HA ' ' A' ' 8' ' ' VAL . 55.7 t80 -117.23 120.77 39.26 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.979 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.57 111.82 5.65 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.06 0.457 . . . . 0.0 109.974 170.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 68.7 t -57.34 127.81 16.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.812 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.28 -174.05 2.38 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.9 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.1 m -41.16 -26.47 0.05 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -173.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.648 ' O ' HG21 ' A' ' 17' ' ' ILE . . . -76.79 59.55 3.43 Favored Glycine 0 C--O 1.225 -0.465 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 170.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -59.27 -1.3 0.19 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -171.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.486 ' O ' HG12 ' A' ' 17' ' ' ILE . 2.3 m -112.69 147.98 35.65 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.515 -0.741 . . . . 0.0 110.383 -168.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -54.45 -48.1 72.14 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.875 -169.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -62.32 -36.56 82.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.016 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 29.1 mmmt -73.56 -47.29 41.82 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.283 -173.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.648 HG21 ' O ' ' A' ' 11' ' ' GLY . 6.9 pt -74.69 -41.52 47.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -177.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.72 -49.86 76.1 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.125 0.266 . . . . 0.0 111.196 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.02 -23.71 62.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.077 0.465 . . . . 0.0 110.335 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 9.7 tt0 -59.96 -46.81 88.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.172 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.414 ' CE1' HG22 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -106.27 13.6 28.59 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.737 179.344 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.19 49.06 17.2 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.645 171.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.681 HG22 ' OD1' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -131.38 175.72 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.208 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.682 ' HB2' HD22 ' A' ' 27' ' ' ASN . 47.7 m -110.86 152.15 27.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.407 0.622 . . . . 0.0 111.699 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.4 HG12 ' HD2' ' A' ' 29' ' ' ARG . 43.8 t -57.73 -40.02 73.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.769 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.31 -47.04 86.87 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.312 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.682 HD22 ' HB2' ' A' ' 24' ' ' SER . 0.4 OUTLIER -71.7 -41.89 68.04 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -176.044 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.871 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 3.2 pp -69.14 -32.33 71.61 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 118.331 -1.348 . . . . 0.0 111.79 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.41 ' N ' HD12 ' A' ' 28' ' ' LEU . 32.0 mtp-105 -63.85 -33.7 76.28 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.055 172.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.8 t -68.8 -45.05 72.26 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.35 -174.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.871 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER -90.72 -2.56 57.81 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.096 -178.486 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 . . . . . 0 C--N 1.326 -0.436 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.825 174.11 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.619 HG22 HG23 ' A' ' 8' ' ' VAL . 4.3 mt . . . . . 0 C--O 1.233 0.214 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.584 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 50.0 p90 -144.41 166.88 23.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.156 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 46.2 t -60.4 129.23 22.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.293 -177.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.77 -15.29 59.78 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.382 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.445 ' OE1' ' HA ' ' A' ' 39' ' ' ILE . 44.2 tt0 -75.28 129.47 37.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.544 0.212 . . . . 0.0 111.076 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -92.11 107.34 19.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.812 0.339 . . . . 0.0 110.237 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.645 HD23 HD12 ' A' ' 17' ' ' ILE . 3.4 pp -109.65 138.58 45.82 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 175.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.429 HD12 ' N ' ' A' ' 46' ' ' ILE . 1.8 mp -65.49 139.35 21.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.063 0.459 . . . . 0.0 110.371 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.695 ' O ' ' HB ' ' A' ' 4' ' ' THR . 11.3 p -149.1 129.13 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 172.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.402 ' HD3' ' OD1' ' A' ' 3' ' ' ASN . 63.3 pttt . . . . . 0 C--N 1.309 -1.156 0 CA-C-O 121.318 0.58 . . . . 0.0 112.223 175.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 . . . . . 0 CA--C 1.516 -0.349 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.703 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 58.0 m -109.54 155.54 21.26 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.617 ' HB3' HD11 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -131.31 139.68 49.62 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.184 0.516 . . . . 0.0 110.674 173.435 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -121.0 141.53 50.65 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.113 -173.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.476 ' O ' ' HG2' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -87.87 120.75 29.5 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.979 171.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.742 HG22 HG22 ' A' ' 39' ' ' ILE . 57.5 t -57.35 127.25 16.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.135 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 7' ' ' THR . 66.1 mmtt -129.72 -178.07 4.54 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.5 m -42.95 125.55 3.55 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.357 0.599 . . . . 0.0 110.11 177.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 17' ' ' ILE . . . 104.52 29.58 5.29 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 108.561 -1.816 . . . . 0.0 108.561 -158.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.498 ' O ' HG23 ' A' ' 39' ' ' ILE . 4.3 p30 -59.84 0.09 0.17 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.454 1.502 . . . . 0.0 114.675 -169.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.515 ' O ' HG12 ' A' ' 17' ' ' ILE . 5.8 m -112.22 145.36 40.05 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 121.571 -0.705 . . . . 0.0 110.19 -172.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.0 mp -53.99 -46.48 71.72 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.04 -166.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -61.72 -36.37 80.75 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.929 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 68.5 mttm -73.79 -47.17 40.78 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.851 -176.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 11' ' ' GLY . 2.4 pt -73.28 -42.92 57.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.537 -178.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.546 ' HA ' ' CE1' ' A' ' 21' ' ' TYR . . . -58.45 -49.02 78.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.039 0.447 . . . . 0.0 111.23 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.83 -22.25 60.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.683 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 35.8 tt0 -64.54 -47.51 78.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.032 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.546 ' CE1' ' HA ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -96.85 -0.3 48.05 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.456 177.45 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.58 48.44 7.28 Favored Glycine 0 N--CA 1.453 -0.17 0 C-N-CA 120.894 -0.67 . . . . 0.0 114.062 171.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.658 HG21 ' OD1' ' A' ' 27' ' ' ASN . 1.1 p -126.82 164.36 27.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 172.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.645 ' HB2' HD22 ' A' ' 27' ' ' ASN . 4.4 m -91.35 145.34 24.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.237 0.542 . . . . 0.0 111.338 -175.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.504 HG11 ' HD3' ' A' ' 29' ' ' ARG . 38.4 t -55.68 -34.73 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.458 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.54 -47.64 78.06 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -177.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.658 ' OD1' HG21 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -71.93 -46.35 57.91 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -176.094 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.823 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -66.27 -31.21 71.88 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.722 -177.214 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.504 ' HD3' HG11 ' A' ' 25' ' ' VAL . 27.9 mtp180 -66.44 -38.73 88.04 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.239 -0.288 . . . . 0.0 111.315 172.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 66.9 m -67.5 -45.43 75.83 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -171.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.823 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -81.74 -6.42 59.03 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.287 -176.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.914 0.387 . . . . 0.0 109.958 174.201 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.742 HG22 HG22 ' A' ' 8' ' ' VAL . 4.7 mt . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.477 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 51.5 p90 -136.38 159.8 40.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.713 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 50.2 t -62.73 129.62 26.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.071 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.89 -20.54 40.86 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.603 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.452 ' NE2' ' HA ' ' A' ' 39' ' ' ILE . 29.4 tt0 -71.78 127.74 33.55 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -94.42 107.63 19.59 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.418 ' C ' HD21 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -115.8 140.55 49.11 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -176.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.617 HD11 ' HB3' ' A' ' 5' ' ' TYR . 49.7 mm -66.17 135.53 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.798 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.703 ' O ' ' HB ' ' A' ' 4' ' ' THR . 13.9 p -147.33 124.63 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 122.072 0.939 . . . . 0.0 110.017 173.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.442 ' O ' ' HH2' ' A' ' 31' ' ' TRP . 57.8 tptt . . . . . 0 C--N 1.303 -1.454 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.669 171.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.687 ' HA ' ' HD2' ' A' ' 48' ' ' LYS . 12.6 m120 . . . . . 0 C--O 1.233 0.233 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.785 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 34.9 m -115.54 153.51 31.05 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 171.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -131.65 150.04 52.29 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.542 170.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -138.53 139.91 38.9 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.175 -171.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.72 123.67 29.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 173.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.63 HG22 HG21 ' A' ' 39' ' ' ILE . 58.8 t -56.74 116.2 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 123.717 0.635 . . . . 0.0 110.036 -177.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.664 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -103.36 -177.71 3.45 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.331 -177.708 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.3 p -42.98 112.7 0.39 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.495 0.664 . . . . 0.0 109.819 172.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.705 ' O ' HG23 ' A' ' 17' ' ' ILE . . . 123.14 34.44 0.77 Allowed Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -164.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.414 ' O ' HG22 ' A' ' 39' ' ' ILE . 10.4 p-10 -52.93 -2.64 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -170.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.426 ' OG1' ' HE2' ' A' ' 16' ' ' LYS . 2.6 m -114.13 154.31 28.02 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 121.156 -0.965 . . . . 0.0 109.99 -171.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 48.4 mt -53.39 -48.16 68.88 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 123.573 0.545 . . . . 0.0 111.755 -170.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -62.26 -37.07 84.06 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.24 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.426 ' HE2' ' OG1' ' A' ' 13' ' ' THR . 59.7 mtmt -74.3 -47.69 33.16 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.085 -174.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.705 HG23 ' O ' ' A' ' 11' ' ' GLY . 12.1 pt -72.88 -45.22 56.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.467 -177.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.462 ' HB1' HD22 ' A' ' 28' ' ' LEU . . . -58.54 -49.59 76.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.784 0.325 . . . . 0.0 111.578 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.16 -22.78 63.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.658 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.424 HE21 ' CA ' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -61.95 -47.12 86.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.935 177.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.618 ' HH ' ' HB ' ' A' ' 17' ' ' ILE . 0.3 OUTLIER -107.38 13.56 26.87 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.209 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.44 31.48 45.87 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.988 -0.625 . . . . 0.0 114.43 168.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.467 ' CG1' HD23 ' A' ' 28' ' ' LEU . 10.9 p -114.68 159.84 14.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.497 ' HB2' ' OD1' ' A' ' 27' ' ' ASN . 19.2 m -93.69 153.33 18.41 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-O 121.59 0.71 . . . . 0.0 110.735 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.8 t -56.86 -38.92 61.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.862 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.86 -48.32 81.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -175.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.497 ' OD1' ' HB2' ' A' ' 24' ' ' SER . 1.6 p-10 -75.55 -34.34 60.72 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -175.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.874 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 3.9 pp -71.69 -31.75 67.11 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 118.221 -1.392 . . . . 0.0 111.107 177.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.485 ' N ' HD11 ' A' ' 28' ' ' LEU . 75.0 mtp180 -64.37 -34.68 78.72 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.636 173.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 52.0 m -71.22 -44.91 64.44 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -173.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.874 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -84.55 -2.53 57.5 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.137 -178.411 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 . . . . . 0 C--N 1.326 -0.45 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.475 174.119 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.63 HG21 HG22 ' A' ' 8' ' ' VAL . 5.2 mt . . . . . 0 C--O 1.233 0.228 0 CA-C-O 120.974 0.416 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -149.35 161.36 42.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.488 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 97.1 t -61.41 129.98 24.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.318 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.36 -20.8 36.67 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.979 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.508 ' OE1' ' HA ' ' A' ' 39' ' ' ILE . 27.4 tt0 -70.28 132.45 45.72 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.425 -0.388 . . . . 0.0 110.508 177.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.789 ' HB3' ' HZ3' ' A' ' 44' ' ' LYS . 2.4 ttpm? -97.15 107.36 19.87 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.82 143.34 45.54 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 -178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.8 mp -67.42 136.28 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.952 0.406 . . . . 0.0 110.718 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.785 ' O ' ' HB ' ' A' ' 4' ' ' THR . 7.9 p -150.58 129.31 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-O 121.606 0.717 . . . . 0.0 109.266 173.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.687 ' HD2' ' HA ' ' A' ' 3' ' ' ASN . 54.8 tttm . . . . . 0 C--N 1.301 -1.504 0 O-C-N 121.584 -0.697 . . . . 0.0 110.861 171.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.507 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 49.4 m -99.51 155.79 17.38 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.685 ' HB3' HD13 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -130.18 139.28 50.87 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.136 0.493 . . . . 0.0 109.859 173.111 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.403 ' CE2' ' HA ' ' A' ' 8' ' ' VAL . 10.1 t80 -123.11 137.42 54.92 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.329 -172.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.441 ' O ' ' HG2' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -83.9 119.7 25.2 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.08 172.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.715 HG21 HG23 ' A' ' 39' ' ' ILE . 61.3 t -56.68 123.15 7.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.426 -176.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 7' ' ' THR . 28.0 mmtp -116.93 -176.05 2.9 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.646 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.4 m -41.12 113.47 0.39 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.61 0.719 . . . . 0.0 110.341 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.652 ' O ' HG23 ' A' ' 17' ' ' ILE . . . 119.02 37.81 0.79 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 -163.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.404 ' O ' HG21 ' A' ' 39' ' ' ILE . 4.1 p30 -53.79 -1.88 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.578 1.551 . . . . 0.0 114.998 -172.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.412 ' H ' ' C ' ' A' ' 11' ' ' GLY . 8.3 m -114.12 152.59 30.88 Favored 'General case' 0 C--N 1.309 -1.152 0 O-C-N 121.439 -0.788 . . . . 0.0 110.01 -169.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.603 HD22 HG13 ' A' ' 25' ' ' VAL . 52.9 mt -53.11 -46.61 68.8 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.977 -171.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -62.11 -36.94 83.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -73.87 -48.88 27.89 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.718 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.652 HG23 ' O ' ' A' ' 11' ' ' GLY . 14.3 pt -74.37 -44.68 48.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.762 -176.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.445 ' HA ' ' CE1' ' A' ' 21' ' ' TYR . . . -59.79 -48.84 80.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.891 0.377 . . . . 0.0 111.189 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.06 -21.88 62.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.851 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -63.38 -46.71 85.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.262 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.445 ' CE1' ' HA ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -99.71 6.05 45.62 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.101 0.477 . . . . 0.0 111.221 176.192 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.28 48.33 11.17 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.854 -0.612 . . . . 0.0 114.125 170.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.436 HG13 ' HE1' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -131.11 168.43 23.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 173.565 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.459 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 47.6 t -91.59 146.86 23.44 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 122.368 1.08 . . . . 0.0 112.032 -176.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.603 HG13 HD22 ' A' ' 14' ' ' LEU . 60.7 t -59.29 -32.11 47.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.341 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.06 83.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.44 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.49 ' HB2' ' CH2' ' A' ' 31' ' ' TRP . 1.3 p-10 -68.4 -45.1 73.58 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.666 -177.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.764 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 2.8 pp -67.92 -32.13 72.38 Favored 'General case' 0 C--O 1.227 -0.12 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.404 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.534 ' HD2' HG11 ' A' ' 25' ' ' VAL . 36.0 mtt-85 -61.81 -34.6 76.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.77 0.319 . . . . 0.0 110.97 172.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.7 t -71.28 -45.49 63.02 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.764 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 1.0 OUTLIER -89.2 -1.78 58.23 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -176.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 . . . . . 0 C--N 1.318 -0.771 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.414 174.176 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.715 HG23 HG21 ' A' ' 8' ' ' VAL . 5.7 mt . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -137.14 160.9 37.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.563 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 61.9 t -65.04 128.78 28.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.488 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.75 -15.49 48.72 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.204 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.477 ' NE2' HG12 ' A' ' 39' ' ' ILE . 24.5 tt0 -75.45 127.85 34.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.758 0.313 . . . . 0.0 110.265 177.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -89.6 107.18 18.94 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.99 140.88 48.68 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.685 HD13 ' HB3' ' A' ' 5' ' ' TYR . 42.8 mm -68.23 137.45 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.281 -176.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.507 ' O ' ' HB ' ' A' ' 4' ' ' THR . 8.5 p -146.76 112.68 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.625 0.726 . . . . 0.0 110.48 173.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.461 ' HB2' ' H ' ' A' ' 4' ' ' THR . 58.3 tptt . . . . . 0 N--CA 1.472 0.635 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.955 169.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.453 ' HA ' ' HB3' ' A' ' 48' ' ' LYS . 3.6 p-10 . . . . . 0 CA--C 1.522 -0.118 0 CA-C-O 121.019 0.438 . . . . 0.0 109.858 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.633 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 57.1 m -108.62 157.91 18.07 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -175.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.442 ' HB2' ' HG3' ' A' ' 44' ' ' LYS . 0.9 OUTLIER -130.85 150.0 52.22 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.101 0.476 . . . . 0.0 109.906 171.048 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.436 ' CE2' ' HA ' ' A' ' 8' ' ' VAL . 1.2 t80 -129.31 139.92 51.59 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.833 -175.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.438 HG21 ' HD3' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -82.99 120.94 26.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.142 173.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.655 HG23 HG23 ' A' ' 39' ' ' ILE . 57.8 t -56.14 124.92 10.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.132 -177.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.665 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -95.23 -175.09 3.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.498 -178.297 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.7 m -57.56 68.41 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.918 0.866 . . . . 0.0 110.849 171.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.603 ' O ' HG22 ' A' ' 17' ' ' ILE . . . -175.03 45.66 0.13 Allowed Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 107.847 -2.101 . . . . 0.0 107.847 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -52.58 -0.26 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.57 1.948 . . . . 0.0 115.406 -170.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.429 ' H ' ' C ' ' A' ' 11' ' ' GLY . 14.8 m -113.13 147.22 37.79 Favored 'General case' 0 C--N 1.311 -1.081 0 O-C-N 121.364 -0.835 . . . . 0.0 109.694 -171.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.498 ' HB3' HG11 ' A' ' 25' ' ' VAL . 54.6 mt -53.74 -47.33 70.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.116 -168.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -66.64 -30.25 70.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.968 -176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -74.13 -47.8 33.68 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.013 0.435 . . . . 0.0 111.05 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.603 HG22 ' O ' ' A' ' 11' ' ' GLY . 11.3 pt -74.61 -40.35 47.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.605 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.406 ' HA ' ' CE1' ' A' ' 21' ' ' TYR . . . -58.02 -49.26 77.47 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.0 0.429 . . . . 0.0 111.232 177.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.93 -23.03 63.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.758 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -60.81 -41.82 96.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.502 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.426 ' CE1' HG23 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -107.19 8.17 29.87 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.697 177.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.4 48.16 11.3 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.726 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.412 HG11 ' HE1' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -133.11 172.58 16.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.4 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -97.34 147.32 24.29 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-O 122.297 1.046 . . . . 0.0 111.574 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.529 HG12 ' HD2' ' A' ' 29' ' ' ARG . 88.2 t -56.74 -35.92 47.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.361 176.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.12 -45.66 87.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.141 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -64.67 -46.17 83.59 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.978 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.814 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 3.4 pp -69.02 -29.49 67.67 Favored 'General case' 0 CA--C 1.523 -0.083 0 C-N-CA 118.719 -1.192 . . . . 0.0 110.853 178.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.529 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -54.54 -41.43 69.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.034 0.445 . . . . 0.0 110.443 171.117 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.6 m -75.9 -44.01 42.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.883 -170.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.814 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -91.38 -1.5 57.58 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -173.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 . . . . . 0 C--N 1.328 -0.334 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.319 178.891 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.655 HG23 HG23 ' A' ' 8' ' ' VAL . 4.9 mt . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.536 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 42.4 p90 -141.94 160.75 39.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.719 -176.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 54.0 t -56.56 128.87 17.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.935 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.76 -16.44 58.61 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.896 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.467 ' NE2' ' HA ' ' A' ' 39' ' ' ILE . 27.5 tt0 -74.96 137.94 41.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.852 0.326 . . . . 0.0 110.877 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.442 ' HG3' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -95.32 107.72 19.86 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.834 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.0 147.08 42.62 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.5 mp -70.41 137.93 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.967 0.413 . . . . 0.0 111.271 -174.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.633 ' O ' ' HB ' ' A' ' 4' ' ' THR . 8.8 p -151.67 124.72 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.735 0.779 . . . . 0.0 109.302 171.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 3' ' ' ASN . 21.6 pttp . . . . . 0 C--N 1.309 -1.158 0 CA-C-O 121.57 0.7 . . . . 0.0 111.411 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.0 t -147.69 149.52 32.61 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 178.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -137.9 131.48 31.02 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.631 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 54.8 m -109.29 84.98 2.01 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 46' ' ' ILE . 2.1 p90 -85.02 123.4 30.52 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.579 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.423 ' CE2' ' HA ' ' A' ' 8' ' ' VAL . 1.0 OUTLIER -117.89 135.82 53.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.117 -167.308 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.429 HG22 ' HD3' ' A' ' 44' ' ' LYS . 1.1 p -80.92 126.21 31.09 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 173.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.752 HG22 HG22 ' A' ' 39' ' ' ILE . 34.0 t -57.14 120.28 3.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.073 -176.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -175.32 2.73 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.35 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.2 t -41.72 114.67 0.55 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.531 0.681 . . . . 0.0 110.122 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.616 ' O ' HG21 ' A' ' 17' ' ' ILE . . . 124.35 31.54 0.9 Allowed Glycine 0 C--O 1.221 -0.718 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -164.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 39' ' ' ILE . 6.1 p-10 -52.93 -3.34 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -170.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.901 ' HB ' ' HD3' ' A' ' 16' ' ' LYS . 7.1 m -112.92 143.68 43.78 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 121.389 -0.819 . . . . 0.0 108.92 -173.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.451 ' CD1' HD13 ' A' ' 28' ' ' LEU . 54.8 tp -56.52 -47.26 79.73 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 123.569 0.543 . . . . 0.0 112.053 -166.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -65.86 -31.02 71.73 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.415 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.901 ' HD3' ' HB ' ' A' ' 13' ' ' THR . 36.0 mtpt -71.43 -47.39 56.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.286 -178.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.616 HG21 ' O ' ' A' ' 11' ' ' GLY . 1.8 pt -74.09 -37.96 47.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.56 0.219 . . . . 0.0 111.533 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.22 -50.01 74.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.031 0.443 . . . . 0.0 110.862 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.43 -22.5 60.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.654 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.535 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 30.7 tt0 -67.28 -47.8 69.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.371 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.583 ' HH ' HD11 ' A' ' 45' ' ' LEU . 3.5 p90 -107.56 13.27 26.91 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.56 49.62 6.55 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.604 -0.808 . . . . 0.0 114.635 167.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.2 p -133.36 143.91 37.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 173.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.498 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 47.0 t -70.38 147.26 49.75 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.526 0.679 . . . . 0.0 110.498 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 36.5 t -57.88 -33.01 44.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.039 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.49 -48.6 64.04 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -174.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.498 ' OD1' ' HB3' ' A' ' 24' ' ' SER . 9.2 p-10 -75.9 -40.46 54.33 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.379 -0.528 . . . . 0.0 112.248 -175.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.843 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -68.98 -31.6 70.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 118.378 -1.329 . . . . 0.0 109.442 -178.37 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -65.04 -35.17 80.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.012 171.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 66.1 m -64.25 -43.96 93.27 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -174.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.843 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.9 OUTLIER -88.33 -2.6 58.69 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.117 -0.633 . . . . 0.0 112.682 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.439 ' HB3' HG13 ' A' ' 34' ' ' ILE . 38.2 m-80 -106.09 -22.66 12.81 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 122.1 -0.375 . . . . 0.0 111.472 175.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.92 39.07 85.53 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.823 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.439 HG13 ' HB3' ' A' ' 32' ' ' ASN . 63.4 mt -105.24 128.75 58.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.993 0.425 . . . . 0.0 111.536 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -108.42 110.63 22.22 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.021 171.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.29 -167.13 16.56 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.609 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.408 ' OD1' ' HB3' ' A' ' 14' ' ' LEU . 16.0 m-20 -104.58 36.47 2.4 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.163 0.185 . . . . 0.0 111.066 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.408 HD11 ' O ' ' A' ' 38' ' ' LEU . 1.0 OUTLIER -76.89 63.8 2.3 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.363 1.077 . . . . 0.0 111.197 -179.205 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.752 HG22 HG22 ' A' ' 8' ' ' VAL . 22.3 mt -124.23 147.14 28.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.236 -176.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -149.95 158.17 43.9 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 89.5 t -59.51 126.93 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 123.247 0.342 . . . . 0.0 110.77 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.45 -21.01 35.98 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.529 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.54 ' NE2' ' HA ' ' A' ' 39' ' ' ILE . 6.5 tt0 -65.33 134.71 54.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.429 ' HD3' HG22 ' A' ' 7' ' ' THR . 13.7 tptm -92.31 107.72 19.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.917 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.583 HD11 ' HH ' ' A' ' 21' ' ' TYR . 2.8 pp -119.82 139.34 52.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.061 0.458 . . . . 0.0 110.517 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 46' ' ' ILE . 2.8 mp -76.3 137.45 22.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.148 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.631 ' O ' ' HB ' ' A' ' 4' ' ' THR . 11.2 p -144.6 115.78 2.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.748 0.785 . . . . 0.0 109.378 166.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.546 ' HD2' ' O ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -146.88 119.75 8.7 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.535 -0.728 . . . . 0.0 112.578 176.04 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.585 ' HD3' ' H ' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -117.45 163.7 16.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.38 -178.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 135.88 -38.78 1.74 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.901 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.814 -0.613 . . . . 0.0 110.207 178.714 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.668 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.9 m -88.27 158.6 18.42 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -152.26 114.03 4.38 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.949 0.404 . . . . 0.0 109.94 173.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.676 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 96.4 m -112.91 154.12 26.88 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.606 ' HB3' HD11 ' A' ' 46' ' ' ILE . 1.8 p90 -130.84 145.66 52.05 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 169.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -116.84 132.67 56.64 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.86 -173.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.41 116.24 19.52 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 168.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.776 HG23 HG23 ' A' ' 39' ' ' ILE . 59.7 t -58.12 125.37 14.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.388 -177.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.513 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 25.0 mmtt -103.83 -174.22 2.49 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.06 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.5 m -42.25 -26.6 0.11 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -173.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.447 ' O ' HG23 ' A' ' 17' ' ' ILE . . . -76.67 66.81 2.68 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 168.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.455 ' O ' HG21 ' A' ' 39' ' ' ILE . 3.5 p30 -63.32 -3.1 1.73 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -168.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.486 ' O ' HG12 ' A' ' 17' ' ' ILE . 1.9 m -113.59 143.48 44.49 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 119.064 -1.055 . . . . 0.0 110.067 -167.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.599 HD11 HD12 ' A' ' 28' ' ' LEU . 14.3 tp -55.91 -46.0 78.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.803 -169.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -61.48 -35.85 78.82 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.398 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -71.67 -47.34 54.91 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.815 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 13' ' ' THR . 4.5 pt -74.09 -37.33 46.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.776 -177.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 23' ' ' VAL . . . -57.1 -49.34 76.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.106 0.479 . . . . 0.0 110.834 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.58 -21.8 61.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.723 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -65.17 -47.22 77.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.064 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.464 ' HH ' ' HB ' ' A' ' 17' ' ' ILE . 0.5 OUTLIER -106.71 7.88 30.7 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 179.534 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.63 49.33 6.67 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 120.517 -0.849 . . . . 0.0 114.348 169.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.431 HG11 ' HD1' ' A' ' 21' ' ' TYR . 6.4 p -132.52 143.82 38.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 172.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.503 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 45.1 t -70.03 148.37 48.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.456 0.646 . . . . 0.0 110.603 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.552 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 78.8 t -52.84 -40.97 37.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.439 174.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.404 ' HA ' ' NE ' ' A' ' 29' ' ' ARG . . . -63.35 -49.07 75.35 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -171.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.503 ' OD1' ' HB3' ' A' ' 24' ' ' SER . 5.2 p-10 -76.51 -35.75 58.16 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 120.443 -0.503 . . . . 0.0 112.29 -175.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.792 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -72.76 -32.77 65.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 119.121 -1.031 . . . . 0.0 110.432 -177.026 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.552 ' HG2' ' O ' ' A' ' 25' ' ' VAL . 40.5 ptt85 -72.78 -31.47 64.89 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 121.506 -0.746 . . . . 0.0 111.053 174.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 72.5 m -64.98 -45.25 86.41 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -176.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.792 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -78.28 -2.84 39.87 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.527 179.734 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.475 ' HB3' HG13 ' A' ' 34' ' ' ILE . 26.7 m-80 -100.07 -20.7 15.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.851 174.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.46 44.38 83.99 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.523 -178.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.475 HG13 ' HB3' ' A' ' 32' ' ' ASN . 65.8 mt -109.95 129.17 65.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.394 0.14 . . . . 0.0 110.64 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.6 m -89.89 107.82 19.34 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 172.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.4 -167.12 33.72 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.858 -0.686 . . . . 0.0 111.638 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -115.71 65.41 0.69 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.554 0.692 . . . . 0.0 111.959 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.456 ' H ' HD22 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -87.44 97.36 10.78 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 170.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.776 HG23 HG23 ' A' ' 8' ' ' VAL . 9.5 mt -138.15 132.64 42.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.395 -172.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.492 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 55.0 p90 -131.34 159.72 37.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.636 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 51.7 t -64.16 131.07 29.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.695 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.46 -13.3 64.43 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.2 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.663 HE22 HG12 ' A' ' 39' ' ' ILE . 28.7 tt0 -70.34 128.64 36.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.97 0.414 . . . . 0.0 111.162 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -81.65 109.12 15.78 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.55 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.426 ' C ' HD21 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -121.93 138.16 54.51 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 175.216 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 5' ' ' TYR . 45.4 mm -65.45 138.08 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.15 0.5 . . . . 0.0 111.435 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.676 ' O ' ' HB ' ' A' ' 4' ' ' THR . 10.0 p -155.18 130.99 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.95 172.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -133.33 122.15 23.4 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.232 -0.918 . . . . 0.0 111.375 169.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -100.43 108.27 20.22 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 127.04 -114.47 1.97 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.88 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.705 -0.664 . . . . 0.0 110.193 -179.194 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.7 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.8 t -149.46 138.96 21.59 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.521 ' HA ' ' HB3' ' A' ' 48' ' ' LYS . 4.5 p-10 -171.51 126.49 0.63 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.56 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.595 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 97.9 m -132.32 158.94 40.58 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -130.65 146.69 52.2 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.058 0.456 . . . . 0.0 110.311 171.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -117.73 126.1 51.85 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.189 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.79 119.76 15.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.285 174.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.577 HG22 HD22 ' A' ' 45' ' ' LEU . 97.2 t -57.13 116.66 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.088 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.799 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 10.5 mmpt? -102.34 -173.47 2.34 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.221 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.1 m -44.04 -18.35 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 178.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 17' ' ' ILE . . . -70.71 60.39 0.93 Allowed Glycine 0 C--O 1.223 -0.562 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 166.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -68.27 -3.39 10.7 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 123.698 0.799 . . . . 0.0 113.148 -172.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.487 ' O ' HG12 ' A' ' 17' ' ' ILE . 25.6 m -116.81 143.76 45.3 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.571 -0.452 . . . . 0.0 109.83 -173.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.784 ' HB3' HG12 ' A' ' 25' ' ' VAL . 3.5 mm? -55.19 -47.42 75.28 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.739 0.649 . . . . 0.0 111.21 -172.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -67.23 -31.11 71.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.281 -175.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.423 ' HE2' ' HB ' ' A' ' 13' ' ' THR . 54.8 mtmt -72.0 -47.88 48.81 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.988 0.423 . . . . 0.0 110.763 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.538 HD11 HD11 ' A' ' 39' ' ' ILE . 4.3 pt -74.74 -38.13 44.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.921 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.424 ' HB2' HD22 ' A' ' 28' ' ' LEU . . . -57.3 -48.42 78.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.088 0.47 . . . . 0.0 110.865 177.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.2 -24.45 64.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.756 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -60.35 -47.45 86.02 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.508 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -104.88 12.99 31.88 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.911 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.13 48.78 37.37 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.701 170.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.408 HG21 ' OD1' ' A' ' 27' ' ' ASN . 1.3 p -131.61 171.25 18.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.46 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 48.0 t -88.1 145.33 26.0 Favored 'General case' 0 C--O 1.251 1.159 0 CA-C-O 122.433 1.111 . . . . 0.0 111.662 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.784 HG12 ' HB3' ' A' ' 14' ' ' LEU . 21.1 t -61.3 -32.28 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 114.141 -1.391 . . . . 0.0 109.679 175.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.89 -46.77 83.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.761 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.46 ' OD1' ' HB3' ' A' ' 24' ' ' SER . 1.8 p-10 -67.13 -46.3 74.55 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.48 -177.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.816 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 2.3 pp -70.61 -31.18 68.06 Favored 'General case' 0 C--O 1.228 -0.067 0 C-N-CA 118.514 -1.274 . . . . 0.0 112.197 -177.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.491 ' HD3' HG13 ' A' ' 25' ' ' VAL . 25.6 mtp-105 -64.66 -36.45 84.29 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 122.137 -0.352 . . . . 0.0 111.144 173.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.1 t -73.22 -46.55 49.63 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -171.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.816 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -83.56 -5.49 59.19 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.721 -176.184 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -98.35 -15.58 19.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.9 0.381 . . . . 0.0 110.205 172.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.43 39.17 87.4 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.009 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 65.7 mt -93.63 127.67 45.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.045 0.45 . . . . 0.0 110.83 -177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.2 t -107.15 108.74 20.33 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.27 -151.56 17.76 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.299 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -117.02 21.7 13.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.359 0.6 . . . . 0.0 110.194 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.493 ' O ' HD12 ' A' ' 38' ' ' LEU . 1.5 pp -73.74 101.85 3.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.798 0.809 . . . . 0.0 111.841 -176.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.538 HD11 HD11 ' A' ' 17' ' ' ILE . 1.5 mt -139.63 123.19 18.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.425 176.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -127.26 151.3 48.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.373 -173.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 57.3 t -59.81 139.7 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.552 -175.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.96 -21.64 44.98 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.43 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.425 ' O ' HG21 ' A' ' 8' ' ' VAL . 21.5 tt0 -73.03 127.35 32.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.603 0.239 . . . . 0.0 110.734 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -85.86 106.47 17.09 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 171.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.577 HD22 HG22 ' A' ' 8' ' ' VAL . 4.6 pp -101.42 140.35 35.83 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.491 ' HB ' ' CD1' ' A' ' 31' ' ' TRP . 50.3 mm -63.71 135.21 28.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.413 0.625 . . . . 0.0 110.817 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.595 ' O ' ' HB ' ' A' ' 4' ' ' THR . 7.6 p -149.44 120.76 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.351 171.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.521 ' HB3' ' HA ' ' A' ' 3' ' ' ASN . 51.9 pttt -147.71 132.27 17.75 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.872 -0.517 . . . . 0.0 111.617 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.53 112.87 16.06 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.25 -11.58 23.55 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.622 -175.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.39 -179.478 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.614 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -82.54 83.9 7.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.929 0.395 . . . . 0.0 111.32 -175.547 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -147.49 104.87 3.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.865 174.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.733 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 92.4 m -107.1 154.63 20.87 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 173.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -130.26 145.38 51.75 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.293 172.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -117.68 115.59 25.37 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.205 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.03 117.29 8.16 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 169.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.568 HG23 HD23 ' A' ' 45' ' ' LEU . 74.7 t -56.75 118.28 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.568 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.802 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 10.1 mmpt? -99.85 -173.21 2.39 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.035 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.1 t -42.82 -17.77 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.897 ' HA2' ' HE3' ' A' ' 16' ' ' LYS . . . -74.18 61.88 2.2 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 167.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -66.4 -3.56 6.32 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -173.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.551 ' O ' HG12 ' A' ' 17' ' ' ILE . 2.8 m -115.8 143.89 44.76 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.002 -170.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.65 ' HB3' HG11 ' A' ' 25' ' ' VAL . 4.0 mm? -55.52 -50.02 71.08 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.228 -171.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -69.47 -29.9 67.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.904 -175.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.897 ' HE3' ' HA2' ' A' ' 11' ' ' GLY . 32.2 ttpt -72.34 -47.48 49.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.956 -176.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 13' ' ' THR . 5.1 pt -74.68 -39.57 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.813 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.02 -49.0 77.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.002 0.43 . . . . 0.0 110.864 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.27 -22.17 61.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.74 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -64.96 -47.7 76.67 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.65 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.415 ' CE1' HG21 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -108.03 11.32 27.85 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -178.64 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.4 48.62 7.28 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.282 169.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.402 HG21 ' N ' ' A' ' 24' ' ' SER . 14.8 p -134.7 160.21 41.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 172.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.572 ' HB2' ' OD1' ' A' ' 27' ' ' ASN . 66.8 m -90.66 149.15 22.2 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.782 0.801 . . . . 0.0 111.083 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' A' ' 14' ' ' LEU . 14.5 t -59.08 -36.4 62.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.626 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.66 -48.07 82.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.902 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.572 ' OD1' ' HB2' ' A' ' 24' ' ' SER . 0.3 OUTLIER -75.37 -36.0 61.01 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -176.601 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.885 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 3.0 pp -71.14 -30.65 66.74 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 118.046 -1.462 . . . . 0.0 111.607 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.404 ' N ' HD13 ' A' ' 28' ' ' LEU . 77.8 mtt180 -59.71 -44.78 93.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.819 0.342 . . . . 0.0 110.906 171.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 64.8 m -69.8 -43.94 71.05 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -171.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.885 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -82.18 -4.05 56.22 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.533 -178.477 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -100.03 -13.31 19.1 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.677 174.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.74 34.96 91.2 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.242 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.9 mt -82.4 126.0 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.861 0.362 . . . . 0.0 110.877 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.6 t -97.08 108.92 21.75 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 170.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.27 -168.02 22.9 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -115.5 60.34 0.71 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 117.297 0.549 . . . . 0.0 110.501 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.471 ' O ' HD12 ' A' ' 38' ' ' LEU . 1.8 pp -94.14 107.54 19.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.717 0.77 . . . . 0.0 110.775 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.477 HD13 HD11 ' A' ' 17' ' ' ILE . 3.0 mt -139.46 120.01 14.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.967 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.458 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 19.5 p90 -134.63 154.81 51.33 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.406 -175.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 41.8 t -63.08 132.31 28.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.272 -173.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.7 -20.93 40.18 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.419 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.41 ' O ' HG22 ' A' ' 8' ' ' VAL . 23.0 tt0 -71.27 127.19 31.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.441 0.162 . . . . 0.0 110.572 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -81.9 107.37 14.57 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 171.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.568 HD23 HG23 ' A' ' 8' ' ' VAL . 4.2 pp -105.47 134.36 48.7 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 175.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.459 ' N ' HD13 ' A' ' 46' ' ' ILE . 1.9 mp -62.45 136.58 25.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.733 ' O ' ' HB ' ' A' ' 4' ' ' THR . 7.7 p -145.59 125.94 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.614 ' HD3' ' O ' ' A' ' 2' ' ' THR . 36.6 pttt -146.65 116.97 7.41 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.091 175.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -79.41 108.13 12.7 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 147.8 83.87 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -175.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.2 m . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.733 -0.651 . . . . 0.0 109.833 178.485 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.581 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.5 m -61.93 -42.29 98.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.913 0.387 . . . . 0.0 110.909 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -95.16 142.8 27.18 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 172.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.735 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 47.7 m -114.01 151.3 32.61 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.496 ' HB3' HD12 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -132.11 153.95 49.96 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 121.772 -0.58 . . . . 0.0 110.296 174.177 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.48 ' OH ' ' HB2' ' A' ' 9' ' ' LYS . 1.4 t80 -145.94 142.41 28.69 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.045 -173.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.39 121.27 28.71 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 174.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.521 HG22 HG22 ' A' ' 39' ' ' ILE . 95.0 t -56.91 125.47 12.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.556 -175.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.628 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -92.15 -173.81 3.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.955 176.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.6 m -43.87 -17.69 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.711 ' HA2' ' HE2' ' A' ' 16' ' ' LYS . . . -75.26 52.59 2.62 Favored Glycine 0 C--O 1.222 -0.622 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 168.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -57.58 -3.43 0.19 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -169.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.9 m -114.77 149.36 37.06 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 121.301 -0.875 . . . . 0.0 109.236 -173.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.791 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 0.7 OUTLIER -53.92 -47.27 71.36 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.605 0.566 . . . . 0.0 110.612 -171.821 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -69.23 -29.18 67.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.056 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.711 ' HE2' ' HA2' ' A' ' 11' ' ' GLY . 60.0 mtpt -71.06 -48.7 51.13 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.522 -178.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.686 HG23 ' O ' ' A' ' 11' ' ' GLY . 4.9 pt -74.31 -41.63 50.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.66 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.23 -49.36 76.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 0.0 111.146 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.38 -22.56 60.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.743 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.509 ' HA ' ' OE1' ' A' ' 20' ' ' GLN . 5.7 tp60 -68.13 -47.26 68.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.478 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.558 ' HE1' HG12 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -100.93 2.79 41.12 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.765 178.664 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.33 48.92 7.1 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.92 -0.657 . . . . 0.0 114.479 169.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.575 HG23 ' OD1' ' A' ' 27' ' ' ASN . 3.0 p -122.74 162.83 22.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 170.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.0 t -74.94 146.5 41.72 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.853 0.835 . . . . 0.0 111.241 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.682 HG11 HD12 ' A' ' 14' ' ' LEU . 91.2 t -58.91 -35.76 58.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.169 172.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.47 -46.61 69.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.233 -175.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.575 ' OD1' HG23 ' A' ' 23' ' ' VAL . 6.9 p30 -74.87 -43.58 53.64 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.491 -174.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.785 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -68.43 -31.99 71.7 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.834 -178.004 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.615 ' HE ' ' HG ' ' A' ' 14' ' ' LEU . 96.5 mtt180 -66.99 -35.81 80.78 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.887 172.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.6 t -64.38 -45.26 88.48 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -172.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.785 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER -89.02 -2.12 58.43 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.148 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.491 ' HB3' HG12 ' A' ' 34' ' ' ILE . 46.4 m-80 -107.19 -23.53 12.24 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.29 176.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.01 38.61 76.29 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -172.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.491 HG12 ' HB3' ' A' ' 32' ' ' ASN . 15.3 mm -114.42 130.12 69.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.142 0.496 . . . . 0.0 111.815 -171.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.535 ' HB2' HD23 ' A' ' 38' ' ' LEU . 8.2 m -79.06 118.1 20.73 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 169.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.791 ' HA3' ' HB2' ' A' ' 14' ' ' LEU . . . -63.19 -0.88 3.56 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-N 116.229 -0.442 . . . . 0.0 114.151 -175.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -74.59 -37.7 62.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.793 0.33 . . . . 0.0 110.482 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.535 HD23 ' HB2' ' A' ' 35' ' ' SER . 0.4 OUTLIER -96.78 35.56 1.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.034 0.445 . . . . 0.0 111.326 -179.359 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.521 HG22 HG22 ' A' ' 8' ' ' VAL . 14.1 mt -96.47 136.61 26.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 175.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -142.28 171.04 14.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.011 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 61.0 t -64.74 128.63 27.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.59 -10.27 60.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.005 -177.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -61.47 127.99 34.13 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 122.44 0.296 . . . . 0.0 110.427 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -92.73 107.21 19.04 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.743 HD21 HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -124.17 140.61 52.8 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.16 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.496 HD12 ' HB3' ' A' ' 5' ' ' TYR . 49.6 mm -70.3 131.51 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.198 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.735 ' O ' ' HB ' ' A' ' 4' ' ' THR . 11.3 p -136.95 123.49 29.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 122.46 1.124 . . . . 0.0 109.36 173.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -135.64 136.79 41.25 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.705 175.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -79.05 106.22 10.93 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.287 0.565 . . . . 0.0 111.218 -174.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -124.44 20.8 6.9 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 172.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.2 m . . . . . 0 C--O 1.246 0.892 0 CA-C-N 114.561 -0.819 . . . . 0.0 109.097 -178.168 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.933 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.0 m -85.41 68.06 10.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.659 0.742 . . . . 0.0 110.151 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.402 ' OD1' ' HD3' ' A' ' 48' ' ' LYS . 24.9 t30 -104.89 113.06 26.43 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.695 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 83.6 m -99.31 157.27 16.51 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -127.42 150.91 49.42 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.621 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CE2' ' HA ' ' A' ' 8' ' ' VAL . 55.7 t80 -117.23 120.77 39.26 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.979 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.57 111.82 5.65 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.06 0.457 . . . . 0.0 109.974 170.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 68.7 t -57.34 127.81 16.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.812 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.28 -174.05 2.38 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.9 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.1 m -41.16 -26.47 0.05 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -173.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.648 ' O ' HG21 ' A' ' 17' ' ' ILE . . . -76.79 59.55 3.43 Favored Glycine 0 C--O 1.225 -0.465 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 170.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -59.27 -1.3 0.19 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -171.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.486 ' O ' HG12 ' A' ' 17' ' ' ILE . 2.3 m -112.69 147.98 35.65 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.515 -0.741 . . . . 0.0 110.383 -168.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -54.45 -48.1 72.14 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.875 -169.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -62.32 -36.56 82.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.016 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 29.1 mmmt -73.56 -47.29 41.82 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.283 -173.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.648 HG21 ' O ' ' A' ' 11' ' ' GLY . 6.9 pt -74.69 -41.52 47.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -177.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.72 -49.86 76.1 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.125 0.266 . . . . 0.0 111.196 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.02 -23.71 62.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.077 0.465 . . . . 0.0 110.335 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 9.7 tt0 -59.96 -46.81 88.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.172 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.414 ' CE1' HG22 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -106.27 13.6 28.59 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.737 179.344 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.19 49.06 17.2 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.645 171.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.681 HG22 ' OD1' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -131.38 175.72 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.208 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.682 ' HB2' HD22 ' A' ' 27' ' ' ASN . 47.7 m -110.86 152.15 27.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.407 0.622 . . . . 0.0 111.699 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.4 HG12 ' HD2' ' A' ' 29' ' ' ARG . 43.8 t -57.73 -40.02 73.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.769 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.31 -47.04 86.87 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.312 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.682 HD22 ' HB2' ' A' ' 24' ' ' SER . 0.4 OUTLIER -71.7 -41.89 68.04 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -176.044 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.871 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 3.2 pp -69.14 -32.33 71.61 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 118.331 -1.348 . . . . 0.0 111.79 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.41 ' N ' HD12 ' A' ' 28' ' ' LEU . 32.0 mtp-105 -63.85 -33.7 76.28 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.055 172.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.8 t -68.8 -45.05 72.26 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.35 -174.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.871 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER -90.72 -2.56 57.81 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.096 -178.486 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -95.0 -22.09 18.17 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.825 174.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.61 14.23 77.79 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.766 175.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.97 161.86 28.11 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 CA-C-O 121.286 0.565 . . . . 0.0 111.622 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.4 t -79.48 141.8 36.42 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 171.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.31 51.43 3.28 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.704 -176.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -101.4 -42.21 6.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.195 0.521 . . . . 0.0 109.652 177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.708 ' H ' HD22 ' A' ' 38' ' ' LEU . 1.4 pt? -96.36 96.96 9.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.088 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.619 HG22 HG23 ' A' ' 8' ' ' VAL . 4.3 mt -139.68 117.39 10.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 171.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.584 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 50.0 p90 -144.41 166.88 23.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.156 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 46.2 t -60.4 129.23 22.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.293 -177.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.77 -15.29 59.78 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.382 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.445 ' OE1' ' HA ' ' A' ' 39' ' ' ILE . 44.2 tt0 -75.28 129.47 37.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.544 0.212 . . . . 0.0 111.076 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -92.11 107.34 19.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.812 0.339 . . . . 0.0 110.237 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.645 HD23 HD12 ' A' ' 17' ' ' ILE . 3.4 pp -109.65 138.58 45.82 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 175.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.429 HD12 ' N ' ' A' ' 46' ' ' ILE . 1.8 mp -65.49 139.35 21.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.063 0.459 . . . . 0.0 110.371 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.695 ' O ' ' HB ' ' A' ' 4' ' ' THR . 11.3 p -149.1 129.13 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 172.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.402 ' HD3' ' OD1' ' A' ' 3' ' ' ASN . 63.3 pttt -151.02 155.77 39.73 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.318 0.58 . . . . 0.0 112.223 175.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -112.5 131.25 55.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.795 172.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 136.85 -112.77 0.97 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.128 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.4 t . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.607 -0.711 . . . . 0.0 109.669 -178.862 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.635 0 N-CA-C 111.876 -0.49 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.8 m -131.15 125.09 32.15 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.647 0.261 . . . . 0.0 110.451 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -74.04 149.55 41.14 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.703 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 58.0 m -109.54 155.54 21.26 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.617 ' HB3' HD11 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -131.31 139.68 49.62 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.184 0.516 . . . . 0.0 110.674 173.435 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -121.0 141.53 50.65 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.113 -173.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.476 ' O ' ' HG2' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -87.87 120.75 29.5 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.979 171.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.742 HG22 HG22 ' A' ' 39' ' ' ILE . 57.5 t -57.35 127.25 16.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.135 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 7' ' ' THR . 66.1 mmtt -129.72 -178.07 4.54 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.5 m -42.95 125.55 3.55 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.357 0.599 . . . . 0.0 110.11 177.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 17' ' ' ILE . . . 104.52 29.58 5.29 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 108.561 -1.816 . . . . 0.0 108.561 -158.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.498 ' O ' HG23 ' A' ' 39' ' ' ILE . 4.3 p30 -59.84 0.09 0.17 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.454 1.502 . . . . 0.0 114.675 -169.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.515 ' O ' HG12 ' A' ' 17' ' ' ILE . 5.8 m -112.22 145.36 40.05 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 121.571 -0.705 . . . . 0.0 110.19 -172.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.0 mp -53.99 -46.48 71.72 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.04 -166.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -61.72 -36.37 80.75 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.929 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 68.5 mttm -73.79 -47.17 40.78 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.851 -176.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 11' ' ' GLY . 2.4 pt -73.28 -42.92 57.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.537 -178.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.546 ' HA ' ' CE1' ' A' ' 21' ' ' TYR . . . -58.45 -49.02 78.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.039 0.447 . . . . 0.0 111.23 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.83 -22.25 60.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.683 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 35.8 tt0 -64.54 -47.51 78.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.032 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.546 ' CE1' ' HA ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -96.85 -0.3 48.05 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.456 177.45 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.58 48.44 7.28 Favored Glycine 0 N--CA 1.453 -0.17 0 C-N-CA 120.894 -0.67 . . . . 0.0 114.062 171.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.658 HG21 ' OD1' ' A' ' 27' ' ' ASN . 1.1 p -126.82 164.36 27.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 172.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.645 ' HB2' HD22 ' A' ' 27' ' ' ASN . 4.4 m -91.35 145.34 24.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.237 0.542 . . . . 0.0 111.338 -175.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.504 HG11 ' HD3' ' A' ' 29' ' ' ARG . 38.4 t -55.68 -34.73 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.458 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.54 -47.64 78.06 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -177.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.658 ' OD1' HG21 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -71.93 -46.35 57.91 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -176.094 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.823 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -66.27 -31.21 71.88 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.722 -177.214 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.504 ' HD3' HG11 ' A' ' 25' ' ' VAL . 27.9 mtp180 -66.44 -38.73 88.04 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.239 -0.288 . . . . 0.0 111.315 172.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 66.9 m -67.5 -45.43 75.83 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -171.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.823 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -81.74 -6.42 59.03 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.287 -176.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -94.74 -21.48 18.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.914 0.387 . . . . 0.0 109.958 174.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.76 43.5 99.07 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.09 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.415 ' H ' HD12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -104.94 146.56 11.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.529 177.284 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.7 m -101.78 109.55 21.34 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.179 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.38 -164.29 12.06 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.154 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -116.94 32.86 5.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.963 0.411 . . . . 0.0 110.736 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.33 101.87 4.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.779 0.8 . . . . 0.0 111.419 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.742 HG22 HG22 ' A' ' 8' ' ' VAL . 4.7 mt -139.94 123.57 18.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.46 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.477 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 51.5 p90 -136.38 159.8 40.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.713 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 50.2 t -62.73 129.62 26.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.071 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.89 -20.54 40.86 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.603 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.452 ' NE2' ' HA ' ' A' ' 39' ' ' ILE . 29.4 tt0 -71.78 127.74 33.55 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -94.42 107.63 19.59 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.418 ' C ' HD21 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -115.8 140.55 49.11 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -176.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.617 HD11 ' HB3' ' A' ' 5' ' ' TYR . 49.7 mm -66.17 135.53 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.798 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.703 ' O ' ' HB ' ' A' ' 4' ' ' THR . 13.9 p -147.33 124.63 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 122.072 0.939 . . . . 0.0 110.017 173.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.442 ' O ' ' HH2' ' A' ' 31' ' ' TRP . 57.8 tptt -136.07 124.57 23.53 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.669 171.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -72.56 107.55 5.14 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.254 0.55 . . . . 0.0 110.796 -173.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -117.18 31.21 5.93 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.173 176.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.4 m . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.701 -0.666 . . . . 0.0 109.51 -178.785 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.602 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.6 m -75.24 -57.14 4.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.967 0.413 . . . . 0.0 110.29 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.687 ' HA ' ' HD2' ' A' ' 48' ' ' LYS . 12.6 m120 -83.9 177.47 8.3 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.785 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 34.9 m -115.54 153.51 31.05 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 171.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -131.65 150.04 52.29 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.542 170.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -138.53 139.91 38.9 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.175 -171.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.72 123.67 29.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 173.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.63 HG22 HG21 ' A' ' 39' ' ' ILE . 58.8 t -56.74 116.2 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 123.717 0.635 . . . . 0.0 110.036 -177.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.664 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -103.36 -177.71 3.45 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.331 -177.708 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.3 p -42.98 112.7 0.39 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.495 0.664 . . . . 0.0 109.819 172.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.705 ' O ' HG23 ' A' ' 17' ' ' ILE . . . 123.14 34.44 0.77 Allowed Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -164.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.414 ' O ' HG22 ' A' ' 39' ' ' ILE . 10.4 p-10 -52.93 -2.64 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -170.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.426 ' OG1' ' HE2' ' A' ' 16' ' ' LYS . 2.6 m -114.13 154.31 28.02 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 121.156 -0.965 . . . . 0.0 109.99 -171.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.699 HD12 ' HA3' ' A' ' 36' ' ' GLY . 48.4 mt -53.39 -48.16 68.88 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 123.573 0.545 . . . . 0.0 111.755 -170.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -62.26 -37.07 84.06 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.24 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.426 ' HE2' ' OG1' ' A' ' 13' ' ' THR . 59.7 mtmt -74.3 -47.69 33.16 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.085 -174.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.705 HG23 ' O ' ' A' ' 11' ' ' GLY . 12.1 pt -72.88 -45.22 56.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.467 -177.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.462 ' HB1' HD22 ' A' ' 28' ' ' LEU . . . -58.54 -49.59 76.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.784 0.325 . . . . 0.0 111.578 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.16 -22.78 63.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.658 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.424 HE21 ' CA ' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -61.95 -47.12 86.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.935 177.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.618 ' HH ' ' HB ' ' A' ' 17' ' ' ILE . 0.3 OUTLIER -107.38 13.56 26.87 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.209 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.512 ' O ' ' HE2' ' A' ' 49' ' ' LYS . . . 78.44 31.48 45.87 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.988 -0.625 . . . . 0.0 114.43 168.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.467 ' CG1' HD23 ' A' ' 28' ' ' LEU . 10.9 p -114.68 159.84 14.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.497 ' HB2' ' OD1' ' A' ' 27' ' ' ASN . 19.2 m -93.69 153.33 18.41 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-O 121.59 0.71 . . . . 0.0 110.735 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.8 t -56.86 -38.92 61.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.862 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.86 -48.32 81.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -175.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.497 ' OD1' ' HB2' ' A' ' 24' ' ' SER . 1.6 p-10 -75.55 -34.34 60.72 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -175.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.874 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 3.9 pp -71.69 -31.75 67.11 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 118.221 -1.392 . . . . 0.0 111.107 177.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.485 ' N ' HD11 ' A' ' 28' ' ' LEU . 75.0 mtp180 -64.37 -34.68 78.72 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.636 173.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 52.0 m -71.22 -44.91 64.44 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -173.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.874 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -84.55 -2.53 57.5 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.137 -178.411 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.477 ' HB3' ' CG1' ' A' ' 34' ' ' ILE . 26.7 m-80 -100.04 -22.32 15.27 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.475 174.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.08 33.97 81.78 Favored Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -169.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.477 ' CG1' ' HB3' ' A' ' 32' ' ' ASN . 19.3 mm -119.18 126.54 75.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.327 -0.436 . . . . 0.0 111.543 -170.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -72.66 113.47 9.73 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 166.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.699 ' HA3' HD12 ' A' ' 14' ' ' LEU . . . -68.01 6.97 2.61 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 114.552 0.581 . . . . 0.0 114.552 -170.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.1 -33.92 75.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.148 0.499 . . . . 0.0 110.155 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.436 HD13 HG22 ' A' ' 34' ' ' ILE . 1.9 pp -96.24 38.44 1.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.149 -176.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.63 HG21 HG22 ' A' ' 8' ' ' VAL . 5.2 mt -92.95 132.49 37.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.974 0.416 . . . . 0.0 110.166 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -149.35 161.36 42.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.488 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 97.1 t -61.41 129.98 24.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.318 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.36 -20.8 36.67 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.979 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.508 ' OE1' ' HA ' ' A' ' 39' ' ' ILE . 27.4 tt0 -70.28 132.45 45.72 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.425 -0.388 . . . . 0.0 110.508 177.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.789 ' HB3' ' HZ3' ' A' ' 44' ' ' LYS . 2.4 ttpm? -97.15 107.36 19.87 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.82 143.34 45.54 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 -178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.8 mp -67.42 136.28 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.952 0.406 . . . . 0.0 110.718 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.785 ' O ' ' HB ' ' A' ' 4' ' ' THR . 7.9 p -150.58 129.31 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-O 121.606 0.717 . . . . 0.0 109.266 173.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.687 ' HD2' ' HA ' ' A' ' 3' ' ' ASN . 54.8 tttm -139.93 121.76 15.48 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.584 -0.697 . . . . 0.0 110.861 171.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.512 ' HE2' ' O ' ' A' ' 22' ' ' GLY . 5.4 tmtt? -82.95 108.79 16.53 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.18 83.43 1.71 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.786 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.7 m . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.645 177.872 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.717 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.6 p -80.68 73.33 7.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.71 0.766 . . . . 0.0 109.886 174.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -84.56 162.84 19.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.082 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.507 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 49.4 m -99.51 155.79 17.38 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.685 ' HB3' HD13 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -130.18 139.28 50.87 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.136 0.493 . . . . 0.0 109.859 173.111 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.403 ' CE2' ' HA ' ' A' ' 8' ' ' VAL . 10.1 t80 -123.11 137.42 54.92 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.329 -172.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.441 ' O ' ' HG2' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -83.9 119.7 25.2 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.08 172.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.715 HG21 HG23 ' A' ' 39' ' ' ILE . 61.3 t -56.68 123.15 7.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.426 -176.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 7' ' ' THR . 28.0 mmtp -116.93 -176.05 2.9 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.646 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.4 m -41.12 113.47 0.39 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.61 0.719 . . . . 0.0 110.341 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.652 ' O ' HG23 ' A' ' 17' ' ' ILE . . . 119.02 37.81 0.79 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 -163.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.404 ' O ' HG21 ' A' ' 39' ' ' ILE . 4.1 p30 -53.79 -1.88 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.578 1.551 . . . . 0.0 114.998 -172.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.412 ' H ' ' C ' ' A' ' 11' ' ' GLY . 8.3 m -114.12 152.59 30.88 Favored 'General case' 0 C--N 1.309 -1.152 0 O-C-N 121.439 -0.788 . . . . 0.0 110.01 -169.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.603 HD22 HG13 ' A' ' 25' ' ' VAL . 52.9 mt -53.11 -46.61 68.8 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.977 -171.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -62.11 -36.94 83.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -73.87 -48.88 27.89 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.718 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.652 HG23 ' O ' ' A' ' 11' ' ' GLY . 14.3 pt -74.37 -44.68 48.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.762 -176.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.445 ' HA ' ' CE1' ' A' ' 21' ' ' TYR . . . -59.79 -48.84 80.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.891 0.377 . . . . 0.0 111.189 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.06 -21.88 62.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.851 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -63.38 -46.71 85.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.262 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.445 ' CE1' ' HA ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -99.71 6.05 45.62 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.101 0.477 . . . . 0.0 111.221 176.192 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.28 48.33 11.17 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.854 -0.612 . . . . 0.0 114.125 170.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.436 HG13 ' HE1' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -131.11 168.43 23.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 173.565 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.459 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 47.6 t -91.59 146.86 23.44 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 122.368 1.08 . . . . 0.0 112.032 -176.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.603 HG13 HD22 ' A' ' 14' ' ' LEU . 60.7 t -59.29 -32.11 47.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.341 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.06 83.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.44 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.49 ' HB2' ' CH2' ' A' ' 31' ' ' TRP . 1.3 p-10 -68.4 -45.1 73.58 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.666 -177.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.764 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 2.8 pp -67.92 -32.13 72.38 Favored 'General case' 0 C--O 1.227 -0.12 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.404 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.534 ' HD2' HG11 ' A' ' 25' ' ' VAL . 36.0 mtt-85 -61.81 -34.6 76.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.77 0.319 . . . . 0.0 110.97 172.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.7 t -71.28 -45.49 63.02 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.764 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 1.0 OUTLIER -89.2 -1.78 58.23 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -176.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -95.15 -21.58 18.41 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.414 174.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.51 21.79 72.79 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.113 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 20.5 mt -130.09 146.31 34.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 37' ' ' ASP . 16.4 m -68.21 108.79 3.3 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 166.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.421 ' O ' HG13 ' A' ' 39' ' ' ILE . . . -69.17 10.54 1.73 Allowed Glycine 0 C--O 1.228 -0.253 0 C-N-CA 121.395 -0.431 . . . . 0.0 113.928 -173.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 35' ' ' SER . 6.9 m-20 -60.7 -36.79 79.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.939 0.399 . . . . 0.0 110.437 178.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.594 HD21 ' H ' ' A' ' 38' ' ' LEU . 0.7 OUTLIER -96.72 90.51 5.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.744 176.416 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.715 HG23 HG21 ' A' ' 8' ' ' VAL . 5.7 mt -123.0 134.31 66.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.0 176.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -137.14 160.9 37.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.563 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 61.9 t -65.04 128.78 28.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.488 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.75 -15.49 48.72 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.204 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.477 ' NE2' HG12 ' A' ' 39' ' ' ILE . 24.5 tt0 -75.45 127.85 34.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.758 0.313 . . . . 0.0 110.265 177.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -89.6 107.18 18.94 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.99 140.88 48.68 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.685 HD13 ' HB3' ' A' ' 5' ' ' TYR . 42.8 mm -68.23 137.45 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.281 -176.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.507 ' O ' ' HB ' ' A' ' 4' ' ' THR . 8.5 p -146.76 112.68 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.625 0.726 . . . . 0.0 110.48 173.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.461 ' HB2' ' H ' ' A' ' 4' ' ' THR . 58.3 tptt 178.51 118.21 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.955 169.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -88.85 112.73 23.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.365 -176.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.62 114.99 3.46 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.353 172.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.343 -0.837 . . . . 0.0 109.482 173.151 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.469 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 89.5 m -82.98 110.78 18.25 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.847 0.356 . . . . 0.0 110.657 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.453 ' HA ' ' HB3' ' A' ' 48' ' ' LYS . 3.6 p-10 -57.68 119.78 7.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.858 176.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.633 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 57.1 m -108.62 157.91 18.07 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -175.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.442 ' HB2' ' HG3' ' A' ' 44' ' ' LYS . 0.9 OUTLIER -130.85 150.0 52.22 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.101 0.476 . . . . 0.0 109.906 171.048 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.436 ' CE2' ' HA ' ' A' ' 8' ' ' VAL . 1.2 t80 -129.31 139.92 51.59 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.833 -175.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.438 HG21 ' HD3' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -82.99 120.94 26.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.142 173.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.655 HG23 HG23 ' A' ' 39' ' ' ILE . 57.8 t -56.14 124.92 10.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.132 -177.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.665 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -95.23 -175.09 3.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.498 -178.297 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.7 m -57.56 68.41 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.918 0.866 . . . . 0.0 110.849 171.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.603 ' O ' HG22 ' A' ' 17' ' ' ILE . . . -175.03 45.66 0.13 Allowed Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 107.847 -2.101 . . . . 0.0 107.847 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -52.58 -0.26 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.57 1.948 . . . . 0.0 115.406 -170.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.429 ' H ' ' C ' ' A' ' 11' ' ' GLY . 14.8 m -113.13 147.22 37.79 Favored 'General case' 0 C--N 1.311 -1.081 0 O-C-N 121.364 -0.835 . . . . 0.0 109.694 -171.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.697 HD11 ' HA3' ' A' ' 36' ' ' GLY . 54.6 mt -53.74 -47.33 70.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.116 -168.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -66.64 -30.25 70.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.968 -176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -74.13 -47.8 33.68 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.013 0.435 . . . . 0.0 111.05 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.603 HG22 ' O ' ' A' ' 11' ' ' GLY . 11.3 pt -74.61 -40.35 47.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.605 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.406 ' HA ' ' CE1' ' A' ' 21' ' ' TYR . . . -58.02 -49.26 77.47 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.0 0.429 . . . . 0.0 111.232 177.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.93 -23.03 63.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.758 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -60.81 -41.82 96.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.502 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.426 ' CE1' HG23 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -107.19 8.17 29.87 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.697 177.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.4 48.16 11.3 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.726 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.412 HG11 ' HE1' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -133.11 172.58 16.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.4 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -97.34 147.32 24.29 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-O 122.297 1.046 . . . . 0.0 111.574 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.529 HG12 ' HD2' ' A' ' 29' ' ' ARG . 88.2 t -56.74 -35.92 47.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.361 176.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.12 -45.66 87.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.141 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -64.67 -46.17 83.59 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.978 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.814 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 3.4 pp -69.02 -29.49 67.67 Favored 'General case' 0 CA--C 1.523 -0.083 0 C-N-CA 118.719 -1.192 . . . . 0.0 110.853 178.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.529 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -54.54 -41.43 69.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.034 0.445 . . . . 0.0 110.443 171.117 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.6 m -75.9 -44.01 42.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.883 -170.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.814 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -91.38 -1.5 57.58 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -173.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.454 ' HB3' HG13 ' A' ' 34' ' ' ILE . 17.3 m-80 -94.81 -24.19 17.17 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.319 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.86 24.77 71.63 Favored Glycine 0 C--N 1.329 0.144 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.98 176.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.454 HG13 ' HB3' ' A' ' 32' ' ' ASN . 0.1 OUTLIER -130.01 161.91 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-O 121.003 0.43 . . . . 0.0 111.629 179.25 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.2 m -68.35 164.28 21.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.558 167.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.697 ' HA3' HD11 ' A' ' 14' ' ' LEU . . . -98.48 3.46 59.51 Favored Glycine 0 C--N 1.319 -0.399 0 C-N-CA 120.802 -0.714 . . . . 0.0 113.415 -172.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -79.93 -29.02 39.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.717 0.294 . . . . 0.0 110.553 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.666 ' H ' HD22 ' A' ' 38' ' ' LEU . 1.4 pt? -96.51 77.06 2.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.699 0.762 . . . . 0.0 111.201 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.655 HG23 HG23 ' A' ' 8' ' ' VAL . 4.9 mt -133.68 121.37 40.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 170.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.536 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 42.4 p90 -141.94 160.75 39.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.719 -176.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 54.0 t -56.56 128.87 17.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.935 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.76 -16.44 58.61 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.896 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.467 ' NE2' ' HA ' ' A' ' 39' ' ' ILE . 27.5 tt0 -74.96 137.94 41.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.852 0.326 . . . . 0.0 110.877 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.442 ' HG3' ' HB2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -95.32 107.72 19.86 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.834 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.0 147.08 42.62 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.5 mp -70.41 137.93 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.967 0.413 . . . . 0.0 111.271 -174.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.633 ' O ' ' HB ' ' A' ' 4' ' ' THR . 8.8 p -151.67 124.72 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.735 0.779 . . . . 0.0 109.302 171.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 3' ' ' ASN . 21.6 pttp -140.69 119.67 12.71 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.57 0.7 . . . . 0.0 111.411 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.15 158.04 33.68 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.158 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.36 43.86 60.97 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.47 177.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.52 -0.752 . . . . 0.0 109.913 177.195 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.401 ' HA ' ' HB3' ' A' ' 48' ' ' LYS . 25.4 m-80 . . . . . 0 CA--C 1.519 -0.217 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.635 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 54.8 m -109.29 84.98 2.01 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 46' ' ' ILE . 2.1 p90 -85.02 123.4 30.52 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.579 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.435 ' CE2' ' HA ' ' A' ' 8' ' ' VAL . 1.0 OUTLIER -117.89 135.82 53.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.117 -167.308 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.401 HG23 ' HD3' ' A' ' 44' ' ' LYS . 1.1 p -80.92 126.21 31.09 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 173.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.74 HG21 HG23 ' A' ' 39' ' ' ILE . 34.0 t -57.14 120.28 3.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.073 -176.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -175.32 2.73 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.35 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.2 t -41.72 114.67 0.55 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.531 0.681 . . . . 0.0 110.122 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.636 ' O ' HG23 ' A' ' 17' ' ' ILE . . . 124.35 31.54 0.9 Allowed Glycine 0 C--O 1.221 -0.718 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -164.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.459 ' O ' HG22 ' A' ' 39' ' ' ILE . 6.1 p-10 -52.93 -3.34 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -170.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.885 ' HB ' ' HD3' ' A' ' 16' ' ' LYS . 7.1 m -112.92 143.68 43.78 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 121.389 -0.819 . . . . 0.0 108.92 -173.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.497 HD11 HD11 ' A' ' 28' ' ' LEU . 54.8 tp -56.52 -47.26 79.73 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 123.569 0.543 . . . . 0.0 112.053 -166.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -65.86 -31.02 71.73 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.415 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.885 ' HD3' ' HB ' ' A' ' 13' ' ' THR . 36.0 mtpt -71.43 -47.39 56.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.286 -178.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 11' ' ' GLY . 1.8 pt -74.09 -37.96 47.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.56 0.219 . . . . 0.0 111.533 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.22 -50.01 74.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.031 0.443 . . . . 0.0 110.862 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.43 -22.5 60.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.654 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.551 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 30.7 tt0 -67.28 -47.8 69.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.371 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.428 ' CE2' ' HB ' ' A' ' 17' ' ' ILE . 3.5 p90 -107.56 13.27 26.91 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.56 49.62 6.55 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.604 -0.808 . . . . 0.0 114.635 167.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.2 p -133.36 143.91 37.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 173.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.504 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 47.0 t -70.38 147.26 49.75 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.526 0.679 . . . . 0.0 110.498 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 36.5 t -57.88 -33.01 44.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.039 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.49 -48.6 64.04 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -174.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.504 ' OD1' ' HB3' ' A' ' 24' ' ' SER . 9.2 p-10 -75.9 -40.46 54.33 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.379 -0.528 . . . . 0.0 112.248 -175.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.864 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -68.98 -31.6 70.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 118.378 -1.329 . . . . 0.0 109.442 -178.37 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -65.04 -35.17 80.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.012 171.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 66.1 m -64.25 -43.96 93.27 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -174.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.864 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.9 OUTLIER -88.33 -2.6 58.69 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.117 -0.633 . . . . 0.0 112.682 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 . . . . . 0 N--CA 1.467 0.387 0 O-C-N 122.1 -0.375 . . . . 0.0 111.472 175.775 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.74 HG23 HG21 ' A' ' 8' ' ' VAL . 22.3 mt . . . . . 0 N--CA 1.445 -0.681 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -149.95 158.17 43.9 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 89.5 t -59.51 126.93 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 123.247 0.342 . . . . 0.0 110.77 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.45 -21.01 35.98 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.529 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.439 ' O ' HG23 ' A' ' 8' ' ' VAL . 46.4 tt0 -65.33 134.71 54.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.401 ' HD3' HG23 ' A' ' 7' ' ' THR . 13.7 tptm -92.31 107.72 19.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.917 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.571 HD23 HG22 ' A' ' 8' ' ' VAL . 2.8 pp -119.82 139.34 52.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.061 0.458 . . . . 0.0 110.517 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.477 ' N ' HD12 ' A' ' 46' ' ' ILE . 2.8 mp -76.3 137.45 22.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.148 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.635 ' O ' ' HB ' ' A' ' 4' ' ' THR . 11.2 p -144.6 115.78 2.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.748 0.785 . . . . 0.0 109.378 166.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.547 ' HD2' ' O ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.8 0 O-C-N 121.535 -0.728 . . . . 0.0 112.578 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.949 0.404 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.702 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 96.4 m -112.91 154.12 26.88 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.622 ' HB3' HD13 ' A' ' 46' ' ' ILE . 1.8 p90 -130.84 145.66 52.05 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 169.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.401 ' HD2' HD11 ' A' ' 45' ' ' LEU . 58.7 t80 -116.84 132.67 56.64 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.86 -173.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.41 116.24 19.52 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 168.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.757 HG21 HG23 ' A' ' 39' ' ' ILE . 59.7 t -58.12 125.37 14.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.388 -177.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 25.0 mmtt -103.83 -174.22 2.49 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.06 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.5 m -42.25 -26.6 0.11 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -173.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.478 ' O ' HG23 ' A' ' 17' ' ' ILE . . . -76.67 66.81 2.68 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 168.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.479 ' O ' HG22 ' A' ' 39' ' ' ILE . 3.5 p30 -63.32 -3.1 1.73 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -168.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.503 ' O ' HG12 ' A' ' 17' ' ' ILE . 1.9 m -113.59 143.48 44.49 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 119.064 -1.055 . . . . 0.0 110.067 -167.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.639 HD11 HD11 ' A' ' 28' ' ' LEU . 14.3 tp -55.91 -46.0 78.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.803 -169.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -61.48 -35.85 78.82 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.398 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -71.67 -47.34 54.91 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.815 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.503 HG12 ' O ' ' A' ' 13' ' ' THR . 4.5 pt -74.09 -37.33 46.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.776 -177.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 23' ' ' VAL . . . -57.1 -49.34 76.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.106 0.479 . . . . 0.0 110.834 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.58 -21.8 61.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.723 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -65.17 -47.22 77.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.064 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.442 ' HD1' HG12 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -106.71 7.88 30.7 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 179.534 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.63 49.33 6.67 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 120.517 -0.849 . . . . 0.0 114.348 169.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.442 HG12 ' HD1' ' A' ' 21' ' ' TYR . 6.4 p -132.52 143.82 38.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 172.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.503 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 45.1 t -70.03 148.37 48.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.456 0.646 . . . . 0.0 110.603 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.539 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 78.8 t -52.84 -40.97 37.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.439 174.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.416 ' HA ' ' NE ' ' A' ' 29' ' ' ARG . . . -63.35 -49.07 75.35 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -171.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.503 ' OD1' ' HB3' ' A' ' 24' ' ' SER . 5.2 p-10 -76.51 -35.75 58.16 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 120.443 -0.503 . . . . 0.0 112.29 -175.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.811 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -72.76 -32.77 65.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 119.121 -1.031 . . . . 0.0 110.432 -177.026 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 25' ' ' VAL . 40.5 ptt85 -72.78 -31.47 64.89 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 121.506 -0.746 . . . . 0.0 111.053 174.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 72.5 m -64.98 -45.25 86.41 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -176.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.811 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -78.28 -2.84 39.87 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.527 179.734 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.851 174.563 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.757 HG23 HG21 ' A' ' 8' ' ' VAL . 9.5 mt . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.501 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 55.0 p90 -131.34 159.72 37.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.636 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 51.7 t -64.16 131.07 29.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.695 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.46 -13.3 64.43 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.2 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -70.34 128.64 36.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.97 0.414 . . . . 0.0 111.162 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -81.65 109.12 15.78 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.55 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.454 HD22 ' C ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -121.93 138.16 54.51 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 175.216 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.622 HD13 ' HB3' ' A' ' 5' ' ' TYR . 45.4 mm -65.45 138.08 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.15 0.5 . . . . 0.0 111.435 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.702 ' O ' ' HB ' ' A' ' 4' ' ' THR . 10.0 p -155.18 130.99 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.95 172.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.3 pttt . . . . . 0 C--N 1.304 -1.404 0 O-C-N 121.232 -0.918 . . . . 0.0 111.375 169.094 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.532 ' HA ' ' HB3' ' A' ' 48' ' ' LYS . 4.5 p-10 . . . . . 0 CA--C 1.52 -0.207 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.612 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 97.9 m -132.32 158.94 40.58 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -130.65 146.69 52.2 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.058 0.456 . . . . 0.0 110.311 171.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -117.73 126.1 51.85 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.189 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.44 HG23 ' HG2' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -70.79 119.76 15.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.285 174.049 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.618 HG22 HD23 ' A' ' 45' ' ' LEU . 97.2 t -57.13 116.66 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.088 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.802 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 10.5 mmpt? -102.34 -173.47 2.34 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.221 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.1 m -44.04 -18.35 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.71 60.39 0.93 Allowed Glycine 0 C--O 1.223 -0.562 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 166.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -68.27 -3.39 10.7 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 123.698 0.799 . . . . 0.0 113.148 -172.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.506 ' O ' HG12 ' A' ' 17' ' ' ILE . 25.6 m -116.81 143.76 45.3 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.571 -0.452 . . . . 0.0 109.83 -173.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.784 ' HB3' HG13 ' A' ' 25' ' ' VAL . 3.5 mm? -55.19 -47.42 75.28 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.739 0.649 . . . . 0.0 111.21 -172.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -67.23 -31.11 71.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.281 -175.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.42 ' HE2' ' HB ' ' A' ' 13' ' ' THR . 54.8 mtmt -72.0 -47.88 48.81 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.988 0.423 . . . . 0.0 110.763 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.561 HD11 HD13 ' A' ' 39' ' ' ILE . 4.3 pt -74.74 -38.13 44.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.921 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.5 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -57.3 -48.42 78.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.088 0.47 . . . . 0.0 110.865 177.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.2 -24.45 64.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.756 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -60.35 -47.45 86.02 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.508 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -104.88 12.99 31.88 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.911 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.13 48.78 37.37 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.701 170.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.41 HG22 ' OD1' ' A' ' 27' ' ' ASN . 1.3 p -131.61 171.25 18.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.468 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 48.0 t -88.1 145.33 26.0 Favored 'General case' 0 C--O 1.251 1.159 0 CA-C-O 122.433 1.111 . . . . 0.0 111.662 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.784 HG13 ' HB3' ' A' ' 14' ' ' LEU . 21.1 t -61.3 -32.28 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 114.141 -1.391 . . . . 0.0 109.679 175.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.89 -46.77 83.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.761 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.468 ' OD1' ' HB3' ' A' ' 24' ' ' SER . 1.8 p-10 -67.13 -46.3 74.55 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.48 -177.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.826 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 2.3 pp -70.61 -31.18 68.06 Favored 'General case' 0 C--O 1.228 -0.067 0 C-N-CA 118.514 -1.274 . . . . 0.0 112.197 -177.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.54 ' HD3' HG12 ' A' ' 25' ' ' VAL . 25.6 mtp-105 -64.66 -36.45 84.29 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 122.137 -0.352 . . . . 0.0 111.144 173.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.1 t -73.22 -46.55 49.63 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -171.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.826 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -83.56 -5.49 59.19 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.721 -176.184 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 . . . . . 0 C--N 1.326 -0.438 0 CA-C-O 120.9 0.381 . . . . 0.0 110.205 172.865 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.561 HD13 HD11 ' A' ' 17' ' ' ILE . 1.5 mt . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -127.26 151.3 48.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.373 -173.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 57.3 t -59.81 139.7 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.552 -175.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.96 -21.64 44.98 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.43 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.435 ' O ' HG23 ' A' ' 8' ' ' VAL . 21.5 tt0 -73.03 127.35 32.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.603 0.239 . . . . 0.0 110.734 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.44 ' HG2' HG23 ' A' ' 7' ' ' THR . 94.6 mttt -85.86 106.47 17.09 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 171.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.618 HD23 HG22 ' A' ' 8' ' ' VAL . 4.6 pp -101.42 140.35 35.83 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.492 ' HB ' ' CD1' ' A' ' 31' ' ' TRP . 50.3 mm -63.71 135.21 28.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.413 0.625 . . . . 0.0 110.817 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.612 ' O ' ' HB ' ' A' ' 4' ' ' THR . 7.6 p -149.44 120.76 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.351 171.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 3' ' ' ASN . 51.9 pttt . . . . . 0 C--N 1.308 -1.219 0 O-C-N 121.872 -0.517 . . . . 0.0 111.617 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.6 m120 . . . . . 0 CA--C 1.516 -0.333 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.746 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 92.4 m -107.1 154.63 20.87 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 173.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -130.26 145.38 51.75 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.293 172.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -117.68 115.59 25.37 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.205 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.426 HG23 ' HG2' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -66.03 117.29 8.16 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 169.263 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.597 HG22 HD23 ' A' ' 45' ' ' LEU . 74.7 t -56.75 118.28 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.568 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.832 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 10.1 mmpt? -99.85 -173.21 2.39 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.035 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.1 t -42.82 -17.77 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.902 ' HA2' ' HE3' ' A' ' 16' ' ' LYS . . . -74.18 61.88 2.2 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 167.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -66.4 -3.56 6.32 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -173.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.568 ' O ' HG12 ' A' ' 17' ' ' ILE . 2.8 m -115.8 143.89 44.76 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.002 -170.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.642 ' HB3' HG13 ' A' ' 25' ' ' VAL . 4.0 mm? -55.52 -50.02 71.08 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.228 -171.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -69.47 -29.9 67.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.904 -175.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.902 ' HE3' ' HA2' ' A' ' 11' ' ' GLY . 32.2 ttpt -72.34 -47.48 49.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.956 -176.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 13' ' ' THR . 5.1 pt -74.68 -39.57 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.813 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 23' ' ' VAL . . . -57.02 -49.0 77.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.002 0.43 . . . . 0.0 110.864 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.27 -22.17 61.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.74 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -64.96 -47.7 76.67 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.65 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.47 ' CE1' HG21 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -108.03 11.32 27.85 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -178.64 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.4 48.62 7.28 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.282 169.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.418 ' O ' ' HB1' ' A' ' 18' ' ' ALA . 14.8 p -134.7 160.21 41.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 172.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.584 ' HB2' ' OD1' ' A' ' 27' ' ' ASN . 66.8 m -90.66 149.15 22.2 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.782 0.801 . . . . 0.0 111.083 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.642 HG13 ' HB3' ' A' ' 14' ' ' LEU . 14.5 t -59.08 -36.4 62.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.626 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.66 -48.07 82.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.902 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.584 ' OD1' ' HB2' ' A' ' 24' ' ' SER . 0.3 OUTLIER -75.37 -36.0 61.01 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -176.601 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.906 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 3.0 pp -71.14 -30.65 66.74 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 118.046 -1.462 . . . . 0.0 111.607 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.406 ' N ' HD12 ' A' ' 28' ' ' LEU . 77.8 mtt180 -59.71 -44.78 93.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.819 0.342 . . . . 0.0 110.906 171.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 64.8 m -69.8 -43.94 71.05 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -171.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.906 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -82.18 -4.05 56.22 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.533 -178.477 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 . . . . . 0 C--N 1.326 -0.419 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.677 174.108 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.516 HD13 HD11 ' A' ' 17' ' ' ILE . 3.0 mt . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.223 0.535 . . . . 0.0 109.967 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.468 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 19.5 p90 -134.63 154.81 51.33 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.406 -175.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 41.8 t -63.08 132.31 28.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.272 -173.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.7 -20.93 40.18 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.419 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.417 ' O ' HG23 ' A' ' 8' ' ' VAL . 23.0 tt0 -71.27 127.19 31.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.441 0.162 . . . . 0.0 110.572 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HG2' HG23 ' A' ' 7' ' ' THR . 33.9 mtmm -81.9 107.37 14.57 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 171.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.597 HD23 HG22 ' A' ' 8' ' ' VAL . 4.2 pp -105.47 134.36 48.7 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 175.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.439 ' N ' HD12 ' A' ' 46' ' ' ILE . 1.9 mp -62.45 136.58 25.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.746 ' O ' ' HB ' ' A' ' 4' ' ' THR . 7.7 p -145.59 125.94 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.522 ' HE3' ' CE3' ' A' ' 31' ' ' TRP . 36.6 pttt . . . . . 0 C--N 1.301 -1.506 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.091 175.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.475 ' N ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.754 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 47.7 m -114.01 151.3 32.61 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.515 ' HB3' HD13 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -132.11 153.95 49.96 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 121.772 -0.58 . . . . 0.0 110.296 174.177 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.491 ' OH ' ' HB2' ' A' ' 9' ' ' LYS . 1.4 t80 -145.94 142.41 28.69 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.045 -173.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.39 121.27 28.71 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 174.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.542 HG21 HG23 ' A' ' 39' ' ' ILE . 95.0 t -56.91 125.47 12.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.556 -175.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.654 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -92.15 -173.81 3.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.955 176.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.6 m -43.87 -17.69 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.726 ' HA2' ' HE2' ' A' ' 16' ' ' LYS . . . -75.26 52.59 2.62 Favored Glycine 0 C--O 1.222 -0.622 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 168.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -57.58 -3.43 0.19 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -169.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.406 ' O ' HG12 ' A' ' 17' ' ' ILE . 7.9 m -114.77 149.36 37.06 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 121.301 -0.875 . . . . 0.0 109.236 -173.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.681 HD12 HG13 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -53.92 -47.27 71.36 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.605 0.566 . . . . 0.0 110.612 -171.821 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -69.23 -29.18 67.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.056 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.726 ' HE2' ' HA2' ' A' ' 11' ' ' GLY . 60.0 mtpt -71.06 -48.7 51.13 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.522 -178.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.694 HG23 ' O ' ' A' ' 11' ' ' GLY . 4.9 pt -74.31 -41.63 50.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.66 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.23 -49.36 76.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 0.0 111.146 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.38 -22.56 60.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.743 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.513 ' OE1' ' HA ' ' A' ' 20' ' ' GLN . 5.7 tp60 -68.13 -47.26 68.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.478 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.566 ' HE1' HG12 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -100.93 2.79 41.12 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.765 178.664 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.33 48.92 7.1 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.92 -0.657 . . . . 0.0 114.479 169.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.573 HG22 ' OD1' ' A' ' 27' ' ' ASN . 3.0 p -122.74 162.83 22.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 170.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.0 t -74.94 146.5 41.72 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.853 0.835 . . . . 0.0 111.241 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.681 HG13 HD12 ' A' ' 14' ' ' LEU . 91.2 t -58.91 -35.76 58.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.169 172.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.47 -46.61 69.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.233 -175.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.573 ' OD1' HG22 ' A' ' 23' ' ' VAL . 6.9 p30 -74.87 -43.58 53.64 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.491 -174.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.799 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -68.43 -31.99 71.7 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.834 -178.004 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.644 ' HE ' ' HG ' ' A' ' 14' ' ' LEU . 96.5 mtt180 -66.99 -35.81 80.78 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.887 172.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.6 t -64.38 -45.26 88.48 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -172.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.799 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER -89.02 -2.12 58.43 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.148 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 . . . . . 0 C--N 1.327 -0.379 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.29 176.188 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.542 HG23 HG21 ' A' ' 8' ' ' VAL . 14.1 mt . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -142.28 171.04 14.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.011 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 61.0 t -64.74 128.63 27.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.59 -10.27 60.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.005 -177.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -61.47 127.99 34.13 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 122.44 0.296 . . . . 0.0 110.427 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -92.73 107.21 19.04 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.746 HD23 HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -124.17 140.61 52.8 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.16 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.515 HD13 ' HB3' ' A' ' 5' ' ' TYR . 49.6 mm -70.3 131.51 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.198 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.754 ' O ' ' HB ' ' A' ' 4' ' ' THR . 11.3 p -136.95 123.49 29.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 122.46 1.124 . . . . 0.0 109.36 173.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.8 tttp . . . . . 0 C--N 1.297 -1.675 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.705 175.711 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.9 t30 . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.704 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 83.6 m -99.31 157.27 16.51 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -127.42 150.91 49.42 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.621 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.428 ' CE2' ' HA ' ' A' ' 8' ' ' VAL . 55.7 t80 -117.23 120.77 39.26 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.979 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.57 111.82 5.65 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.06 0.457 . . . . 0.0 109.974 170.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 68.7 t -57.34 127.81 16.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.812 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.28 -174.05 2.38 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.9 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.1 m -41.16 -26.47 0.05 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -173.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.662 ' O ' HG23 ' A' ' 17' ' ' ILE . . . -76.79 59.55 3.43 Favored Glycine 0 C--O 1.225 -0.465 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 170.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -59.27 -1.3 0.19 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -171.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.501 ' O ' HG12 ' A' ' 17' ' ' ILE . 2.3 m -112.69 147.98 35.65 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.515 -0.741 . . . . 0.0 110.383 -168.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -54.45 -48.1 72.14 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.875 -169.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -62.32 -36.56 82.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.016 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 29.1 mmmt -73.56 -47.29 41.82 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.283 -173.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 11' ' ' GLY . 6.9 pt -74.69 -41.52 47.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -177.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.72 -49.86 76.1 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.125 0.266 . . . . 0.0 111.196 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.02 -23.71 62.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.077 0.465 . . . . 0.0 110.335 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.503 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 63.7 tt0 -59.96 -46.81 88.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.172 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.476 ' CE1' HG21 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -106.27 13.6 28.59 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.737 179.344 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.19 49.06 17.2 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.645 171.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.682 HG22 ' OD1' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -131.38 175.72 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.208 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.68 ' HB2' HD21 ' A' ' 27' ' ' ASN . 47.7 m -110.86 152.15 27.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.407 0.622 . . . . 0.0 111.699 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.421 HG12 ' HD2' ' A' ' 29' ' ' ARG . 43.8 t -57.73 -40.02 73.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.769 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.31 -47.04 86.87 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.312 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.682 ' OD1' HG22 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -71.7 -41.89 68.04 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -176.044 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.9 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 3.2 pp -69.14 -32.33 71.61 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 118.331 -1.348 . . . . 0.0 111.79 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.421 ' HD2' HG12 ' A' ' 25' ' ' VAL . 32.0 mtp-105 -63.85 -33.7 76.28 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.055 172.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.8 t -68.8 -45.05 72.26 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.35 -174.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.9 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER -90.72 -2.56 57.81 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.096 -178.486 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 . . . . . 0 C--N 1.326 -0.436 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.825 174.11 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.631 HG23 HG21 ' A' ' 8' ' ' VAL . 4.3 mt . . . . . 0 C--O 1.233 0.214 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.593 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 50.0 p90 -144.41 166.88 23.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.156 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 46.2 t -60.4 129.23 22.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.293 -177.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.77 -15.29 59.78 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.382 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.433 ' OE1' ' HA ' ' A' ' 39' ' ' ILE . 44.2 tt0 -75.28 129.47 37.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.544 0.212 . . . . 0.0 111.076 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -92.11 107.34 19.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.812 0.339 . . . . 0.0 110.237 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.636 HD21 HD12 ' A' ' 17' ' ' ILE . 3.4 pp -109.65 138.58 45.82 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 175.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.457 ' N ' HD12 ' A' ' 46' ' ' ILE . 1.8 mp -65.49 139.35 21.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.063 0.459 . . . . 0.0 110.371 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.704 ' O ' ' HB ' ' A' ' 4' ' ' THR . 11.3 p -149.1 129.13 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 172.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.3 pttt . . . . . 0 C--N 1.309 -1.156 0 CA-C-O 121.318 0.58 . . . . 0.0 112.223 175.659 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 . . . . . 0 CA--C 1.516 -0.349 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.72 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 58.0 m -109.54 155.54 21.26 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.628 ' HB3' HD13 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -131.31 139.68 49.62 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.184 0.516 . . . . 0.0 110.674 173.435 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.437 ' HD2' HD11 ' A' ' 45' ' ' LEU . 36.1 t80 -121.0 141.53 50.65 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.113 -173.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.49 ' O ' ' HG2' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -87.87 120.75 29.5 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.979 171.816 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.73 HG21 HG23 ' A' ' 39' ' ' ILE . 57.5 t -57.35 127.25 16.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.135 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 7' ' ' THR . 66.1 mmtt -129.72 -178.07 4.54 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.5 m -42.95 125.55 3.55 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.357 0.599 . . . . 0.0 110.11 177.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.609 ' O ' HG23 ' A' ' 17' ' ' ILE . . . 104.52 29.58 5.29 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 108.561 -1.816 . . . . 0.0 108.561 -158.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.546 ' O ' HG22 ' A' ' 39' ' ' ILE . 4.3 p30 -59.84 0.09 0.17 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.454 1.502 . . . . 0.0 114.675 -169.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.531 ' O ' HG12 ' A' ' 17' ' ' ILE . 5.8 m -112.22 145.36 40.05 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 121.571 -0.705 . . . . 0.0 110.19 -172.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.518 ' HG ' HD12 ' A' ' 39' ' ' ILE . 7.0 mp -53.99 -46.48 71.72 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.04 -166.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -61.72 -36.37 80.75 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.929 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 68.5 mttm -73.79 -47.17 40.78 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.851 -176.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 11' ' ' GLY . 2.4 pt -73.28 -42.92 57.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.537 -178.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.561 ' HA ' ' CE1' ' A' ' 21' ' ' TYR . . . -58.45 -49.02 78.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.039 0.447 . . . . 0.0 111.23 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.83 -22.25 60.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.683 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 35.8 tt0 -64.54 -47.51 78.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.032 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.561 ' CE1' ' HA ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -96.85 -0.3 48.05 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.456 177.45 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.58 48.44 7.28 Favored Glycine 0 N--CA 1.453 -0.17 0 C-N-CA 120.894 -0.67 . . . . 0.0 114.062 171.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.661 HG22 ' OD1' ' A' ' 27' ' ' ASN . 1.1 p -126.82 164.36 27.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 172.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.636 ' HB2' ' ND2' ' A' ' 27' ' ' ASN . 4.4 m -91.35 145.34 24.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.237 0.542 . . . . 0.0 111.338 -175.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.527 HG12 ' HD3' ' A' ' 29' ' ' ARG . 38.4 t -55.68 -34.73 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.458 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.54 -47.64 78.06 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -177.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.661 ' OD1' HG22 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -71.93 -46.35 57.91 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -176.094 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.837 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -66.27 -31.21 71.88 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.722 -177.214 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.527 ' HD3' HG12 ' A' ' 25' ' ' VAL . 27.9 mtp180 -66.44 -38.73 88.04 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.239 -0.288 . . . . 0.0 111.315 172.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 66.9 m -67.5 -45.43 75.83 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -171.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.837 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -81.74 -6.42 59.03 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.287 -176.631 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.914 0.387 . . . . 0.0 109.958 174.201 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.73 HG23 HG21 ' A' ' 8' ' ' VAL . 4.7 mt . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.484 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 51.5 p90 -136.38 159.8 40.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.713 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 50.2 t -62.73 129.62 26.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.071 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.89 -20.54 40.86 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.603 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -71.78 127.74 33.55 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -94.42 107.63 19.59 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.437 HD11 ' HD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -115.8 140.55 49.11 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -176.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.628 HD13 ' HB3' ' A' ' 5' ' ' TYR . 49.7 mm -66.17 135.53 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.798 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.72 ' O ' ' HB ' ' A' ' 4' ' ' THR . 13.9 p -147.33 124.63 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 122.072 0.939 . . . . 0.0 110.017 173.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.448 ' O ' ' HH2' ' A' ' 31' ' ' TRP . 57.8 tptt . . . . . 0 C--N 1.303 -1.454 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.669 171.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.701 ' HA ' ' HD2' ' A' ' 48' ' ' LYS . 12.6 m120 . . . . . 0 C--O 1.233 0.233 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.799 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 34.9 m -115.54 153.51 31.05 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 171.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -131.65 150.04 52.29 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.542 170.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -138.53 139.91 38.9 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.175 -171.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.72 123.67 29.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 173.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.635 HG21 HG23 ' A' ' 39' ' ' ILE . 58.8 t -56.74 116.2 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 123.717 0.635 . . . . 0.0 110.036 -177.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.677 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -103.36 -177.71 3.45 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.331 -177.708 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.3 p -42.98 112.7 0.39 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.495 0.664 . . . . 0.0 109.819 172.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.714 ' O ' HG23 ' A' ' 17' ' ' ILE . . . 123.14 34.44 0.77 Allowed Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -164.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.446 ' O ' HG22 ' A' ' 39' ' ' ILE . 10.4 p-10 -52.93 -2.64 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -170.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.437 ' OG1' ' HE2' ' A' ' 16' ' ' LYS . 2.6 m -114.13 154.31 28.02 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 121.156 -0.965 . . . . 0.0 109.99 -171.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 48.4 mt -53.39 -48.16 68.88 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 123.573 0.545 . . . . 0.0 111.755 -170.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -62.26 -37.07 84.06 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.24 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.437 ' HE2' ' OG1' ' A' ' 13' ' ' THR . 59.7 mtmt -74.3 -47.69 33.16 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.085 -174.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.714 HG23 ' O ' ' A' ' 11' ' ' GLY . 12.1 pt -72.88 -45.22 56.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.467 -177.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.465 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -58.54 -49.59 76.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.784 0.325 . . . . 0.0 111.578 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.16 -22.78 63.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.658 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -47.12 86.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.935 177.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.621 ' CE1' HG21 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -107.38 13.56 26.87 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.209 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.44 31.48 45.87 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.988 -0.625 . . . . 0.0 114.43 168.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.482 ' CG1' HD23 ' A' ' 28' ' ' LEU . 10.9 p -114.68 159.84 14.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.499 ' HB2' ' OD1' ' A' ' 27' ' ' ASN . 19.2 m -93.69 153.33 18.41 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-O 121.59 0.71 . . . . 0.0 110.735 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.414 HG12 ' CD ' ' A' ' 29' ' ' ARG . 76.8 t -56.86 -38.92 61.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.862 178.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.86 -48.32 81.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -175.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.499 ' OD1' ' HB2' ' A' ' 24' ' ' SER . 1.6 p-10 -75.55 -34.34 60.72 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -175.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.89 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 3.9 pp -71.69 -31.75 67.11 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 118.221 -1.392 . . . . 0.0 111.107 177.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.495 ' N ' HD12 ' A' ' 28' ' ' LEU . 75.0 mtp180 -64.37 -34.68 78.72 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.636 173.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 52.0 m -71.22 -44.91 64.44 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -173.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.89 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -84.55 -2.53 57.5 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.137 -178.411 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 . . . . . 0 C--N 1.326 -0.45 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.475 174.119 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.635 HG23 HG21 ' A' ' 8' ' ' VAL . 5.2 mt . . . . . 0 C--O 1.233 0.228 0 CA-C-O 120.974 0.416 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -149.35 161.36 42.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.488 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 97.1 t -61.41 129.98 24.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.318 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.36 -20.8 36.67 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.979 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.507 ' OE1' ' HA ' ' A' ' 39' ' ' ILE . 27.4 tt0 -70.28 132.45 45.72 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.425 -0.388 . . . . 0.0 110.508 177.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.588 ' HB3' ' NZ ' ' A' ' 44' ' ' LYS . 2.4 ttpm? -97.15 107.36 19.87 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.82 143.34 45.54 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 -178.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.8 mp -67.42 136.28 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.952 0.406 . . . . 0.0 110.718 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.799 ' O ' ' HB ' ' A' ' 4' ' ' THR . 7.9 p -150.58 129.31 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-O 121.606 0.717 . . . . 0.0 109.266 173.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.701 ' HD2' ' HA ' ' A' ' 3' ' ' ASN . 54.8 tttm . . . . . 0 C--N 1.301 -1.504 0 O-C-N 121.584 -0.697 . . . . 0.0 110.861 171.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.514 ' N ' HD21 ' A' ' 3' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.548 ' H ' ' HB2' ' A' ' 48' ' ' LYS . 49.4 m -99.51 155.79 17.38 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.704 ' HB3' HD13 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -130.18 139.28 50.87 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.136 0.493 . . . . 0.0 109.859 173.111 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CE2' ' HA ' ' A' ' 8' ' ' VAL . 10.1 t80 -123.11 137.42 54.92 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.329 -172.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.446 ' O ' ' HG2' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -83.9 119.7 25.2 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.08 172.721 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.695 HG21 HG23 ' A' ' 39' ' ' ILE . 61.3 t -56.68 123.15 7.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.426 -176.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 7' ' ' THR . 28.0 mmtp -116.93 -176.05 2.9 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.646 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.4 m -41.12 113.47 0.39 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.61 0.719 . . . . 0.0 110.341 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.664 ' O ' HG23 ' A' ' 17' ' ' ILE . . . 119.02 37.81 0.79 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 -163.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.47 ' O ' HG22 ' A' ' 39' ' ' ILE . 4.1 p30 -53.79 -1.88 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.578 1.551 . . . . 0.0 114.998 -172.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 m -114.12 152.59 30.88 Favored 'General case' 0 C--N 1.309 -1.152 0 O-C-N 121.439 -0.788 . . . . 0.0 110.01 -169.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.634 HD22 HG13 ' A' ' 25' ' ' VAL . 52.9 mt -53.11 -46.61 68.8 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.977 -171.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -62.11 -36.94 83.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -73.87 -48.88 27.89 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.718 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.664 HG23 ' O ' ' A' ' 11' ' ' GLY . 14.3 pt -74.37 -44.68 48.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.762 -176.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.462 ' HA ' ' CE1' ' A' ' 21' ' ' TYR . . . -59.79 -48.84 80.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.891 0.377 . . . . 0.0 111.189 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.06 -21.88 62.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.851 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -63.38 -46.71 85.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.262 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.462 ' CE1' ' HA ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -99.71 6.05 45.62 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.101 0.477 . . . . 0.0 111.221 176.192 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.28 48.33 11.17 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.854 -0.612 . . . . 0.0 114.125 170.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.11 168.43 23.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 173.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.465 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 47.6 t -91.59 146.86 23.44 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 122.368 1.08 . . . . 0.0 112.032 -176.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.634 HG13 HD22 ' A' ' 14' ' ' LEU . 60.7 t -59.29 -32.11 47.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.341 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.06 83.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.44 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.49 ' HB2' ' CH2' ' A' ' 31' ' ' TRP . 1.3 p-10 -68.4 -45.1 73.58 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.666 -177.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.776 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 2.8 pp -67.92 -32.13 72.38 Favored 'General case' 0 C--O 1.227 -0.12 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.404 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.532 ' HD2' HG12 ' A' ' 25' ' ' VAL . 36.0 mtt-85 -61.81 -34.6 76.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.77 0.319 . . . . 0.0 110.97 172.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.7 t -71.28 -45.49 63.02 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.776 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 1.0 OUTLIER -89.2 -1.78 58.23 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -176.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 . . . . . 0 C--N 1.318 -0.771 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.414 174.176 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.695 HG23 HG21 ' A' ' 8' ' ' VAL . 5.7 mt . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -137.14 160.9 37.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.563 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 61.9 t -65.04 128.78 28.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.488 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.75 -15.49 48.72 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.204 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -75.45 127.85 34.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.758 0.313 . . . . 0.0 110.265 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -89.6 107.18 18.94 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.416 HD22 ' C ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -114.99 140.88 48.68 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.704 HD13 ' HB3' ' A' ' 5' ' ' TYR . 42.8 mm -68.23 137.45 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.281 -176.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.518 ' O ' ' HB ' ' A' ' 4' ' ' THR . 8.5 p -146.76 112.68 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.625 0.726 . . . . 0.0 110.48 173.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.548 ' HB2' ' H ' ' A' ' 4' ' ' THR . 58.3 tptt . . . . . 0 N--CA 1.472 0.635 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.955 169.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.48 ' HA ' ' HB3' ' A' ' 48' ' ' LYS . 3.6 p-10 . . . . . 0 CA--C 1.522 -0.118 0 CA-C-O 121.019 0.438 . . . . 0.0 109.858 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.649 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 57.1 m -108.62 157.91 18.07 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -175.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.459 ' HB2' ' HG3' ' A' ' 44' ' ' LYS . 0.9 OUTLIER -130.85 150.0 52.22 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.101 0.476 . . . . 0.0 109.906 171.048 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.455 ' HD2' HD11 ' A' ' 45' ' ' LEU . 1.2 t80 -129.31 139.92 51.59 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.833 -175.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.465 HG23 ' HD3' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -82.99 120.94 26.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.142 173.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.73 HG21 HG23 ' A' ' 39' ' ' ILE . 57.8 t -56.14 124.92 10.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.132 -177.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.691 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -95.23 -175.09 3.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.498 -178.297 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.7 m -57.56 68.41 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.918 0.866 . . . . 0.0 110.849 171.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.618 ' O ' HG23 ' A' ' 17' ' ' ILE . . . -175.03 45.66 0.13 Allowed Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 107.847 -2.101 . . . . 0.0 107.847 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -52.58 -0.26 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.57 1.948 . . . . 0.0 115.406 -170.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.8 m -113.13 147.22 37.79 Favored 'General case' 0 C--N 1.311 -1.081 0 O-C-N 121.364 -0.835 . . . . 0.0 109.694 -171.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.571 HD23 HD12 ' A' ' 39' ' ' ILE . 54.6 mt -53.74 -47.33 70.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.116 -168.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -66.64 -30.25 70.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.968 -176.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -74.13 -47.8 33.68 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.013 0.435 . . . . 0.0 111.05 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.618 HG23 ' O ' ' A' ' 11' ' ' GLY . 11.3 pt -74.61 -40.35 47.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.605 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.442 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -58.02 -49.26 77.47 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.0 0.429 . . . . 0.0 111.232 177.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.93 -23.03 63.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.758 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -60.81 -41.82 96.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.502 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.486 ' CE1' HG21 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -107.19 8.17 29.87 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.697 177.601 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.4 48.16 11.3 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.726 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -133.11 172.58 16.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -97.34 147.32 24.29 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-O 122.297 1.046 . . . . 0.0 111.574 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.586 HG12 ' HD2' ' A' ' 29' ' ' ARG . 88.2 t -56.74 -35.92 47.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.361 176.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.12 -45.66 87.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.141 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -64.67 -46.17 83.59 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.978 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.836 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 3.4 pp -69.02 -29.49 67.67 Favored 'General case' 0 CA--C 1.523 -0.083 0 C-N-CA 118.719 -1.192 . . . . 0.0 110.853 178.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.586 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -54.54 -41.43 69.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.034 0.445 . . . . 0.0 110.443 171.117 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.6 m -75.9 -44.01 42.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.883 -170.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.836 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -91.38 -1.5 57.58 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -173.542 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 . . . . . 0 C--N 1.328 -0.334 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.319 178.891 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.73 HG23 HG21 ' A' ' 8' ' ' VAL . 4.9 mt . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.544 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 42.4 p90 -141.94 160.75 39.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.719 -176.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 54.0 t -56.56 128.87 17.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.935 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.76 -16.44 58.61 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.896 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -74.96 137.94 41.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.852 0.326 . . . . 0.0 110.877 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.465 ' HD3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -95.32 107.72 19.86 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.834 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.455 HD11 ' HD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -117.0 147.08 42.62 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.89 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.42 ' N ' HD12 ' A' ' 46' ' ' ILE . 2.5 mp -70.41 137.93 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.967 0.413 . . . . 0.0 111.271 -174.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.649 ' O ' ' HB ' ' A' ' 4' ' ' THR . 8.8 p -151.67 124.72 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.735 0.779 . . . . 0.0 109.302 171.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.48 ' HB3' ' HA ' ' A' ' 3' ' ' ASN . 21.6 pttp . . . . . 0 C--N 1.309 -1.158 0 CA-C-O 121.57 0.7 . . . . 0.0 111.411 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.0 t -147.69 149.52 32.61 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 178.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.401 ' HA ' ' HB3' ' A' ' 48' ' ' LYS . 25.4 m-80 -137.9 131.48 31.02 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.635 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 54.8 m -109.29 84.98 2.01 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 46' ' ' ILE . 2.1 p90 -85.02 123.4 30.52 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.579 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.435 ' CE2' ' HA ' ' A' ' 8' ' ' VAL . 1.0 OUTLIER -117.89 135.82 53.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.117 -167.308 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.401 HG23 ' HD3' ' A' ' 44' ' ' LYS . 1.1 p -80.92 126.21 31.09 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 173.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.74 HG21 HG23 ' A' ' 39' ' ' ILE . 34.0 t -57.14 120.28 3.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.073 -176.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -175.32 2.73 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.35 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.2 t -41.72 114.67 0.55 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.531 0.681 . . . . 0.0 110.122 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.636 ' O ' HG23 ' A' ' 17' ' ' ILE . . . 124.35 31.54 0.9 Allowed Glycine 0 C--O 1.221 -0.718 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -164.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.459 ' O ' HG22 ' A' ' 39' ' ' ILE . 6.1 p-10 -52.93 -3.34 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -170.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.885 ' HB ' ' HD3' ' A' ' 16' ' ' LYS . 7.1 m -112.92 143.68 43.78 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 121.389 -0.819 . . . . 0.0 108.92 -173.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.497 HD11 HD11 ' A' ' 28' ' ' LEU . 54.8 tp -56.52 -47.26 79.73 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 123.569 0.543 . . . . 0.0 112.053 -166.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -65.86 -31.02 71.73 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.415 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.885 ' HD3' ' HB ' ' A' ' 13' ' ' THR . 36.0 mtpt -71.43 -47.39 56.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.286 -178.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 11' ' ' GLY . 1.8 pt -74.09 -37.96 47.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.56 0.219 . . . . 0.0 111.533 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.22 -50.01 74.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.031 0.443 . . . . 0.0 110.862 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.43 -22.5 60.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.654 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.551 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 30.7 tt0 -67.28 -47.8 69.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.371 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.428 ' CE2' ' HB ' ' A' ' 17' ' ' ILE . 3.5 p90 -107.56 13.27 26.91 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.56 49.62 6.55 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.604 -0.808 . . . . 0.0 114.635 167.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.2 p -133.36 143.91 37.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 173.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.504 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 47.0 t -70.38 147.26 49.75 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.526 0.679 . . . . 0.0 110.498 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 36.5 t -57.88 -33.01 44.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.039 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.49 -48.6 64.04 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -174.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.504 ' OD1' ' HB3' ' A' ' 24' ' ' SER . 9.2 p-10 -75.9 -40.46 54.33 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.379 -0.528 . . . . 0.0 112.248 -175.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.864 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -68.98 -31.6 70.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 118.378 -1.329 . . . . 0.0 109.442 -178.37 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -65.04 -35.17 80.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.012 171.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 66.1 m -64.25 -43.96 93.27 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -174.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.864 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.9 OUTLIER -88.33 -2.6 58.69 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.117 -0.633 . . . . 0.0 112.682 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.456 ' HB3' HG13 ' A' ' 34' ' ' ILE . 38.2 m-80 -106.09 -22.66 12.81 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 122.1 -0.375 . . . . 0.0 111.472 175.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.92 39.07 85.53 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.823 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.456 HG13 ' HB3' ' A' ' 32' ' ' ASN . 63.4 mt -105.24 128.75 58.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.993 0.425 . . . . 0.0 111.536 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -108.42 110.63 22.22 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.021 171.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.29 -167.13 16.56 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.609 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.42 ' OD1' ' HB3' ' A' ' 14' ' ' LEU . 16.0 m-20 -104.58 36.47 2.4 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.163 0.185 . . . . 0.0 111.066 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.478 ' H ' ' HG ' ' A' ' 38' ' ' LEU . 1.0 OUTLIER -76.89 63.8 2.3 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.363 1.077 . . . . 0.0 111.197 -179.205 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.74 HG23 HG21 ' A' ' 8' ' ' VAL . 22.3 mt -124.23 147.14 28.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.236 -176.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -149.95 158.17 43.9 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 89.5 t -59.51 126.93 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 123.247 0.342 . . . . 0.0 110.77 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.45 -21.01 35.98 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.529 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.439 ' O ' HG23 ' A' ' 8' ' ' VAL . 46.4 tt0 -65.33 134.71 54.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.401 ' HD3' HG23 ' A' ' 7' ' ' THR . 13.7 tptm -92.31 107.72 19.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.917 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.571 HD23 HG22 ' A' ' 8' ' ' VAL . 2.8 pp -119.82 139.34 52.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.061 0.458 . . . . 0.0 110.517 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.477 ' N ' HD12 ' A' ' 46' ' ' ILE . 2.8 mp -76.3 137.45 22.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.148 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.635 ' O ' ' HB ' ' A' ' 4' ' ' THR . 11.2 p -144.6 115.78 2.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.748 0.785 . . . . 0.0 109.378 166.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.547 ' HD2' ' O ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -146.88 119.75 8.7 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.535 -0.728 . . . . 0.0 112.578 176.04 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.689 ' H ' ' HD3' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -117.45 163.7 16.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.38 -178.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 135.88 -38.78 1.74 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.901 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.814 -0.613 . . . . 0.0 110.207 178.714 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.668 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.409 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 7.9 m -88.27 158.6 18.42 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -152.26 114.03 4.38 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.949 0.404 . . . . 0.0 109.94 173.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.702 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 96.4 m -112.91 154.12 26.88 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.622 ' HB3' HD13 ' A' ' 46' ' ' ILE . 1.8 p90 -130.84 145.66 52.05 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 169.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.401 ' HD2' HD11 ' A' ' 45' ' ' LEU . 58.7 t80 -116.84 132.67 56.64 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.86 -173.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.41 116.24 19.52 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 168.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.757 HG21 HG23 ' A' ' 39' ' ' ILE . 59.7 t -58.12 125.37 14.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.388 -177.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 25.0 mmtt -103.83 -174.22 2.49 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.06 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.5 m -42.25 -26.6 0.11 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -173.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.478 ' O ' HG23 ' A' ' 17' ' ' ILE . . . -76.67 66.81 2.68 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 168.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.479 ' O ' HG22 ' A' ' 39' ' ' ILE . 3.5 p30 -63.32 -3.1 1.73 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -168.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.503 ' O ' HG12 ' A' ' 17' ' ' ILE . 1.9 m -113.59 143.48 44.49 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 119.064 -1.055 . . . . 0.0 110.067 -167.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.639 HD11 HD11 ' A' ' 28' ' ' LEU . 14.3 tp -55.91 -46.0 78.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.803 -169.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -61.48 -35.85 78.82 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.398 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -71.67 -47.34 54.91 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.815 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.503 HG12 ' O ' ' A' ' 13' ' ' THR . 4.5 pt -74.09 -37.33 46.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.776 -177.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 23' ' ' VAL . . . -57.1 -49.34 76.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.106 0.479 . . . . 0.0 110.834 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.58 -21.8 61.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.723 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -65.17 -47.22 77.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.064 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.442 ' HD1' HG12 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -106.71 7.88 30.7 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 179.534 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.63 49.33 6.67 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 120.517 -0.849 . . . . 0.0 114.348 169.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.442 HG12 ' HD1' ' A' ' 21' ' ' TYR . 6.4 p -132.52 143.82 38.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 172.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.503 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 45.1 t -70.03 148.37 48.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.456 0.646 . . . . 0.0 110.603 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.539 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 78.8 t -52.84 -40.97 37.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.439 174.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.416 ' HA ' ' NE ' ' A' ' 29' ' ' ARG . . . -63.35 -49.07 75.35 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -171.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.503 ' OD1' ' HB3' ' A' ' 24' ' ' SER . 5.2 p-10 -76.51 -35.75 58.16 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 120.443 -0.503 . . . . 0.0 112.29 -175.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.811 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -72.76 -32.77 65.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 119.121 -1.031 . . . . 0.0 110.432 -177.026 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 25' ' ' VAL . 40.5 ptt85 -72.78 -31.47 64.89 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 121.506 -0.746 . . . . 0.0 111.053 174.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 72.5 m -64.98 -45.25 86.41 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -176.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.811 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -78.28 -2.84 39.87 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.527 179.734 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.492 ' HB3' HG13 ' A' ' 34' ' ' ILE . 26.7 m-80 -100.07 -20.7 15.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.851 174.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.46 44.38 83.99 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.523 -178.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.492 HG13 ' HB3' ' A' ' 32' ' ' ASN . 65.8 mt -109.95 129.17 65.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.394 0.14 . . . . 0.0 110.64 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.6 m -89.89 107.82 19.34 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 172.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.4 -167.12 33.72 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.858 -0.686 . . . . 0.0 111.638 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.421 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 17.7 p-10 -115.71 65.41 0.69 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.554 0.692 . . . . 0.0 111.959 -178.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.516 HD23 ' H ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -87.44 97.36 10.78 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 170.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.757 HG23 HG21 ' A' ' 8' ' ' VAL . 9.5 mt -138.15 132.64 42.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.395 -172.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.501 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 55.0 p90 -131.34 159.72 37.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.636 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 51.7 t -64.16 131.07 29.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.695 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.46 -13.3 64.43 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.2 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -70.34 128.64 36.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.97 0.414 . . . . 0.0 111.162 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -81.65 109.12 15.78 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.55 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.454 HD22 ' C ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -121.93 138.16 54.51 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 175.216 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.622 HD13 ' HB3' ' A' ' 5' ' ' TYR . 45.4 mm -65.45 138.08 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.15 0.5 . . . . 0.0 111.435 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.702 ' O ' ' HB ' ' A' ' 4' ' ' THR . 10.0 p -155.18 130.99 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.95 172.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.409 ' HD3' ' O ' ' A' ' 2' ' ' THR . 55.3 pttt -133.33 122.15 23.4 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.232 -0.918 . . . . 0.0 111.375 169.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -100.43 108.27 20.22 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 127.04 -114.47 1.97 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.88 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.705 -0.664 . . . . 0.0 110.193 -179.194 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.7 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.8 t -149.46 138.96 21.59 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.532 ' HA ' ' HB3' ' A' ' 48' ' ' LYS . 4.5 p-10 -171.51 126.49 0.63 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.56 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.612 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 97.9 m -132.32 158.94 40.58 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -130.65 146.69 52.2 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.058 0.456 . . . . 0.0 110.311 171.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -117.73 126.1 51.85 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.189 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.44 HG23 ' HG2' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -70.79 119.76 15.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.285 174.049 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.618 HG22 HD23 ' A' ' 45' ' ' LEU . 97.2 t -57.13 116.66 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.088 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.802 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 10.5 mmpt? -102.34 -173.47 2.34 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.221 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.1 m -44.04 -18.35 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.71 60.39 0.93 Allowed Glycine 0 C--O 1.223 -0.562 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 166.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -68.27 -3.39 10.7 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 123.698 0.799 . . . . 0.0 113.148 -172.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.506 ' O ' HG12 ' A' ' 17' ' ' ILE . 25.6 m -116.81 143.76 45.3 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.571 -0.452 . . . . 0.0 109.83 -173.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.784 ' HB3' HG13 ' A' ' 25' ' ' VAL . 3.5 mm? -55.19 -47.42 75.28 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.739 0.649 . . . . 0.0 111.21 -172.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -67.23 -31.11 71.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.281 -175.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.42 ' HE2' ' HB ' ' A' ' 13' ' ' THR . 54.8 mtmt -72.0 -47.88 48.81 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.988 0.423 . . . . 0.0 110.763 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.561 HD11 HD13 ' A' ' 39' ' ' ILE . 4.3 pt -74.74 -38.13 44.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.921 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.5 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -57.3 -48.42 78.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.088 0.47 . . . . 0.0 110.865 177.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.2 -24.45 64.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.756 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -60.35 -47.45 86.02 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.508 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -104.88 12.99 31.88 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.911 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.13 48.78 37.37 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.701 170.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.41 HG22 ' OD1' ' A' ' 27' ' ' ASN . 1.3 p -131.61 171.25 18.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.468 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 48.0 t -88.1 145.33 26.0 Favored 'General case' 0 C--O 1.251 1.159 0 CA-C-O 122.433 1.111 . . . . 0.0 111.662 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.784 HG13 ' HB3' ' A' ' 14' ' ' LEU . 21.1 t -61.3 -32.28 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 114.141 -1.391 . . . . 0.0 109.679 175.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.89 -46.77 83.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.761 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.468 ' OD1' ' HB3' ' A' ' 24' ' ' SER . 1.8 p-10 -67.13 -46.3 74.55 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.48 -177.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.826 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 2.3 pp -70.61 -31.18 68.06 Favored 'General case' 0 C--O 1.228 -0.067 0 C-N-CA 118.514 -1.274 . . . . 0.0 112.197 -177.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.54 ' HD3' HG12 ' A' ' 25' ' ' VAL . 25.6 mtp-105 -64.66 -36.45 84.29 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 122.137 -0.352 . . . . 0.0 111.144 173.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.1 t -73.22 -46.55 49.63 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -171.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.826 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -83.56 -5.49 59.19 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.721 -176.184 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -98.35 -15.58 19.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.9 0.381 . . . . 0.0 110.205 172.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.43 39.17 87.4 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.009 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 65.7 mt -93.63 127.67 45.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.045 0.45 . . . . 0.0 110.83 -177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.2 t -107.15 108.74 20.33 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.27 -151.56 17.76 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.299 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -117.02 21.7 13.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.359 0.6 . . . . 0.0 110.194 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.499 ' O ' HD12 ' A' ' 38' ' ' LEU . 1.5 pp -73.74 101.85 3.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.798 0.809 . . . . 0.0 111.841 -176.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.561 HD13 HD11 ' A' ' 17' ' ' ILE . 1.5 mt -139.63 123.19 18.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.425 176.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -127.26 151.3 48.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.373 -173.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 57.3 t -59.81 139.7 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.552 -175.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.96 -21.64 44.98 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.43 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.435 ' O ' HG23 ' A' ' 8' ' ' VAL . 21.5 tt0 -73.03 127.35 32.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.603 0.239 . . . . 0.0 110.734 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.44 ' HG2' HG23 ' A' ' 7' ' ' THR . 94.6 mttt -85.86 106.47 17.09 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 171.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.618 HD23 HG22 ' A' ' 8' ' ' VAL . 4.6 pp -101.42 140.35 35.83 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.492 ' HB ' ' CD1' ' A' ' 31' ' ' TRP . 50.3 mm -63.71 135.21 28.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.413 0.625 . . . . 0.0 110.817 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.612 ' O ' ' HB ' ' A' ' 4' ' ' THR . 7.6 p -149.44 120.76 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.351 171.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 3' ' ' ASN . 51.9 pttt -147.71 132.27 17.75 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.872 -0.517 . . . . 0.0 111.617 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.53 112.87 16.06 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.25 -11.58 23.55 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.622 -175.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.39 -179.478 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.636 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -82.54 83.9 7.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.929 0.395 . . . . 0.0 111.32 -175.547 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -147.49 104.87 3.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.865 174.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.746 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 92.4 m -107.1 154.63 20.87 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 173.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -130.26 145.38 51.75 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.293 172.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -117.68 115.59 25.37 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.205 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.426 HG23 ' HG2' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -66.03 117.29 8.16 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 169.263 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.597 HG22 HD23 ' A' ' 45' ' ' LEU . 74.7 t -56.75 118.28 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.568 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.832 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 10.1 mmpt? -99.85 -173.21 2.39 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.035 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.1 t -42.82 -17.77 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.902 ' HA2' ' HE3' ' A' ' 16' ' ' LYS . . . -74.18 61.88 2.2 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 167.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -66.4 -3.56 6.32 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -173.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.568 ' O ' HG12 ' A' ' 17' ' ' ILE . 2.8 m -115.8 143.89 44.76 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.002 -170.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.642 ' HB3' HG13 ' A' ' 25' ' ' VAL . 4.0 mm? -55.52 -50.02 71.08 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.228 -171.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -69.47 -29.9 67.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.904 -175.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.902 ' HE3' ' HA2' ' A' ' 11' ' ' GLY . 32.2 ttpt -72.34 -47.48 49.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.956 -176.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 13' ' ' THR . 5.1 pt -74.68 -39.57 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.813 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 23' ' ' VAL . . . -57.02 -49.0 77.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.002 0.43 . . . . 0.0 110.864 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.27 -22.17 61.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.74 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -64.96 -47.7 76.67 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.65 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.47 ' CE1' HG21 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -108.03 11.32 27.85 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -178.64 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.4 48.62 7.28 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.282 169.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.418 ' O ' ' HB1' ' A' ' 18' ' ' ALA . 14.8 p -134.7 160.21 41.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 172.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.584 ' HB2' ' OD1' ' A' ' 27' ' ' ASN . 66.8 m -90.66 149.15 22.2 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.782 0.801 . . . . 0.0 111.083 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.642 HG13 ' HB3' ' A' ' 14' ' ' LEU . 14.5 t -59.08 -36.4 62.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.626 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.66 -48.07 82.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.902 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.584 ' OD1' ' HB2' ' A' ' 24' ' ' SER . 0.3 OUTLIER -75.37 -36.0 61.01 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -176.601 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.906 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 3.0 pp -71.14 -30.65 66.74 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 118.046 -1.462 . . . . 0.0 111.607 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.406 ' N ' HD12 ' A' ' 28' ' ' LEU . 77.8 mtt180 -59.71 -44.78 93.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.819 0.342 . . . . 0.0 110.906 171.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 64.8 m -69.8 -43.94 71.05 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -171.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.906 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -82.18 -4.05 56.22 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.533 -178.477 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -100.03 -13.31 19.1 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.677 174.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.74 34.96 91.2 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.242 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.9 mt -82.4 126.0 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.861 0.362 . . . . 0.0 110.877 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.6 t -97.08 108.92 21.75 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 170.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.27 -168.02 22.9 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -115.5 60.34 0.71 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 117.297 0.549 . . . . 0.0 110.501 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.478 ' O ' HD12 ' A' ' 38' ' ' LEU . 1.8 pp -94.14 107.54 19.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.717 0.77 . . . . 0.0 110.775 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.516 HD13 HD11 ' A' ' 17' ' ' ILE . 3.0 mt -139.46 120.01 14.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.967 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.468 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 19.5 p90 -134.63 154.81 51.33 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.406 -175.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 41.8 t -63.08 132.31 28.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.272 -173.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.7 -20.93 40.18 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.419 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.417 ' O ' HG23 ' A' ' 8' ' ' VAL . 23.0 tt0 -71.27 127.19 31.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.441 0.162 . . . . 0.0 110.572 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HG2' HG23 ' A' ' 7' ' ' THR . 33.9 mtmm -81.9 107.37 14.57 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 171.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.597 HD23 HG22 ' A' ' 8' ' ' VAL . 4.2 pp -105.47 134.36 48.7 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 175.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.439 ' N ' HD12 ' A' ' 46' ' ' ILE . 1.9 mp -62.45 136.58 25.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.746 ' O ' ' HB ' ' A' ' 4' ' ' THR . 7.7 p -145.59 125.94 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.636 ' HD3' ' O ' ' A' ' 2' ' ' THR . 36.6 pttt -146.65 116.97 7.41 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.091 175.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -79.41 108.13 12.7 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 147.8 83.87 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -175.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.2 m . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.733 -0.651 . . . . 0.0 109.833 178.485 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.581 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.5 m -61.93 -42.29 98.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.913 0.387 . . . . 0.0 110.909 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -95.16 142.8 27.18 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 172.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.754 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 47.7 m -114.01 151.3 32.61 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.515 ' HB3' HD13 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -132.11 153.95 49.96 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 121.772 -0.58 . . . . 0.0 110.296 174.177 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.491 ' OH ' ' HB2' ' A' ' 9' ' ' LYS . 1.4 t80 -145.94 142.41 28.69 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.045 -173.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.39 121.27 28.71 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 174.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.542 HG21 HG23 ' A' ' 39' ' ' ILE . 95.0 t -56.91 125.47 12.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.556 -175.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.654 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -92.15 -173.81 3.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.955 176.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.6 m -43.87 -17.69 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.726 ' HA2' ' HE2' ' A' ' 16' ' ' LYS . . . -75.26 52.59 2.62 Favored Glycine 0 C--O 1.222 -0.622 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 168.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -57.58 -3.43 0.19 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -169.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.406 ' O ' HG12 ' A' ' 17' ' ' ILE . 7.9 m -114.77 149.36 37.06 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 121.301 -0.875 . . . . 0.0 109.236 -173.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.815 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 0.7 OUTLIER -53.92 -47.27 71.36 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.605 0.566 . . . . 0.0 110.612 -171.821 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -69.23 -29.18 67.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.056 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.726 ' HE2' ' HA2' ' A' ' 11' ' ' GLY . 60.0 mtpt -71.06 -48.7 51.13 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.522 -178.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.694 HG23 ' O ' ' A' ' 11' ' ' GLY . 4.9 pt -74.31 -41.63 50.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.66 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.23 -49.36 76.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 0.0 111.146 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.38 -22.56 60.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.743 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.513 ' OE1' ' HA ' ' A' ' 20' ' ' GLN . 5.7 tp60 -68.13 -47.26 68.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.478 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.566 ' HE1' HG12 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -100.93 2.79 41.12 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.765 178.664 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.33 48.92 7.1 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.92 -0.657 . . . . 0.0 114.479 169.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.573 HG22 ' OD1' ' A' ' 27' ' ' ASN . 3.0 p -122.74 162.83 22.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 170.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.0 t -74.94 146.5 41.72 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.853 0.835 . . . . 0.0 111.241 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.681 HG13 HD12 ' A' ' 14' ' ' LEU . 91.2 t -58.91 -35.76 58.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.169 172.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.47 -46.61 69.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.233 -175.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.573 ' OD1' HG22 ' A' ' 23' ' ' VAL . 6.9 p30 -74.87 -43.58 53.64 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.491 -174.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.799 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -68.43 -31.99 71.7 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.834 -178.004 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.644 ' HE ' ' HG ' ' A' ' 14' ' ' LEU . 96.5 mtt180 -66.99 -35.81 80.78 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.887 172.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.6 t -64.38 -45.26 88.48 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -172.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.799 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER -89.02 -2.12 58.43 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.148 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.532 ' HB3' HG12 ' A' ' 34' ' ' ILE . 46.4 m-80 -107.19 -23.53 12.24 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.29 176.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.01 38.61 76.29 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -172.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.532 HG12 ' HB3' ' A' ' 32' ' ' ASN . 15.3 mm -114.42 130.12 69.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.142 0.496 . . . . 0.0 111.815 -171.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.556 ' HB2' HD21 ' A' ' 38' ' ' LEU . 8.2 m -79.06 118.1 20.73 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 169.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.815 ' HA3' ' HB2' ' A' ' 14' ' ' LEU . . . -63.19 -0.88 3.56 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-N 116.229 -0.442 . . . . 0.0 114.151 -175.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -74.59 -37.7 62.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.793 0.33 . . . . 0.0 110.482 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.556 HD21 ' HB2' ' A' ' 35' ' ' SER . 0.4 OUTLIER -96.78 35.56 1.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.034 0.445 . . . . 0.0 111.326 -179.359 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.542 HG23 HG21 ' A' ' 8' ' ' VAL . 14.1 mt -96.47 136.61 26.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 175.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -142.28 171.04 14.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.011 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 61.0 t -64.74 128.63 27.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.59 -10.27 60.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.005 -177.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -61.47 127.99 34.13 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 122.44 0.296 . . . . 0.0 110.427 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -92.73 107.21 19.04 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.746 HD23 HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -124.17 140.61 52.8 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.16 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.515 HD13 ' HB3' ' A' ' 5' ' ' TYR . 49.6 mm -70.3 131.51 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.198 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.754 ' O ' ' HB ' ' A' ' 4' ' ' THR . 11.3 p -136.95 123.49 29.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 122.46 1.124 . . . . 0.0 109.36 173.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -135.64 136.79 41.25 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.705 175.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -79.05 106.22 10.93 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.287 0.565 . . . . 0.0 111.218 -174.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -124.44 20.8 6.9 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 172.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.2 m . . . . . 0 C--O 1.246 0.892 0 CA-C-N 114.561 -0.819 . . . . 0.0 109.097 -178.168 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.933 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.0 m -85.41 68.06 10.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.659 0.742 . . . . 0.0 110.151 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -104.89 113.06 26.43 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.704 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 83.6 m -99.31 157.27 16.51 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -127.42 150.91 49.42 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.621 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.428 ' CE2' ' HA ' ' A' ' 8' ' ' VAL . 55.7 t80 -117.23 120.77 39.26 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.979 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.57 111.82 5.65 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.06 0.457 . . . . 0.0 109.974 170.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 68.7 t -57.34 127.81 16.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.812 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.28 -174.05 2.38 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.9 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.1 m -41.16 -26.47 0.05 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -173.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.662 ' O ' HG23 ' A' ' 17' ' ' ILE . . . -76.79 59.55 3.43 Favored Glycine 0 C--O 1.225 -0.465 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 170.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -59.27 -1.3 0.19 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -171.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.501 ' O ' HG12 ' A' ' 17' ' ' ILE . 2.3 m -112.69 147.98 35.65 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.515 -0.741 . . . . 0.0 110.383 -168.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -54.45 -48.1 72.14 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.875 -169.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -62.32 -36.56 82.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.016 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 29.1 mmmt -73.56 -47.29 41.82 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.283 -173.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 11' ' ' GLY . 6.9 pt -74.69 -41.52 47.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -177.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.72 -49.86 76.1 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.125 0.266 . . . . 0.0 111.196 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.02 -23.71 62.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.077 0.465 . . . . 0.0 110.335 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.503 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 63.7 tt0 -59.96 -46.81 88.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.172 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.476 ' CE1' HG21 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -106.27 13.6 28.59 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.737 179.344 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.19 49.06 17.2 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.645 171.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.682 HG22 ' OD1' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -131.38 175.72 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.208 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.68 ' HB2' HD21 ' A' ' 27' ' ' ASN . 47.7 m -110.86 152.15 27.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.407 0.622 . . . . 0.0 111.699 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.421 HG12 ' HD2' ' A' ' 29' ' ' ARG . 43.8 t -57.73 -40.02 73.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.769 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.31 -47.04 86.87 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.312 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.682 ' OD1' HG22 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -71.7 -41.89 68.04 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -176.044 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.9 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 3.2 pp -69.14 -32.33 71.61 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 118.331 -1.348 . . . . 0.0 111.79 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.421 ' HD2' HG12 ' A' ' 25' ' ' VAL . 32.0 mtp-105 -63.85 -33.7 76.28 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.055 172.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.8 t -68.8 -45.05 72.26 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.35 -174.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.9 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER -90.72 -2.56 57.81 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.096 -178.486 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -95.0 -22.09 18.17 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.825 174.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.61 14.23 77.79 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.766 175.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.97 161.86 28.11 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 CA-C-O 121.286 0.565 . . . . 0.0 111.622 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.4 t -79.48 141.8 36.42 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 171.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.31 51.43 3.28 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.704 -176.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -101.4 -42.21 6.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.195 0.521 . . . . 0.0 109.652 177.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.785 HD23 ' H ' ' A' ' 38' ' ' LEU . 1.4 pt? -96.36 96.96 9.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.088 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.631 HG23 HG21 ' A' ' 8' ' ' VAL . 4.3 mt -139.68 117.39 10.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 171.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.593 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 50.0 p90 -144.41 166.88 23.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.156 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 46.2 t -60.4 129.23 22.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.293 -177.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.77 -15.29 59.78 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.382 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.433 ' OE1' ' HA ' ' A' ' 39' ' ' ILE . 44.2 tt0 -75.28 129.47 37.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.544 0.212 . . . . 0.0 111.076 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -92.11 107.34 19.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.812 0.339 . . . . 0.0 110.237 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.636 HD21 HD12 ' A' ' 17' ' ' ILE . 3.4 pp -109.65 138.58 45.82 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 175.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.457 ' N ' HD12 ' A' ' 46' ' ' ILE . 1.8 mp -65.49 139.35 21.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.063 0.459 . . . . 0.0 110.371 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.704 ' O ' ' HB ' ' A' ' 4' ' ' THR . 11.3 p -149.1 129.13 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 172.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -151.02 155.77 39.73 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.318 0.58 . . . . 0.0 112.223 175.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -112.5 131.25 55.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.795 172.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 136.85 -112.77 0.97 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.128 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.4 t . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.607 -0.711 . . . . 0.0 109.669 -178.862 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.635 0 N-CA-C 111.876 -0.49 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.8 m -131.15 125.09 32.15 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.647 0.261 . . . . 0.0 110.451 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -74.04 149.55 41.14 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.72 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 58.0 m -109.54 155.54 21.26 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.628 ' HB3' HD13 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -131.31 139.68 49.62 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.184 0.516 . . . . 0.0 110.674 173.435 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.437 ' HD2' HD11 ' A' ' 45' ' ' LEU . 36.1 t80 -121.0 141.53 50.65 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.113 -173.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.49 ' O ' ' HG2' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -87.87 120.75 29.5 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.979 171.816 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.73 HG21 HG23 ' A' ' 39' ' ' ILE . 57.5 t -57.35 127.25 16.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.135 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 7' ' ' THR . 66.1 mmtt -129.72 -178.07 4.54 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.5 m -42.95 125.55 3.55 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.357 0.599 . . . . 0.0 110.11 177.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.609 ' O ' HG23 ' A' ' 17' ' ' ILE . . . 104.52 29.58 5.29 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 108.561 -1.816 . . . . 0.0 108.561 -158.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.546 ' O ' HG22 ' A' ' 39' ' ' ILE . 4.3 p30 -59.84 0.09 0.17 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.454 1.502 . . . . 0.0 114.675 -169.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.531 ' O ' HG12 ' A' ' 17' ' ' ILE . 5.8 m -112.22 145.36 40.05 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 121.571 -0.705 . . . . 0.0 110.19 -172.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.518 ' HG ' HD12 ' A' ' 39' ' ' ILE . 7.0 mp -53.99 -46.48 71.72 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.04 -166.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -61.72 -36.37 80.75 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.929 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 68.5 mttm -73.79 -47.17 40.78 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.851 -176.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 11' ' ' GLY . 2.4 pt -73.28 -42.92 57.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.537 -178.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.561 ' HA ' ' CE1' ' A' ' 21' ' ' TYR . . . -58.45 -49.02 78.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.039 0.447 . . . . 0.0 111.23 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.83 -22.25 60.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.683 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 35.8 tt0 -64.54 -47.51 78.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.032 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.561 ' CE1' ' HA ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -96.85 -0.3 48.05 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.456 177.45 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.58 48.44 7.28 Favored Glycine 0 N--CA 1.453 -0.17 0 C-N-CA 120.894 -0.67 . . . . 0.0 114.062 171.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.661 HG22 ' OD1' ' A' ' 27' ' ' ASN . 1.1 p -126.82 164.36 27.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 172.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.636 ' HB2' ' ND2' ' A' ' 27' ' ' ASN . 4.4 m -91.35 145.34 24.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.237 0.542 . . . . 0.0 111.338 -175.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.527 HG12 ' HD3' ' A' ' 29' ' ' ARG . 38.4 t -55.68 -34.73 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.458 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.54 -47.64 78.06 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -177.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.661 ' OD1' HG22 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -71.93 -46.35 57.91 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -176.094 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.837 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -66.27 -31.21 71.88 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.722 -177.214 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.527 ' HD3' HG12 ' A' ' 25' ' ' VAL . 27.9 mtp180 -66.44 -38.73 88.04 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.239 -0.288 . . . . 0.0 111.315 172.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 66.9 m -67.5 -45.43 75.83 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -171.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.837 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -81.74 -6.42 59.03 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.287 -176.631 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -94.74 -21.48 18.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.914 0.387 . . . . 0.0 109.958 174.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.76 43.5 99.07 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.09 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.508 HD12 ' H ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -104.94 146.56 11.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.529 177.284 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.7 m -101.78 109.55 21.34 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.179 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.38 -164.29 12.06 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.154 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -116.94 32.86 5.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.963 0.411 . . . . 0.0 110.736 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.33 101.87 4.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.779 0.8 . . . . 0.0 111.419 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.73 HG23 HG21 ' A' ' 8' ' ' VAL . 4.7 mt -139.94 123.57 18.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.46 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.484 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 51.5 p90 -136.38 159.8 40.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.713 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 50.2 t -62.73 129.62 26.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.071 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.89 -20.54 40.86 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.603 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -71.78 127.74 33.55 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -94.42 107.63 19.59 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.437 HD11 ' HD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -115.8 140.55 49.11 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -176.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.628 HD13 ' HB3' ' A' ' 5' ' ' TYR . 49.7 mm -66.17 135.53 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.798 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.72 ' O ' ' HB ' ' A' ' 4' ' ' THR . 13.9 p -147.33 124.63 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 122.072 0.939 . . . . 0.0 110.017 173.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.448 ' O ' ' HH2' ' A' ' 31' ' ' TRP . 57.8 tptt -136.07 124.57 23.53 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.669 171.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -72.56 107.55 5.14 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.254 0.55 . . . . 0.0 110.796 -173.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -117.18 31.21 5.93 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.173 176.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.4 m . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.701 -0.666 . . . . 0.0 109.51 -178.785 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.602 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.6 m -75.24 -57.14 4.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.967 0.413 . . . . 0.0 110.29 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.701 ' HA ' ' HD2' ' A' ' 48' ' ' LYS . 12.6 m120 -83.9 177.47 8.3 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.799 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 34.9 m -115.54 153.51 31.05 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 171.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -131.65 150.04 52.29 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.542 170.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -138.53 139.91 38.9 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.175 -171.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.72 123.67 29.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 173.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.635 HG21 HG23 ' A' ' 39' ' ' ILE . 58.8 t -56.74 116.2 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 123.717 0.635 . . . . 0.0 110.036 -177.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.677 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -103.36 -177.71 3.45 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.331 -177.708 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.3 p -42.98 112.7 0.39 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.495 0.664 . . . . 0.0 109.819 172.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.714 ' O ' HG23 ' A' ' 17' ' ' ILE . . . 123.14 34.44 0.77 Allowed Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -164.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.446 ' O ' HG22 ' A' ' 39' ' ' ILE . 10.4 p-10 -52.93 -2.64 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -170.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.437 ' OG1' ' HE2' ' A' ' 16' ' ' LYS . 2.6 m -114.13 154.31 28.02 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 121.156 -0.965 . . . . 0.0 109.99 -171.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.718 HD11 ' HA3' ' A' ' 36' ' ' GLY . 48.4 mt -53.39 -48.16 68.88 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 123.573 0.545 . . . . 0.0 111.755 -170.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -62.26 -37.07 84.06 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.24 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.437 ' HE2' ' OG1' ' A' ' 13' ' ' THR . 59.7 mtmt -74.3 -47.69 33.16 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.085 -174.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.714 HG23 ' O ' ' A' ' 11' ' ' GLY . 12.1 pt -72.88 -45.22 56.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.467 -177.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.465 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -58.54 -49.59 76.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.784 0.325 . . . . 0.0 111.578 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.16 -22.78 63.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.658 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -47.12 86.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.935 177.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.621 ' CE1' HG21 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -107.38 13.56 26.87 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.209 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.523 ' O ' ' HE2' ' A' ' 49' ' ' LYS . . . 78.44 31.48 45.87 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.988 -0.625 . . . . 0.0 114.43 168.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.482 ' CG1' HD23 ' A' ' 28' ' ' LEU . 10.9 p -114.68 159.84 14.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.499 ' HB2' ' OD1' ' A' ' 27' ' ' ASN . 19.2 m -93.69 153.33 18.41 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-O 121.59 0.71 . . . . 0.0 110.735 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.414 HG12 ' CD ' ' A' ' 29' ' ' ARG . 76.8 t -56.86 -38.92 61.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.862 178.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.86 -48.32 81.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -175.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.499 ' OD1' ' HB2' ' A' ' 24' ' ' SER . 1.6 p-10 -75.55 -34.34 60.72 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -175.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.89 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 3.9 pp -71.69 -31.75 67.11 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 118.221 -1.392 . . . . 0.0 111.107 177.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.495 ' N ' HD12 ' A' ' 28' ' ' LEU . 75.0 mtp180 -64.37 -34.68 78.72 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.636 173.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 52.0 m -71.22 -44.91 64.44 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -173.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.89 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -84.55 -2.53 57.5 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.137 -178.411 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.489 ' HB3' ' CG1' ' A' ' 34' ' ' ILE . 26.7 m-80 -100.04 -22.32 15.27 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.475 174.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.08 33.97 81.78 Favored Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -169.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.489 ' CG1' ' HB3' ' A' ' 32' ' ' ASN . 19.3 mm -119.18 126.54 75.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.327 -0.436 . . . . 0.0 111.543 -170.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -72.66 113.47 9.73 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 166.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.718 ' HA3' HD11 ' A' ' 14' ' ' LEU . . . -68.01 6.97 2.61 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 114.552 0.581 . . . . 0.0 114.552 -170.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.1 -33.92 75.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.148 0.499 . . . . 0.0 110.155 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.447 HD11 HG23 ' A' ' 34' ' ' ILE . 1.9 pp -96.24 38.44 1.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.149 -176.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.635 HG23 HG21 ' A' ' 8' ' ' VAL . 5.2 mt -92.95 132.49 37.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.974 0.416 . . . . 0.0 110.166 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -149.35 161.36 42.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.488 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 97.1 t -61.41 129.98 24.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.318 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.36 -20.8 36.67 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.979 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.507 ' OE1' ' HA ' ' A' ' 39' ' ' ILE . 27.4 tt0 -70.28 132.45 45.72 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.425 -0.388 . . . . 0.0 110.508 177.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.588 ' HB3' ' NZ ' ' A' ' 44' ' ' LYS . 2.4 ttpm? -97.15 107.36 19.87 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.82 143.34 45.54 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 -178.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.8 mp -67.42 136.28 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.952 0.406 . . . . 0.0 110.718 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.799 ' O ' ' HB ' ' A' ' 4' ' ' THR . 7.9 p -150.58 129.31 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-O 121.606 0.717 . . . . 0.0 109.266 173.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.701 ' HD2' ' HA ' ' A' ' 3' ' ' ASN . 54.8 tttm -139.93 121.76 15.48 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.584 -0.697 . . . . 0.0 110.861 171.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.523 ' HE2' ' O ' ' A' ' 22' ' ' GLY . 5.4 tmtt? -82.95 108.79 16.53 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.18 83.43 1.71 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.786 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.7 m . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.645 177.872 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.717 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.6 p -80.68 73.33 7.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.71 0.766 . . . . 0.0 109.886 174.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -84.56 162.84 19.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.082 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.548 ' H ' ' HB2' ' A' ' 48' ' ' LYS . 49.4 m -99.51 155.79 17.38 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.704 ' HB3' HD13 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -130.18 139.28 50.87 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.136 0.493 . . . . 0.0 109.859 173.111 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CE2' ' HA ' ' A' ' 8' ' ' VAL . 10.1 t80 -123.11 137.42 54.92 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.329 -172.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.446 ' O ' ' HG2' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -83.9 119.7 25.2 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.08 172.721 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.695 HG21 HG23 ' A' ' 39' ' ' ILE . 61.3 t -56.68 123.15 7.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.426 -176.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 7' ' ' THR . 28.0 mmtp -116.93 -176.05 2.9 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.646 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.4 m -41.12 113.47 0.39 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.61 0.719 . . . . 0.0 110.341 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.664 ' O ' HG23 ' A' ' 17' ' ' ILE . . . 119.02 37.81 0.79 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 -163.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.47 ' O ' HG22 ' A' ' 39' ' ' ILE . 4.1 p30 -53.79 -1.88 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.578 1.551 . . . . 0.0 114.998 -172.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 m -114.12 152.59 30.88 Favored 'General case' 0 C--N 1.309 -1.152 0 O-C-N 121.439 -0.788 . . . . 0.0 110.01 -169.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.634 HD22 HG13 ' A' ' 25' ' ' VAL . 52.9 mt -53.11 -46.61 68.8 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.977 -171.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -62.11 -36.94 83.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -73.87 -48.88 27.89 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.718 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.664 HG23 ' O ' ' A' ' 11' ' ' GLY . 14.3 pt -74.37 -44.68 48.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.762 -176.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.462 ' HA ' ' CE1' ' A' ' 21' ' ' TYR . . . -59.79 -48.84 80.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.891 0.377 . . . . 0.0 111.189 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.06 -21.88 62.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.851 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -63.38 -46.71 85.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.262 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.462 ' CE1' ' HA ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -99.71 6.05 45.62 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.101 0.477 . . . . 0.0 111.221 176.192 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.28 48.33 11.17 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.854 -0.612 . . . . 0.0 114.125 170.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.11 168.43 23.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 173.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.465 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 47.6 t -91.59 146.86 23.44 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 122.368 1.08 . . . . 0.0 112.032 -176.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.634 HG13 HD22 ' A' ' 14' ' ' LEU . 60.7 t -59.29 -32.11 47.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.341 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.06 83.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.44 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.49 ' HB2' ' CH2' ' A' ' 31' ' ' TRP . 1.3 p-10 -68.4 -45.1 73.58 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.666 -177.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.776 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 2.8 pp -67.92 -32.13 72.38 Favored 'General case' 0 C--O 1.227 -0.12 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.404 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.532 ' HD2' HG12 ' A' ' 25' ' ' VAL . 36.0 mtt-85 -61.81 -34.6 76.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.77 0.319 . . . . 0.0 110.97 172.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.7 t -71.28 -45.49 63.02 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.776 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 1.0 OUTLIER -89.2 -1.78 58.23 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -176.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.404 ' O ' HG13 ' A' ' 34' ' ' ILE . 22.8 m-80 -95.15 -21.58 18.41 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.414 174.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.51 21.79 72.79 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.113 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 32' ' ' ASN . 20.5 mt -130.09 146.31 34.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.4 m -68.21 108.79 3.3 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 166.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.419 ' O ' HG13 ' A' ' 39' ' ' ILE . . . -69.17 10.54 1.73 Allowed Glycine 0 C--O 1.228 -0.253 0 C-N-CA 121.395 -0.431 . . . . 0.0 113.928 -173.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -60.7 -36.79 79.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.939 0.399 . . . . 0.0 110.437 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.652 HD23 ' H ' ' A' ' 38' ' ' LEU . 0.7 OUTLIER -96.72 90.51 5.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.744 176.416 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.695 HG23 HG21 ' A' ' 8' ' ' VAL . 5.7 mt -123.0 134.31 66.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.0 176.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -137.14 160.9 37.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.563 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 61.9 t -65.04 128.78 28.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.488 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.75 -15.49 48.72 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.204 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -75.45 127.85 34.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.758 0.313 . . . . 0.0 110.265 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -89.6 107.18 18.94 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.416 HD22 ' C ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -114.99 140.88 48.68 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.704 HD13 ' HB3' ' A' ' 5' ' ' TYR . 42.8 mm -68.23 137.45 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.281 -176.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.518 ' O ' ' HB ' ' A' ' 4' ' ' THR . 8.5 p -146.76 112.68 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.625 0.726 . . . . 0.0 110.48 173.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.548 ' HB2' ' H ' ' A' ' 4' ' ' THR . 58.3 tptt 178.51 118.21 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.955 169.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -88.85 112.73 23.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.365 -176.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.62 114.99 3.46 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.353 172.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.343 -0.837 . . . . 0.0 109.482 173.151 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.469 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 89.5 m -82.98 110.78 18.25 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.847 0.356 . . . . 0.0 110.657 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.48 ' HA ' ' HB3' ' A' ' 48' ' ' LYS . 3.6 p-10 -57.68 119.78 7.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.858 176.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.649 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 57.1 m -108.62 157.91 18.07 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -175.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.459 ' HB2' ' HG3' ' A' ' 44' ' ' LYS . 0.9 OUTLIER -130.85 150.0 52.22 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.101 0.476 . . . . 0.0 109.906 171.048 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.455 ' HD2' HD11 ' A' ' 45' ' ' LEU . 1.2 t80 -129.31 139.92 51.59 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.833 -175.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.465 HG23 ' HD3' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -82.99 120.94 26.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.142 173.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.73 HG21 HG23 ' A' ' 39' ' ' ILE . 57.8 t -56.14 124.92 10.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.132 -177.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.691 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -95.23 -175.09 3.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.498 -178.297 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.7 m -57.56 68.41 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.918 0.866 . . . . 0.0 110.849 171.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.618 ' O ' HG23 ' A' ' 17' ' ' ILE . . . -175.03 45.66 0.13 Allowed Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 107.847 -2.101 . . . . 0.0 107.847 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -52.58 -0.26 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.57 1.948 . . . . 0.0 115.406 -170.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.8 m -113.13 147.22 37.79 Favored 'General case' 0 C--N 1.311 -1.081 0 O-C-N 121.364 -0.835 . . . . 0.0 109.694 -171.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.718 HD11 ' HA3' ' A' ' 36' ' ' GLY . 54.6 mt -53.74 -47.33 70.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.116 -168.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -66.64 -30.25 70.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.968 -176.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -74.13 -47.8 33.68 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.013 0.435 . . . . 0.0 111.05 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.618 HG23 ' O ' ' A' ' 11' ' ' GLY . 11.3 pt -74.61 -40.35 47.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.605 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.442 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -58.02 -49.26 77.47 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.0 0.429 . . . . 0.0 111.232 177.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.93 -23.03 63.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.758 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -60.81 -41.82 96.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.502 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.486 ' CE1' HG21 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -107.19 8.17 29.87 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.697 177.601 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.4 48.16 11.3 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.726 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -133.11 172.58 16.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -97.34 147.32 24.29 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-O 122.297 1.046 . . . . 0.0 111.574 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.586 HG12 ' HD2' ' A' ' 29' ' ' ARG . 88.2 t -56.74 -35.92 47.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.361 176.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.12 -45.66 87.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.141 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -64.67 -46.17 83.59 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.978 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.836 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 3.4 pp -69.02 -29.49 67.67 Favored 'General case' 0 CA--C 1.523 -0.083 0 C-N-CA 118.719 -1.192 . . . . 0.0 110.853 178.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.586 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -54.54 -41.43 69.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.034 0.445 . . . . 0.0 110.443 171.117 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.6 m -75.9 -44.01 42.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.883 -170.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.836 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -91.38 -1.5 57.58 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -173.542 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.485 ' HB3' HG13 ' A' ' 34' ' ' ILE . 17.3 m-80 -94.81 -24.19 17.17 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.319 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.86 24.77 71.63 Favored Glycine 0 C--N 1.329 0.144 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.98 176.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.485 HG13 ' HB3' ' A' ' 32' ' ' ASN . 0.1 OUTLIER -130.01 161.91 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-O 121.003 0.43 . . . . 0.0 111.629 179.25 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.2 m -68.35 164.28 21.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.558 167.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.718 ' HA3' HD11 ' A' ' 14' ' ' LEU . . . -98.48 3.46 59.51 Favored Glycine 0 C--N 1.319 -0.399 0 C-N-CA 120.802 -0.714 . . . . 0.0 113.415 -172.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -79.93 -29.02 39.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.717 0.294 . . . . 0.0 110.553 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.742 HD23 ' H ' ' A' ' 38' ' ' LEU . 1.4 pt? -96.51 77.06 2.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.699 0.762 . . . . 0.0 111.201 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.73 HG23 HG21 ' A' ' 8' ' ' VAL . 4.9 mt -133.68 121.37 40.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 170.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.544 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 42.4 p90 -141.94 160.75 39.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.719 -176.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 54.0 t -56.56 128.87 17.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.935 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.76 -16.44 58.61 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.896 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.482 ' NE2' ' HA ' ' A' ' 39' ' ' ILE . 27.5 tt0 -74.96 137.94 41.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.852 0.326 . . . . 0.0 110.877 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.465 ' HD3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -95.32 107.72 19.86 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.834 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.455 HD11 ' HD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -117.0 147.08 42.62 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.89 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.42 ' N ' HD12 ' A' ' 46' ' ' ILE . 2.5 mp -70.41 137.93 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.967 0.413 . . . . 0.0 111.271 -174.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.649 ' O ' ' HB ' ' A' ' 4' ' ' THR . 8.8 p -151.67 124.72 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.735 0.779 . . . . 0.0 109.302 171.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.48 ' HB3' ' HA ' ' A' ' 3' ' ' ASN . 21.6 pttp -140.69 119.67 12.71 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.57 0.7 . . . . 0.0 111.411 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.15 158.04 33.68 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.158 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.36 43.86 60.97 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.47 177.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.52 -0.752 . . . . 0.0 109.913 177.195 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.401 ' HA ' ' HB3' ' A' ' 48' ' ' LYS . 15.0 m120 . . . . . 0 CA--C 1.519 -0.217 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.635 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 54.8 m -109.29 84.98 2.01 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 46' ' ' ILE . 2.1 p90 -85.02 123.4 30.52 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.579 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.435 ' CE2' ' HA ' ' A' ' 8' ' ' VAL . 1.0 OUTLIER -117.89 135.82 53.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.117 -167.308 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.401 HG23 ' HD3' ' A' ' 44' ' ' LYS . 1.1 p -80.92 126.21 31.09 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 173.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.74 HG21 HG23 ' A' ' 39' ' ' ILE . 34.0 t -57.14 120.28 3.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.073 -176.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -175.32 2.73 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.35 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.2 t -41.72 114.67 0.55 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.531 0.681 . . . . 0.0 110.122 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.636 ' O ' HG23 ' A' ' 17' ' ' ILE . . . 124.35 31.54 0.9 Allowed Glycine 0 C--O 1.221 -0.718 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -164.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.459 ' O ' HG22 ' A' ' 39' ' ' ILE . 6.1 p-10 -52.93 -3.34 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -170.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.885 ' HB ' ' HD3' ' A' ' 16' ' ' LYS . 7.1 m -112.92 143.68 43.78 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 121.389 -0.819 . . . . 0.0 108.92 -173.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.497 HD11 HD11 ' A' ' 28' ' ' LEU . 54.8 tp -56.52 -47.26 79.73 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 123.569 0.543 . . . . 0.0 112.053 -166.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -65.86 -31.02 71.73 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.415 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.885 ' HD3' ' HB ' ' A' ' 13' ' ' THR . 36.0 mtpt -71.43 -47.39 56.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.286 -178.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 11' ' ' GLY . 1.8 pt -74.09 -37.96 47.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.56 0.219 . . . . 0.0 111.533 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.22 -50.01 74.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.031 0.443 . . . . 0.0 110.862 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.43 -22.5 60.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.654 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.551 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 30.7 tt0 -67.28 -47.8 69.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.371 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.428 ' CE2' ' HB ' ' A' ' 17' ' ' ILE . 3.5 p90 -107.56 13.27 26.91 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.56 49.62 6.55 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.604 -0.808 . . . . 0.0 114.635 167.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.2 p -133.36 143.91 37.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 173.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.504 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 47.0 t -70.38 147.26 49.75 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.526 0.679 . . . . 0.0 110.498 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 36.5 t -57.88 -33.01 44.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.039 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.49 -48.6 64.04 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -174.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.504 ' OD1' ' HB3' ' A' ' 24' ' ' SER . 9.2 p-10 -75.9 -40.46 54.33 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.379 -0.528 . . . . 0.0 112.248 -175.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.864 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -68.98 -31.6 70.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 118.378 -1.329 . . . . 0.0 109.442 -178.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -65.04 -35.17 80.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.012 171.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 66.1 m -64.25 -43.96 93.27 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -174.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.864 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.9 OUTLIER -88.33 -2.6 58.69 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.117 -0.633 . . . . 0.0 112.682 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 . . . . . 0 N--CA 1.467 0.387 0 O-C-N 122.1 -0.375 . . . . 0.0 111.472 175.775 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.74 HG23 HG21 ' A' ' 8' ' ' VAL . 22.3 mt . . . . . 0 N--CA 1.445 -0.681 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -149.95 158.17 43.9 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 89.5 t -59.51 126.93 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 123.247 0.342 . . . . 0.0 110.77 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.45 -21.01 35.98 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.529 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.549 ' NE2' ' HA ' ' A' ' 39' ' ' ILE . 6.5 tt0 -65.33 134.71 54.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.401 ' HD3' HG23 ' A' ' 7' ' ' THR . 13.7 tptm -92.31 107.72 19.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.917 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.571 HD23 HG22 ' A' ' 8' ' ' VAL . 2.8 pp -119.82 139.34 52.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.061 0.458 . . . . 0.0 110.517 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.477 HD12 ' N ' ' A' ' 46' ' ' ILE . 2.8 mp -76.3 137.45 22.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.148 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.635 ' O ' ' HB ' ' A' ' 4' ' ' THR . 11.2 p -144.6 115.78 2.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.748 0.785 . . . . 0.0 109.378 166.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.547 ' HD2' ' O ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.8 0 O-C-N 121.535 -0.728 . . . . 0.0 112.578 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.949 0.404 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.702 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 96.4 m -112.91 154.12 26.88 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.622 ' HB3' HD13 ' A' ' 46' ' ' ILE . 1.8 p90 -130.84 145.66 52.05 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 169.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.401 ' HD2' HD11 ' A' ' 45' ' ' LEU . 58.7 t80 -116.84 132.67 56.64 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.86 -173.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.41 116.24 19.52 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 168.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.757 HG21 HG23 ' A' ' 39' ' ' ILE . 59.7 t -58.12 125.37 14.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.388 -177.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 25.0 mmtt -103.83 -174.22 2.49 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.06 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.5 m -42.25 -26.6 0.11 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -173.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.478 ' O ' HG23 ' A' ' 17' ' ' ILE . . . -76.67 66.81 2.68 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 168.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.479 ' O ' HG22 ' A' ' 39' ' ' ILE . 3.5 p30 -63.32 -3.1 1.73 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -168.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.503 ' O ' HG12 ' A' ' 17' ' ' ILE . 1.9 m -113.59 143.48 44.49 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 119.064 -1.055 . . . . 0.0 110.067 -167.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.639 HD11 HD11 ' A' ' 28' ' ' LEU . 14.3 tp -55.91 -46.0 78.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.803 -169.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -61.48 -35.85 78.82 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.398 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -71.67 -47.34 54.91 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.815 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.503 HG12 ' O ' ' A' ' 13' ' ' THR . 4.5 pt -74.09 -37.33 46.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.776 -177.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 23' ' ' VAL . . . -57.1 -49.34 76.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.106 0.479 . . . . 0.0 110.834 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.58 -21.8 61.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.723 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -65.17 -47.22 77.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.064 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.442 ' HD1' HG12 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -106.71 7.88 30.7 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 179.534 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.63 49.33 6.67 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 120.517 -0.849 . . . . 0.0 114.348 169.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.442 HG12 ' HD1' ' A' ' 21' ' ' TYR . 6.4 p -132.52 143.82 38.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 172.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.503 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 45.1 t -70.03 148.37 48.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.456 0.646 . . . . 0.0 110.603 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.539 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 78.8 t -52.84 -40.97 37.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.439 174.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.416 ' HA ' ' NE ' ' A' ' 29' ' ' ARG . . . -63.35 -49.07 75.35 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -171.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.503 ' OD1' ' HB3' ' A' ' 24' ' ' SER . 5.2 p-10 -76.51 -35.75 58.16 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 120.443 -0.503 . . . . 0.0 112.29 -175.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.811 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -72.76 -32.77 65.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 119.121 -1.031 . . . . 0.0 110.432 -177.026 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 25' ' ' VAL . 40.5 ptt85 -72.78 -31.47 64.89 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 121.506 -0.746 . . . . 0.0 111.053 174.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 72.5 m -64.98 -45.25 86.41 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -176.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.811 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -78.28 -2.84 39.87 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.527 179.734 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.851 174.563 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.757 HG23 HG21 ' A' ' 8' ' ' VAL . 9.5 mt . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.501 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 55.0 p90 -131.34 159.72 37.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.636 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 51.7 t -64.16 131.07 29.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.695 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.46 -13.3 64.43 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.2 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.713 HE22 HG12 ' A' ' 39' ' ' ILE . 28.7 tt0 -70.34 128.64 36.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.97 0.414 . . . . 0.0 111.162 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -81.65 109.12 15.78 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.55 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.454 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -121.93 138.16 54.51 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 175.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.622 HD13 ' HB3' ' A' ' 5' ' ' TYR . 45.4 mm -65.45 138.08 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.15 0.5 . . . . 0.0 111.435 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.702 ' O ' ' HB ' ' A' ' 4' ' ' THR . 10.0 p -155.18 130.99 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.95 172.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.3 pttt . . . . . 0 C--N 1.304 -1.404 0 O-C-N 121.232 -0.918 . . . . 0.0 111.375 169.094 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.532 ' HA ' ' HB3' ' A' ' 48' ' ' LYS . 4.5 p-10 . . . . . 0 CA--C 1.52 -0.207 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.612 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 97.9 m -132.32 158.94 40.58 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -130.65 146.69 52.2 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.058 0.456 . . . . 0.0 110.311 171.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -117.73 126.1 51.85 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.189 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.44 HG23 ' HG2' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -70.79 119.76 15.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.285 174.049 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.618 HG22 HD23 ' A' ' 45' ' ' LEU . 97.2 t -57.13 116.66 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.088 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.802 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 10.5 mmpt? -102.34 -173.47 2.34 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.221 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.1 m -44.04 -18.35 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.71 60.39 0.93 Allowed Glycine 0 C--O 1.223 -0.562 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 166.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -68.27 -3.39 10.7 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 123.698 0.799 . . . . 0.0 113.148 -172.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.506 ' O ' HG12 ' A' ' 17' ' ' ILE . 25.6 m -116.81 143.76 45.3 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.571 -0.452 . . . . 0.0 109.83 -173.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.784 ' HB3' HG13 ' A' ' 25' ' ' VAL . 3.5 mm? -55.19 -47.42 75.28 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.739 0.649 . . . . 0.0 111.21 -172.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -67.23 -31.11 71.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.281 -175.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.42 ' HE2' ' HB ' ' A' ' 13' ' ' THR . 54.8 mtmt -72.0 -47.88 48.81 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.988 0.423 . . . . 0.0 110.763 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.561 HD11 HD13 ' A' ' 39' ' ' ILE . 4.3 pt -74.74 -38.13 44.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.921 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.5 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -57.3 -48.42 78.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.088 0.47 . . . . 0.0 110.865 177.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.2 -24.45 64.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.756 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -60.35 -47.45 86.02 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.508 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -104.88 12.99 31.88 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.911 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.13 48.78 37.37 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.701 170.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.41 HG22 ' OD1' ' A' ' 27' ' ' ASN . 1.3 p -131.61 171.25 18.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.468 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 48.0 t -88.1 145.33 26.0 Favored 'General case' 0 C--O 1.251 1.159 0 CA-C-O 122.433 1.111 . . . . 0.0 111.662 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.784 HG13 ' HB3' ' A' ' 14' ' ' LEU . 21.1 t -61.3 -32.28 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 114.141 -1.391 . . . . 0.0 109.679 175.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.89 -46.77 83.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.761 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.468 ' OD1' ' HB3' ' A' ' 24' ' ' SER . 1.8 p-10 -67.13 -46.3 74.55 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.48 -177.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.826 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 2.3 pp -70.61 -31.18 68.06 Favored 'General case' 0 C--O 1.228 -0.067 0 C-N-CA 118.514 -1.274 . . . . 0.0 112.197 -177.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.54 ' HD3' HG12 ' A' ' 25' ' ' VAL . 25.6 mtp-105 -64.66 -36.45 84.29 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 122.137 -0.352 . . . . 0.0 111.144 173.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.1 t -73.22 -46.55 49.63 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -171.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.826 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -83.56 -5.49 59.19 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.721 -176.184 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 . . . . . 0 C--N 1.326 -0.438 0 CA-C-O 120.9 0.381 . . . . 0.0 110.205 172.865 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.561 HD13 HD11 ' A' ' 17' ' ' ILE . 1.5 mt . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -127.26 151.3 48.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.373 -173.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 57.3 t -59.81 139.7 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.552 -175.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.96 -21.64 44.98 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.43 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.435 ' O ' HG23 ' A' ' 8' ' ' VAL . 21.5 tt0 -73.03 127.35 32.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.603 0.239 . . . . 0.0 110.734 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.44 ' HG2' HG23 ' A' ' 7' ' ' THR . 94.6 mttt -85.86 106.47 17.09 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 171.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.618 HD23 HG22 ' A' ' 8' ' ' VAL . 4.6 pp -101.42 140.35 35.83 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.492 ' HB ' ' CD1' ' A' ' 31' ' ' TRP . 50.3 mm -63.71 135.21 28.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.413 0.625 . . . . 0.0 110.817 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.612 ' O ' ' HB ' ' A' ' 4' ' ' THR . 7.6 p -149.44 120.76 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.351 171.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 3' ' ' ASN . 51.9 pttt . . . . . 0 C--N 1.308 -1.219 0 O-C-N 121.872 -0.517 . . . . 0.0 111.617 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.6 m120 . . . . . 0 CA--C 1.516 -0.333 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.746 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 92.4 m -107.1 154.63 20.87 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 173.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -130.26 145.38 51.75 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.293 172.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -117.68 115.59 25.37 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.205 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.426 HG23 ' HG2' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -66.03 117.29 8.16 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 169.263 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.597 HG22 HD23 ' A' ' 45' ' ' LEU . 74.7 t -56.75 118.28 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.568 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.832 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 10.1 mmpt? -99.85 -173.21 2.39 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.035 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.1 t -42.82 -17.77 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.902 ' HA2' ' HE3' ' A' ' 16' ' ' LYS . . . -74.18 61.88 2.2 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 167.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -66.4 -3.56 6.32 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -173.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.568 ' O ' HG12 ' A' ' 17' ' ' ILE . 2.8 m -115.8 143.89 44.76 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.002 -170.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.642 ' HB3' HG13 ' A' ' 25' ' ' VAL . 4.0 mm? -55.52 -50.02 71.08 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.228 -171.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -69.47 -29.9 67.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.904 -175.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.902 ' HE3' ' HA2' ' A' ' 11' ' ' GLY . 32.2 ttpt -72.34 -47.48 49.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.956 -176.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 13' ' ' THR . 5.1 pt -74.68 -39.57 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.813 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 23' ' ' VAL . . . -57.02 -49.0 77.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.002 0.43 . . . . 0.0 110.864 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.27 -22.17 61.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.74 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -64.96 -47.7 76.67 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.65 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.47 ' CE1' HG21 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -108.03 11.32 27.85 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -178.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.4 48.62 7.28 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.282 169.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.418 ' O ' ' HB1' ' A' ' 18' ' ' ALA . 14.8 p -134.7 160.21 41.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 172.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.584 ' HB2' ' OD1' ' A' ' 27' ' ' ASN . 66.8 m -90.66 149.15 22.2 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.782 0.801 . . . . 0.0 111.083 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.642 HG13 ' HB3' ' A' ' 14' ' ' LEU . 14.5 t -59.08 -36.4 62.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.626 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.66 -48.07 82.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.902 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.584 ' OD1' ' HB2' ' A' ' 24' ' ' SER . 0.3 OUTLIER -75.37 -36.0 61.01 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -176.601 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.906 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 3.0 pp -71.14 -30.65 66.74 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 118.046 -1.462 . . . . 0.0 111.607 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.406 ' N ' HD12 ' A' ' 28' ' ' LEU . 77.8 mtt180 -59.71 -44.78 93.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.819 0.342 . . . . 0.0 110.906 171.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 64.8 m -69.8 -43.94 71.05 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -171.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.906 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -82.18 -4.05 56.22 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.533 -178.477 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 . . . . . 0 C--N 1.326 -0.419 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.677 174.108 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.516 HD13 HD11 ' A' ' 17' ' ' ILE . 3.0 mt . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.223 0.535 . . . . 0.0 109.967 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.468 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 19.5 p90 -134.63 154.81 51.33 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.406 -175.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 41.8 t -63.08 132.31 28.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.272 -173.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.7 -20.93 40.18 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.419 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.417 ' O ' HG23 ' A' ' 8' ' ' VAL . 23.0 tt0 -71.27 127.19 31.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.441 0.162 . . . . 0.0 110.572 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HG2' HG23 ' A' ' 7' ' ' THR . 33.9 mtmm -81.9 107.37 14.57 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 171.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.597 HD23 HG22 ' A' ' 8' ' ' VAL . 4.2 pp -105.47 134.36 48.7 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 175.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.439 HD12 ' N ' ' A' ' 46' ' ' ILE . 1.9 mp -62.45 136.58 25.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.746 ' O ' ' HB ' ' A' ' 4' ' ' THR . 7.7 p -145.59 125.94 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.522 ' HE3' ' CE3' ' A' ' 31' ' ' TRP . 36.6 pttt . . . . . 0 C--N 1.301 -1.506 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.091 175.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.754 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 47.7 m -114.01 151.3 32.61 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.515 ' HB3' HD13 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -132.11 153.95 49.96 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 121.772 -0.58 . . . . 0.0 110.296 174.177 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.491 ' OH ' ' HB2' ' A' ' 9' ' ' LYS . 1.4 t80 -145.94 142.41 28.69 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.045 -173.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.39 121.27 28.71 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 174.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.542 HG21 HG23 ' A' ' 39' ' ' ILE . 95.0 t -56.91 125.47 12.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.556 -175.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.654 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -92.15 -173.81 3.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.955 176.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.6 m -43.87 -17.69 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.726 ' HA2' ' HE2' ' A' ' 16' ' ' LYS . . . -75.26 52.59 2.62 Favored Glycine 0 C--O 1.222 -0.622 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 168.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -57.58 -3.43 0.19 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -169.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.406 ' O ' HG12 ' A' ' 17' ' ' ILE . 7.9 m -114.77 149.36 37.06 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 121.301 -0.875 . . . . 0.0 109.236 -173.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.681 HD12 HG13 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -53.92 -47.27 71.36 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.605 0.566 . . . . 0.0 110.612 -171.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -69.23 -29.18 67.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.056 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.726 ' HE2' ' HA2' ' A' ' 11' ' ' GLY . 60.0 mtpt -71.06 -48.7 51.13 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.522 -178.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.694 HG23 ' O ' ' A' ' 11' ' ' GLY . 4.9 pt -74.31 -41.63 50.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.66 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.23 -49.36 76.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 0.0 111.146 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.38 -22.56 60.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.743 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.513 ' HA ' ' OE1' ' A' ' 20' ' ' GLN . 5.7 tp60 -68.13 -47.26 68.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.478 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.566 ' HE1' HG12 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -100.93 2.79 41.12 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.765 178.664 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.33 48.92 7.1 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.92 -0.657 . . . . 0.0 114.479 169.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.573 HG22 ' OD1' ' A' ' 27' ' ' ASN . 3.0 p -122.74 162.83 22.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 170.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.0 t -74.94 146.5 41.72 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.853 0.835 . . . . 0.0 111.241 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.681 HG13 HD12 ' A' ' 14' ' ' LEU . 91.2 t -58.91 -35.76 58.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.169 172.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.47 -46.61 69.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.233 -175.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.573 ' OD1' HG22 ' A' ' 23' ' ' VAL . 6.9 p30 -74.87 -43.58 53.64 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.491 -174.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.799 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -68.43 -31.99 71.7 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.834 -178.004 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.644 ' HE ' ' HG ' ' A' ' 14' ' ' LEU . 96.5 mtt180 -66.99 -35.81 80.78 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.887 172.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.6 t -64.38 -45.26 88.48 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -172.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.799 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER -89.02 -2.12 58.43 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.148 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 . . . . . 0 C--N 1.327 -0.379 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.29 176.188 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.542 HG23 HG21 ' A' ' 8' ' ' VAL . 14.1 mt . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -142.28 171.04 14.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.011 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 61.0 t -64.74 128.63 27.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.59 -10.27 60.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.005 -177.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -61.47 127.99 34.13 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 122.44 0.296 . . . . 0.0 110.427 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -92.73 107.21 19.04 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.746 HD23 HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -124.17 140.61 52.8 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.16 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.515 HD13 ' HB3' ' A' ' 5' ' ' TYR . 49.6 mm -70.3 131.51 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.198 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.754 ' O ' ' HB ' ' A' ' 4' ' ' THR . 11.3 p -136.95 123.49 29.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 122.46 1.124 . . . . 0.0 109.36 173.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.8 tttp . . . . . 0 C--N 1.297 -1.675 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.705 175.711 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.9 t30 . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.704 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 83.6 m -99.31 157.27 16.51 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -127.42 150.91 49.42 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.621 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.428 ' CE2' ' HA ' ' A' ' 8' ' ' VAL . 55.7 t80 -117.23 120.77 39.26 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.979 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.57 111.82 5.65 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.06 0.457 . . . . 0.0 109.974 170.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 68.7 t -57.34 127.81 16.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.812 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.28 -174.05 2.38 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.9 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.1 m -41.16 -26.47 0.05 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -173.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.662 ' O ' HG23 ' A' ' 17' ' ' ILE . . . -76.79 59.55 3.43 Favored Glycine 0 C--O 1.225 -0.465 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 170.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -59.27 -1.3 0.19 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -171.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.501 ' O ' HG12 ' A' ' 17' ' ' ILE . 2.3 m -112.69 147.98 35.65 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.515 -0.741 . . . . 0.0 110.383 -168.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -54.45 -48.1 72.14 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.875 -169.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -62.32 -36.56 82.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.016 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 29.1 mmmt -73.56 -47.29 41.82 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.283 -173.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 11' ' ' GLY . 6.9 pt -74.69 -41.52 47.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -177.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.72 -49.86 76.1 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.125 0.266 . . . . 0.0 111.196 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.02 -23.71 62.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.077 0.465 . . . . 0.0 110.335 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.503 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 9.7 tt0 -59.96 -46.81 88.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.172 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.476 ' CE1' HG21 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -106.27 13.6 28.59 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.737 179.344 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.19 49.06 17.2 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.645 171.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.682 HG22 ' OD1' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -131.38 175.72 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.208 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.68 ' HB2' HD21 ' A' ' 27' ' ' ASN . 47.7 m -110.86 152.15 27.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.407 0.622 . . . . 0.0 111.699 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.421 HG12 ' HD2' ' A' ' 29' ' ' ARG . 43.8 t -57.73 -40.02 73.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.769 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.31 -47.04 86.87 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.312 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.682 ' OD1' HG22 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -71.7 -41.89 68.04 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -176.044 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.9 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 3.2 pp -69.14 -32.33 71.61 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 118.331 -1.348 . . . . 0.0 111.79 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.421 ' HD2' HG12 ' A' ' 25' ' ' VAL . 32.0 mtp-105 -63.85 -33.7 76.28 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.055 172.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.8 t -68.8 -45.05 72.26 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.35 -174.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.9 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER -90.72 -2.56 57.81 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.096 -178.486 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 . . . . . 0 C--N 1.326 -0.436 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.825 174.11 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.631 HG23 HG21 ' A' ' 8' ' ' VAL . 4.3 mt . . . . . 0 C--O 1.233 0.214 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.593 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 50.0 p90 -144.41 166.88 23.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.156 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 46.2 t -60.4 129.23 22.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.293 -177.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.77 -15.29 59.78 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.382 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.433 ' OE1' ' HA ' ' A' ' 39' ' ' ILE . 44.2 tt0 -75.28 129.47 37.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.544 0.212 . . . . 0.0 111.076 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -92.11 107.34 19.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.812 0.339 . . . . 0.0 110.237 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.636 HD21 HD12 ' A' ' 17' ' ' ILE . 3.4 pp -109.65 138.58 45.82 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 175.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 46' ' ' ILE . 1.8 mp -65.49 139.35 21.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.063 0.459 . . . . 0.0 110.371 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.704 ' O ' ' HB ' ' A' ' 4' ' ' THR . 11.3 p -149.1 129.13 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 172.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.3 pttt . . . . . 0 C--N 1.309 -1.156 0 CA-C-O 121.318 0.58 . . . . 0.0 112.223 175.659 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 . . . . . 0 CA--C 1.516 -0.349 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.72 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 58.0 m -109.54 155.54 21.26 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.628 ' HB3' HD13 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -131.31 139.68 49.62 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.184 0.516 . . . . 0.0 110.674 173.435 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.437 ' HD2' HD11 ' A' ' 45' ' ' LEU . 36.1 t80 -121.0 141.53 50.65 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.113 -173.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.49 ' O ' ' HG2' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -87.87 120.75 29.5 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.979 171.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.73 HG21 HG23 ' A' ' 39' ' ' ILE . 57.5 t -57.35 127.25 16.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.135 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 7' ' ' THR . 66.1 mmtt -129.72 -178.07 4.54 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.5 m -42.95 125.55 3.55 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.357 0.599 . . . . 0.0 110.11 177.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.609 ' O ' HG23 ' A' ' 17' ' ' ILE . . . 104.52 29.58 5.29 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 108.561 -1.816 . . . . 0.0 108.561 -158.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.546 ' O ' HG22 ' A' ' 39' ' ' ILE . 4.3 p30 -59.84 0.09 0.17 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.454 1.502 . . . . 0.0 114.675 -169.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.531 ' O ' HG12 ' A' ' 17' ' ' ILE . 5.8 m -112.22 145.36 40.05 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 121.571 -0.705 . . . . 0.0 110.19 -172.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.518 ' HG ' HD12 ' A' ' 39' ' ' ILE . 7.0 mp -53.99 -46.48 71.72 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.04 -166.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -61.72 -36.37 80.75 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.929 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 68.5 mttm -73.79 -47.17 40.78 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.851 -176.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 11' ' ' GLY . 2.4 pt -73.28 -42.92 57.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.537 -178.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.561 ' HA ' ' CE1' ' A' ' 21' ' ' TYR . . . -58.45 -49.02 78.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.039 0.447 . . . . 0.0 111.23 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.83 -22.25 60.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.683 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 35.8 tt0 -64.54 -47.51 78.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.032 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.561 ' CE1' ' HA ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -96.85 -0.3 48.05 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.456 177.45 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.58 48.44 7.28 Favored Glycine 0 N--CA 1.453 -0.17 0 C-N-CA 120.894 -0.67 . . . . 0.0 114.062 171.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.661 HG22 ' OD1' ' A' ' 27' ' ' ASN . 1.1 p -126.82 164.36 27.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 172.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.636 ' HB2' ' ND2' ' A' ' 27' ' ' ASN . 4.4 m -91.35 145.34 24.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.237 0.542 . . . . 0.0 111.338 -175.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.527 HG12 ' HD3' ' A' ' 29' ' ' ARG . 38.4 t -55.68 -34.73 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.458 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.54 -47.64 78.06 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -177.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.661 ' OD1' HG22 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -71.93 -46.35 57.91 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -176.094 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.837 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -66.27 -31.21 71.88 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.722 -177.214 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.527 ' HD3' HG12 ' A' ' 25' ' ' VAL . 27.9 mtp180 -66.44 -38.73 88.04 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.239 -0.288 . . . . 0.0 111.315 172.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 66.9 m -67.5 -45.43 75.83 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -171.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.837 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -81.74 -6.42 59.03 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.287 -176.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.914 0.387 . . . . 0.0 109.958 174.201 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.73 HG23 HG21 ' A' ' 8' ' ' VAL . 4.7 mt . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.484 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 51.5 p90 -136.38 159.8 40.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.713 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 50.2 t -62.73 129.62 26.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.071 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.89 -20.54 40.86 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.603 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.469 ' NE2' ' HA ' ' A' ' 39' ' ' ILE . 29.4 tt0 -71.78 127.74 33.55 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -94.42 107.63 19.59 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.437 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -115.8 140.55 49.11 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -176.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.628 HD13 ' HB3' ' A' ' 5' ' ' TYR . 49.7 mm -66.17 135.53 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.798 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.72 ' O ' ' HB ' ' A' ' 4' ' ' THR . 13.9 p -147.33 124.63 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 122.072 0.939 . . . . 0.0 110.017 173.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.448 ' O ' ' HH2' ' A' ' 31' ' ' TRP . 57.8 tptt . . . . . 0 C--N 1.303 -1.454 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.669 171.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.701 ' HA ' ' HD2' ' A' ' 48' ' ' LYS . 12.6 m120 . . . . . 0 C--O 1.233 0.233 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.799 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 34.9 m -115.54 153.51 31.05 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 171.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -131.65 150.04 52.29 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.542 170.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -138.53 139.91 38.9 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.175 -171.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.72 123.67 29.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 173.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.635 HG21 HG23 ' A' ' 39' ' ' ILE . 58.8 t -56.74 116.2 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 123.717 0.635 . . . . 0.0 110.036 -177.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.677 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -103.36 -177.71 3.45 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.331 -177.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.3 p -42.98 112.7 0.39 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.495 0.664 . . . . 0.0 109.819 172.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.714 ' O ' HG23 ' A' ' 17' ' ' ILE . . . 123.14 34.44 0.77 Allowed Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -164.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.446 ' O ' HG22 ' A' ' 39' ' ' ILE . 10.4 p-10 -52.93 -2.64 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -170.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.437 ' OG1' ' HE2' ' A' ' 16' ' ' LYS . 2.6 m -114.13 154.31 28.02 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 121.156 -0.965 . . . . 0.0 109.99 -171.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 48.4 mt -53.39 -48.16 68.88 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 123.573 0.545 . . . . 0.0 111.755 -170.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -62.26 -37.07 84.06 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.24 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.437 ' HE2' ' OG1' ' A' ' 13' ' ' THR . 59.7 mtmt -74.3 -47.69 33.16 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.085 -174.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.714 HG23 ' O ' ' A' ' 11' ' ' GLY . 12.1 pt -72.88 -45.22 56.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.467 -177.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.465 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -58.54 -49.59 76.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.784 0.325 . . . . 0.0 111.578 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.16 -22.78 63.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.658 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.433 HE21 ' CA ' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -61.95 -47.12 86.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.935 177.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.621 ' CE1' HG21 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -107.38 13.56 26.87 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.209 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.44 31.48 45.87 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.988 -0.625 . . . . 0.0 114.43 168.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.482 ' CG1' HD23 ' A' ' 28' ' ' LEU . 10.9 p -114.68 159.84 14.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.499 ' HB2' ' OD1' ' A' ' 27' ' ' ASN . 19.2 m -93.69 153.33 18.41 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-O 121.59 0.71 . . . . 0.0 110.735 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.414 HG12 ' CD ' ' A' ' 29' ' ' ARG . 76.8 t -56.86 -38.92 61.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.862 178.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.86 -48.32 81.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -175.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.499 ' OD1' ' HB2' ' A' ' 24' ' ' SER . 1.6 p-10 -75.55 -34.34 60.72 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -175.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.89 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 3.9 pp -71.69 -31.75 67.11 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 118.221 -1.392 . . . . 0.0 111.107 177.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.495 ' N ' HD12 ' A' ' 28' ' ' LEU . 75.0 mtp180 -64.37 -34.68 78.72 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.636 173.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 52.0 m -71.22 -44.91 64.44 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -173.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.89 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -84.55 -2.53 57.5 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.137 -178.411 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 . . . . . 0 C--N 1.326 -0.45 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.475 174.119 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.635 HG23 HG21 ' A' ' 8' ' ' VAL . 5.2 mt . . . . . 0 C--O 1.233 0.228 0 CA-C-O 120.974 0.416 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -149.35 161.36 42.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.488 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 97.1 t -61.41 129.98 24.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.318 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.36 -20.8 36.67 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.979 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.507 ' OE1' ' HA ' ' A' ' 39' ' ' ILE . 27.4 tt0 -70.28 132.45 45.72 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.425 -0.388 . . . . 0.0 110.508 177.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.588 ' NZ ' ' HB3' ' A' ' 44' ' ' LYS . 2.4 ttpm? -97.15 107.36 19.87 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.82 143.34 45.54 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 -178.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.8 mp -67.42 136.28 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.952 0.406 . . . . 0.0 110.718 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.799 ' O ' ' HB ' ' A' ' 4' ' ' THR . 7.9 p -150.58 129.31 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-O 121.606 0.717 . . . . 0.0 109.266 173.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.701 ' HD2' ' HA ' ' A' ' 3' ' ' ASN . 54.8 tttm . . . . . 0 C--N 1.301 -1.504 0 O-C-N 121.584 -0.697 . . . . 0.0 110.861 171.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.548 ' H ' ' HB2' ' A' ' 48' ' ' LYS . 49.4 m -99.51 155.79 17.38 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.704 ' HB3' HD13 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -130.18 139.28 50.87 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.136 0.493 . . . . 0.0 109.859 173.111 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CE2' ' HA ' ' A' ' 8' ' ' VAL . 10.1 t80 -123.11 137.42 54.92 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.329 -172.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.446 ' O ' ' HG2' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -83.9 119.7 25.2 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.08 172.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.695 HG21 HG23 ' A' ' 39' ' ' ILE . 61.3 t -56.68 123.15 7.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.426 -176.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 7' ' ' THR . 28.0 mmtp -116.93 -176.05 2.9 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.646 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.4 m -41.12 113.47 0.39 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.61 0.719 . . . . 0.0 110.341 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.664 ' O ' HG23 ' A' ' 17' ' ' ILE . . . 119.02 37.81 0.79 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 -163.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.47 ' O ' HG22 ' A' ' 39' ' ' ILE . 4.1 p30 -53.79 -1.88 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.578 1.551 . . . . 0.0 114.998 -172.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 m -114.12 152.59 30.88 Favored 'General case' 0 C--N 1.309 -1.152 0 O-C-N 121.439 -0.788 . . . . 0.0 110.01 -169.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.634 HD22 HG13 ' A' ' 25' ' ' VAL . 52.9 mt -53.11 -46.61 68.8 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.977 -171.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -62.11 -36.94 83.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -73.87 -48.88 27.89 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.718 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.664 HG23 ' O ' ' A' ' 11' ' ' GLY . 14.3 pt -74.37 -44.68 48.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.762 -176.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.462 ' HA ' ' CE1' ' A' ' 21' ' ' TYR . . . -59.79 -48.84 80.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.891 0.377 . . . . 0.0 111.189 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.06 -21.88 62.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.851 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -63.38 -46.71 85.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.262 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.462 ' CE1' ' HA ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -99.71 6.05 45.62 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.101 0.477 . . . . 0.0 111.221 176.192 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.28 48.33 11.17 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.854 -0.612 . . . . 0.0 114.125 170.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.11 168.43 23.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 173.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.465 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 47.6 t -91.59 146.86 23.44 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 122.368 1.08 . . . . 0.0 112.032 -176.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.634 HG13 HD22 ' A' ' 14' ' ' LEU . 60.7 t -59.29 -32.11 47.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.341 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.06 83.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.44 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.49 ' HB2' ' CH2' ' A' ' 31' ' ' TRP . 1.3 p-10 -68.4 -45.1 73.58 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.666 -177.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.776 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 2.8 pp -67.92 -32.13 72.38 Favored 'General case' 0 C--O 1.227 -0.12 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.404 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.532 ' HD2' HG12 ' A' ' 25' ' ' VAL . 36.0 mtt-85 -61.81 -34.6 76.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.77 0.319 . . . . 0.0 110.97 172.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.7 t -71.28 -45.49 63.02 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.776 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 1.0 OUTLIER -89.2 -1.78 58.23 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -176.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 . . . . . 0 C--N 1.318 -0.771 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.414 174.176 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.695 HG23 HG21 ' A' ' 8' ' ' VAL . 5.7 mt . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -137.14 160.9 37.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.563 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 61.9 t -65.04 128.78 28.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.488 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.75 -15.49 48.72 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.204 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.489 ' NE2' HG12 ' A' ' 39' ' ' ILE . 24.5 tt0 -75.45 127.85 34.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.758 0.313 . . . . 0.0 110.265 177.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -89.6 107.18 18.94 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.416 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -114.99 140.88 48.68 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.704 HD13 ' HB3' ' A' ' 5' ' ' TYR . 42.8 mm -68.23 137.45 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.281 -176.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.518 ' O ' ' HB ' ' A' ' 4' ' ' THR . 8.5 p -146.76 112.68 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.625 0.726 . . . . 0.0 110.48 173.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.548 ' HB2' ' H ' ' A' ' 4' ' ' THR . 58.3 tptt . . . . . 0 N--CA 1.472 0.635 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.955 169.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.48 ' HA ' ' HB3' ' A' ' 48' ' ' LYS . 3.6 p-10 . . . . . 0 CA--C 1.522 -0.118 0 CA-C-O 121.019 0.438 . . . . 0.0 109.858 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.649 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 57.1 m -108.62 157.91 18.07 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -175.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.459 ' HB2' ' HG3' ' A' ' 44' ' ' LYS . 0.9 OUTLIER -130.85 150.0 52.22 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.101 0.476 . . . . 0.0 109.906 171.048 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.455 ' HD2' HD11 ' A' ' 45' ' ' LEU . 1.2 t80 -129.31 139.92 51.59 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.833 -175.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.465 HG23 ' HD3' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -82.99 120.94 26.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.142 173.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.73 HG21 HG23 ' A' ' 39' ' ' ILE . 57.8 t -56.14 124.92 10.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.132 -177.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.691 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -95.23 -175.09 3.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.498 -178.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.7 m -57.56 68.41 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.918 0.866 . . . . 0.0 110.849 171.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.618 ' O ' HG23 ' A' ' 17' ' ' ILE . . . -175.03 45.66 0.13 Allowed Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 107.847 -2.101 . . . . 0.0 107.847 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -52.58 -0.26 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.57 1.948 . . . . 0.0 115.406 -170.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.8 m -113.13 147.22 37.79 Favored 'General case' 0 C--N 1.311 -1.081 0 O-C-N 121.364 -0.835 . . . . 0.0 109.694 -171.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.571 HD23 HD12 ' A' ' 39' ' ' ILE . 54.6 mt -53.74 -47.33 70.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.116 -168.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -66.64 -30.25 70.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.968 -176.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -74.13 -47.8 33.68 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.013 0.435 . . . . 0.0 111.05 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.618 HG23 ' O ' ' A' ' 11' ' ' GLY . 11.3 pt -74.61 -40.35 47.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.605 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.442 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -58.02 -49.26 77.47 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.0 0.429 . . . . 0.0 111.232 177.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.93 -23.03 63.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.758 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -60.81 -41.82 96.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.502 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.486 ' CE1' HG21 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -107.19 8.17 29.87 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.697 177.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.4 48.16 11.3 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.726 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -133.11 172.58 16.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -97.34 147.32 24.29 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-O 122.297 1.046 . . . . 0.0 111.574 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.586 HG12 ' HD2' ' A' ' 29' ' ' ARG . 88.2 t -56.74 -35.92 47.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.361 176.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.12 -45.66 87.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.141 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -64.67 -46.17 83.59 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.978 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.836 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 3.4 pp -69.02 -29.49 67.67 Favored 'General case' 0 CA--C 1.523 -0.083 0 C-N-CA 118.719 -1.192 . . . . 0.0 110.853 178.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.586 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -54.54 -41.43 69.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.034 0.445 . . . . 0.0 110.443 171.117 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.6 m -75.9 -44.01 42.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.883 -170.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.836 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -91.38 -1.5 57.58 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -173.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 . . . . . 0 C--N 1.328 -0.334 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.319 178.891 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.73 HG23 HG21 ' A' ' 8' ' ' VAL . 4.9 mt . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.544 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 42.4 p90 -141.94 160.75 39.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.719 -176.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 54.0 t -56.56 128.87 17.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.935 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.76 -16.44 58.61 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.896 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.482 ' NE2' ' HA ' ' A' ' 39' ' ' ILE . 27.5 tt0 -74.96 137.94 41.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.852 0.326 . . . . 0.0 110.877 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.465 ' HD3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -95.32 107.72 19.86 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.834 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.455 HD11 ' HD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -117.0 147.08 42.62 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 46' ' ' ILE . 2.5 mp -70.41 137.93 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.967 0.413 . . . . 0.0 111.271 -174.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.649 ' O ' ' HB ' ' A' ' 4' ' ' THR . 8.8 p -151.67 124.72 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.735 0.779 . . . . 0.0 109.302 171.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.48 ' HB3' ' HA ' ' A' ' 3' ' ' ASN . 21.6 pttp . . . . . 0 C--N 1.309 -1.158 0 CA-C-O 121.57 0.7 . . . . 0.0 111.411 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 111.947 -0.461 . . . . 0.0 111.947 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.0 t -147.69 149.52 32.61 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 178.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.401 ' HA ' ' HB3' ' A' ' 48' ' ' LYS . 15.0 m120 -137.9 131.48 31.02 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.635 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 54.8 m -109.29 84.98 2.01 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 46' ' ' ILE . 2.1 p90 -85.02 123.4 30.52 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.579 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.435 ' CE2' ' HA ' ' A' ' 8' ' ' VAL . 1.0 OUTLIER -117.89 135.82 53.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.117 -167.308 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.401 HG23 ' HD3' ' A' ' 44' ' ' LYS . 1.1 p -80.92 126.21 31.09 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 173.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.74 HG21 HG23 ' A' ' 39' ' ' ILE . 34.0 t -57.14 120.28 3.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.073 -176.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -175.32 2.73 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.35 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.2 t -41.72 114.67 0.55 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.531 0.681 . . . . 0.0 110.122 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.636 ' O ' HG23 ' A' ' 17' ' ' ILE . . . 124.35 31.54 0.9 Allowed Glycine 0 C--O 1.221 -0.718 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -164.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.459 ' O ' HG22 ' A' ' 39' ' ' ILE . 6.1 p-10 -52.93 -3.34 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -170.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.885 ' HB ' ' HD3' ' A' ' 16' ' ' LYS . 7.1 m -112.92 143.68 43.78 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 121.389 -0.819 . . . . 0.0 108.92 -173.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.497 HD11 HD11 ' A' ' 28' ' ' LEU . 54.8 tp -56.52 -47.26 79.73 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 123.569 0.543 . . . . 0.0 112.053 -166.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -65.86 -31.02 71.73 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.415 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.885 ' HD3' ' HB ' ' A' ' 13' ' ' THR . 36.0 mtpt -71.43 -47.39 56.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.286 -178.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 11' ' ' GLY . 1.8 pt -74.09 -37.96 47.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.56 0.219 . . . . 0.0 111.533 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.22 -50.01 74.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.031 0.443 . . . . 0.0 110.862 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.43 -22.5 60.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.654 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.551 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 30.7 tt0 -67.28 -47.8 69.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.371 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.428 ' CE2' ' HB ' ' A' ' 17' ' ' ILE . 3.5 p90 -107.56 13.27 26.91 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.56 49.62 6.55 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.604 -0.808 . . . . 0.0 114.635 167.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.2 p -133.36 143.91 37.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 173.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.504 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 47.0 t -70.38 147.26 49.75 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.526 0.679 . . . . 0.0 110.498 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 36.5 t -57.88 -33.01 44.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.039 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.49 -48.6 64.04 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -174.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.504 ' OD1' ' HB3' ' A' ' 24' ' ' SER . 9.2 p-10 -75.9 -40.46 54.33 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.379 -0.528 . . . . 0.0 112.248 -175.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.864 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -68.98 -31.6 70.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 118.378 -1.329 . . . . 0.0 109.442 -178.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -65.04 -35.17 80.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.012 171.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 66.1 m -64.25 -43.96 93.27 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -174.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.864 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.9 OUTLIER -88.33 -2.6 58.69 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.117 -0.633 . . . . 0.0 112.682 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.456 ' HB3' HG13 ' A' ' 34' ' ' ILE . 38.2 m-80 -106.09 -22.66 12.81 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 122.1 -0.375 . . . . 0.0 111.472 175.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.92 39.07 85.53 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.823 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.456 HG13 ' HB3' ' A' ' 32' ' ' ASN . 63.4 mt -105.24 128.75 58.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.993 0.425 . . . . 0.0 111.536 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -108.42 110.63 22.22 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.021 171.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.29 -167.13 16.56 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.609 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.42 ' OD1' ' HB3' ' A' ' 14' ' ' LEU . 16.0 m-20 -104.58 36.47 2.4 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.163 0.185 . . . . 0.0 111.066 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.478 ' H ' ' HG ' ' A' ' 38' ' ' LEU . 1.0 OUTLIER -76.89 63.8 2.3 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.363 1.077 . . . . 0.0 111.197 -179.205 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.74 HG23 HG21 ' A' ' 8' ' ' VAL . 22.3 mt -124.23 147.14 28.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.236 -176.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -149.95 158.17 43.9 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 89.5 t -59.51 126.93 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 123.247 0.342 . . . . 0.0 110.77 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.45 -21.01 35.98 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.529 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.549 ' NE2' ' HA ' ' A' ' 39' ' ' ILE . 6.5 tt0 -65.33 134.71 54.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.401 ' HD3' HG23 ' A' ' 7' ' ' THR . 13.7 tptm -92.31 107.72 19.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.917 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.571 HD23 HG22 ' A' ' 8' ' ' VAL . 2.8 pp -119.82 139.34 52.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.061 0.458 . . . . 0.0 110.517 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.477 HD12 ' N ' ' A' ' 46' ' ' ILE . 2.8 mp -76.3 137.45 22.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.148 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.635 ' O ' ' HB ' ' A' ' 4' ' ' THR . 11.2 p -144.6 115.78 2.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.748 0.785 . . . . 0.0 109.378 166.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.547 ' HD2' ' O ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -146.88 119.75 8.7 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.535 -0.728 . . . . 0.0 112.578 176.04 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.689 ' HD3' ' H ' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -117.45 163.7 16.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.38 -178.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 135.88 -38.78 1.74 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.901 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.814 -0.613 . . . . 0.0 110.207 178.714 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.668 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.409 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 7.9 m -88.27 158.6 18.42 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -152.26 114.03 4.38 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.949 0.404 . . . . 0.0 109.94 173.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.702 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 96.4 m -112.91 154.12 26.88 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.622 ' HB3' HD13 ' A' ' 46' ' ' ILE . 1.8 p90 -130.84 145.66 52.05 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 169.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.401 ' HD2' HD11 ' A' ' 45' ' ' LEU . 58.7 t80 -116.84 132.67 56.64 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.86 -173.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.41 116.24 19.52 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 168.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.757 HG21 HG23 ' A' ' 39' ' ' ILE . 59.7 t -58.12 125.37 14.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.388 -177.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 25.0 mmtt -103.83 -174.22 2.49 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.06 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.5 m -42.25 -26.6 0.11 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -173.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.478 ' O ' HG23 ' A' ' 17' ' ' ILE . . . -76.67 66.81 2.68 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 168.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.479 ' O ' HG22 ' A' ' 39' ' ' ILE . 3.5 p30 -63.32 -3.1 1.73 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -168.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.503 ' O ' HG12 ' A' ' 17' ' ' ILE . 1.9 m -113.59 143.48 44.49 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 119.064 -1.055 . . . . 0.0 110.067 -167.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.639 HD11 HD11 ' A' ' 28' ' ' LEU . 14.3 tp -55.91 -46.0 78.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.803 -169.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -61.48 -35.85 78.82 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.398 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -71.67 -47.34 54.91 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.815 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.503 HG12 ' O ' ' A' ' 13' ' ' THR . 4.5 pt -74.09 -37.33 46.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.776 -177.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 23' ' ' VAL . . . -57.1 -49.34 76.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.106 0.479 . . . . 0.0 110.834 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.58 -21.8 61.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.723 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -65.17 -47.22 77.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.064 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.442 ' HD1' HG12 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -106.71 7.88 30.7 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 179.534 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.63 49.33 6.67 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 120.517 -0.849 . . . . 0.0 114.348 169.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.442 HG12 ' HD1' ' A' ' 21' ' ' TYR . 6.4 p -132.52 143.82 38.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 172.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.503 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 45.1 t -70.03 148.37 48.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.456 0.646 . . . . 0.0 110.603 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.539 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 78.8 t -52.84 -40.97 37.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.439 174.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.416 ' HA ' ' NE ' ' A' ' 29' ' ' ARG . . . -63.35 -49.07 75.35 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -171.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.503 ' OD1' ' HB3' ' A' ' 24' ' ' SER . 5.2 p-10 -76.51 -35.75 58.16 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 120.443 -0.503 . . . . 0.0 112.29 -175.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.811 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -72.76 -32.77 65.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 119.121 -1.031 . . . . 0.0 110.432 -177.026 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 25' ' ' VAL . 40.5 ptt85 -72.78 -31.47 64.89 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 121.506 -0.746 . . . . 0.0 111.053 174.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 72.5 m -64.98 -45.25 86.41 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -176.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.811 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -78.28 -2.84 39.87 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.527 179.734 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.492 ' HB3' HG13 ' A' ' 34' ' ' ILE . 26.7 m-80 -100.07 -20.7 15.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.851 174.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.46 44.38 83.99 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.523 -178.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.492 HG13 ' HB3' ' A' ' 32' ' ' ASN . 65.8 mt -109.95 129.17 65.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.394 0.14 . . . . 0.0 110.64 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.6 m -89.89 107.82 19.34 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 172.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.4 -167.12 33.72 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.858 -0.686 . . . . 0.0 111.638 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.421 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 17.7 p-10 -115.71 65.41 0.69 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.554 0.692 . . . . 0.0 111.959 -178.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.516 ' H ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -87.44 97.36 10.78 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 170.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.757 HG23 HG21 ' A' ' 8' ' ' VAL . 9.5 mt -138.15 132.64 42.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.395 -172.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.501 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 55.0 p90 -131.34 159.72 37.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.636 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 51.7 t -64.16 131.07 29.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.695 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.46 -13.3 64.43 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.2 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.713 HE22 HG12 ' A' ' 39' ' ' ILE . 28.7 tt0 -70.34 128.64 36.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.97 0.414 . . . . 0.0 111.162 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -81.65 109.12 15.78 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.55 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.454 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -121.93 138.16 54.51 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 175.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.622 HD13 ' HB3' ' A' ' 5' ' ' TYR . 45.4 mm -65.45 138.08 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.15 0.5 . . . . 0.0 111.435 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.702 ' O ' ' HB ' ' A' ' 4' ' ' THR . 10.0 p -155.18 130.99 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.95 172.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.409 ' HD3' ' O ' ' A' ' 2' ' ' THR . 55.3 pttt -133.33 122.15 23.4 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.232 -0.918 . . . . 0.0 111.375 169.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -100.43 108.27 20.22 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 127.04 -114.47 1.97 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.88 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.705 -0.664 . . . . 0.0 110.193 -179.194 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.7 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.8 t -149.46 138.96 21.59 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.532 ' HA ' ' HB3' ' A' ' 48' ' ' LYS . 4.5 p-10 -171.51 126.49 0.63 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.56 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.612 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 97.9 m -132.32 158.94 40.58 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -130.65 146.69 52.2 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.058 0.456 . . . . 0.0 110.311 171.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -117.73 126.1 51.85 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.189 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.44 HG23 ' HG2' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -70.79 119.76 15.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.285 174.049 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.618 HG22 HD23 ' A' ' 45' ' ' LEU . 97.2 t -57.13 116.66 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.088 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.802 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 10.5 mmpt? -102.34 -173.47 2.34 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.221 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.1 m -44.04 -18.35 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.71 60.39 0.93 Allowed Glycine 0 C--O 1.223 -0.562 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 166.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -68.27 -3.39 10.7 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 123.698 0.799 . . . . 0.0 113.148 -172.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.506 ' O ' HG12 ' A' ' 17' ' ' ILE . 25.6 m -116.81 143.76 45.3 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.571 -0.452 . . . . 0.0 109.83 -173.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.784 ' HB3' HG13 ' A' ' 25' ' ' VAL . 3.5 mm? -55.19 -47.42 75.28 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.739 0.649 . . . . 0.0 111.21 -172.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -67.23 -31.11 71.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.281 -175.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.42 ' HE2' ' HB ' ' A' ' 13' ' ' THR . 54.8 mtmt -72.0 -47.88 48.81 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.988 0.423 . . . . 0.0 110.763 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.561 HD11 HD13 ' A' ' 39' ' ' ILE . 4.3 pt -74.74 -38.13 44.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.921 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.5 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -57.3 -48.42 78.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.088 0.47 . . . . 0.0 110.865 177.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.2 -24.45 64.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.756 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -60.35 -47.45 86.02 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.508 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -104.88 12.99 31.88 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.911 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.13 48.78 37.37 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.701 170.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.41 HG22 ' OD1' ' A' ' 27' ' ' ASN . 1.3 p -131.61 171.25 18.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.468 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 48.0 t -88.1 145.33 26.0 Favored 'General case' 0 C--O 1.251 1.159 0 CA-C-O 122.433 1.111 . . . . 0.0 111.662 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.784 HG13 ' HB3' ' A' ' 14' ' ' LEU . 21.1 t -61.3 -32.28 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 114.141 -1.391 . . . . 0.0 109.679 175.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.89 -46.77 83.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.761 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.468 ' OD1' ' HB3' ' A' ' 24' ' ' SER . 1.8 p-10 -67.13 -46.3 74.55 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.48 -177.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.826 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 2.3 pp -70.61 -31.18 68.06 Favored 'General case' 0 C--O 1.228 -0.067 0 C-N-CA 118.514 -1.274 . . . . 0.0 112.197 -177.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.54 ' HD3' HG12 ' A' ' 25' ' ' VAL . 25.6 mtp-105 -64.66 -36.45 84.29 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 122.137 -0.352 . . . . 0.0 111.144 173.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.1 t -73.22 -46.55 49.63 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -171.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.826 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -83.56 -5.49 59.19 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.721 -176.184 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -98.35 -15.58 19.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.9 0.381 . . . . 0.0 110.205 172.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.43 39.17 87.4 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.009 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 65.7 mt -93.63 127.67 45.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.045 0.45 . . . . 0.0 110.83 -177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.2 t -107.15 108.74 20.33 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.27 -151.56 17.76 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.299 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -117.02 21.7 13.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.359 0.6 . . . . 0.0 110.194 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.499 ' O ' HD12 ' A' ' 38' ' ' LEU . 1.5 pp -73.74 101.85 3.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.798 0.809 . . . . 0.0 111.841 -176.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.561 HD13 HD11 ' A' ' 17' ' ' ILE . 1.5 mt -139.63 123.19 18.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.425 176.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -127.26 151.3 48.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.373 -173.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 57.3 t -59.81 139.7 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.552 -175.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.96 -21.64 44.98 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.43 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.435 ' O ' HG23 ' A' ' 8' ' ' VAL . 21.5 tt0 -73.03 127.35 32.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.603 0.239 . . . . 0.0 110.734 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.44 ' HG2' HG23 ' A' ' 7' ' ' THR . 94.6 mttt -85.86 106.47 17.09 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 171.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.618 HD23 HG22 ' A' ' 8' ' ' VAL . 4.6 pp -101.42 140.35 35.83 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.492 ' HB ' ' CD1' ' A' ' 31' ' ' TRP . 50.3 mm -63.71 135.21 28.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.413 0.625 . . . . 0.0 110.817 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.612 ' O ' ' HB ' ' A' ' 4' ' ' THR . 7.6 p -149.44 120.76 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.351 171.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 3' ' ' ASN . 51.9 pttt -147.71 132.27 17.75 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.872 -0.517 . . . . 0.0 111.617 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.53 112.87 16.06 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.25 -11.58 23.55 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.622 -175.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.39 -179.478 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.636 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -82.54 83.9 7.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.929 0.395 . . . . 0.0 111.32 -175.547 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -147.49 104.87 3.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.865 174.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.746 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 92.4 m -107.1 154.63 20.87 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 173.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -130.26 145.38 51.75 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.293 172.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -117.68 115.59 25.37 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.205 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.426 HG23 ' HG2' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -66.03 117.29 8.16 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 169.263 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.597 HG22 HD23 ' A' ' 45' ' ' LEU . 74.7 t -56.75 118.28 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.568 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.832 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 10.1 mmpt? -99.85 -173.21 2.39 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.035 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.1 t -42.82 -17.77 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.902 ' HA2' ' HE3' ' A' ' 16' ' ' LYS . . . -74.18 61.88 2.2 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 167.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -66.4 -3.56 6.32 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -173.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.568 ' O ' HG12 ' A' ' 17' ' ' ILE . 2.8 m -115.8 143.89 44.76 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.002 -170.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.642 ' HB3' HG13 ' A' ' 25' ' ' VAL . 4.0 mm? -55.52 -50.02 71.08 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.228 -171.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -69.47 -29.9 67.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.904 -175.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.902 ' HE3' ' HA2' ' A' ' 11' ' ' GLY . 32.2 ttpt -72.34 -47.48 49.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.956 -176.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 13' ' ' THR . 5.1 pt -74.68 -39.57 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.813 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 23' ' ' VAL . . . -57.02 -49.0 77.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.002 0.43 . . . . 0.0 110.864 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.27 -22.17 61.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.74 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -64.96 -47.7 76.67 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.65 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.47 ' CE1' HG21 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -108.03 11.32 27.85 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -178.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.4 48.62 7.28 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.282 169.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.418 ' O ' ' HB1' ' A' ' 18' ' ' ALA . 14.8 p -134.7 160.21 41.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 172.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.584 ' HB2' ' OD1' ' A' ' 27' ' ' ASN . 66.8 m -90.66 149.15 22.2 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.782 0.801 . . . . 0.0 111.083 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.642 HG13 ' HB3' ' A' ' 14' ' ' LEU . 14.5 t -59.08 -36.4 62.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.626 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.66 -48.07 82.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.902 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.584 ' OD1' ' HB2' ' A' ' 24' ' ' SER . 0.3 OUTLIER -75.37 -36.0 61.01 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -176.601 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.906 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 3.0 pp -71.14 -30.65 66.74 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 118.046 -1.462 . . . . 0.0 111.607 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.406 ' N ' HD12 ' A' ' 28' ' ' LEU . 77.8 mtt180 -59.71 -44.78 93.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.819 0.342 . . . . 0.0 110.906 171.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 64.8 m -69.8 -43.94 71.05 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -171.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.906 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -82.18 -4.05 56.22 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.533 -178.477 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -100.03 -13.31 19.1 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.677 174.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.74 34.96 91.2 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.242 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.9 mt -82.4 126.0 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.861 0.362 . . . . 0.0 110.877 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.6 t -97.08 108.92 21.75 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 170.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.27 -168.02 22.9 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -115.5 60.34 0.71 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 117.297 0.549 . . . . 0.0 110.501 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.478 ' O ' HD12 ' A' ' 38' ' ' LEU . 1.8 pp -94.14 107.54 19.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.717 0.77 . . . . 0.0 110.775 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.516 HD13 HD11 ' A' ' 17' ' ' ILE . 3.0 mt -139.46 120.01 14.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.967 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.468 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 19.5 p90 -134.63 154.81 51.33 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.406 -175.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 41.8 t -63.08 132.31 28.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.272 -173.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.7 -20.93 40.18 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.419 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.417 ' O ' HG23 ' A' ' 8' ' ' VAL . 23.0 tt0 -71.27 127.19 31.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.441 0.162 . . . . 0.0 110.572 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HG2' HG23 ' A' ' 7' ' ' THR . 33.9 mtmm -81.9 107.37 14.57 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 171.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.597 HD23 HG22 ' A' ' 8' ' ' VAL . 4.2 pp -105.47 134.36 48.7 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 175.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.439 HD12 ' N ' ' A' ' 46' ' ' ILE . 1.9 mp -62.45 136.58 25.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.746 ' O ' ' HB ' ' A' ' 4' ' ' THR . 7.7 p -145.59 125.94 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.636 ' HD3' ' O ' ' A' ' 2' ' ' THR . 36.6 pttt -146.65 116.97 7.41 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.091 175.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -79.41 108.13 12.7 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 147.8 83.87 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -175.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.2 m . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.733 -0.651 . . . . 0.0 109.833 178.485 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.581 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.5 m -61.93 -42.29 98.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.913 0.387 . . . . 0.0 110.909 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -95.16 142.8 27.18 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 172.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.754 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 47.7 m -114.01 151.3 32.61 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.515 ' HB3' HD13 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -132.11 153.95 49.96 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 121.772 -0.58 . . . . 0.0 110.296 174.177 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.491 ' OH ' ' HB2' ' A' ' 9' ' ' LYS . 1.4 t80 -145.94 142.41 28.69 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.045 -173.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.39 121.27 28.71 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 174.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.542 HG21 HG23 ' A' ' 39' ' ' ILE . 95.0 t -56.91 125.47 12.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.556 -175.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.654 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -92.15 -173.81 3.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.955 176.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.6 m -43.87 -17.69 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.726 ' HA2' ' HE2' ' A' ' 16' ' ' LYS . . . -75.26 52.59 2.62 Favored Glycine 0 C--O 1.222 -0.622 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 168.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -57.58 -3.43 0.19 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -169.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.406 ' O ' HG12 ' A' ' 17' ' ' ILE . 7.9 m -114.77 149.36 37.06 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 121.301 -0.875 . . . . 0.0 109.236 -173.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.815 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 0.7 OUTLIER -53.92 -47.27 71.36 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.605 0.566 . . . . 0.0 110.612 -171.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -69.23 -29.18 67.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.056 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.726 ' HE2' ' HA2' ' A' ' 11' ' ' GLY . 60.0 mtpt -71.06 -48.7 51.13 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.522 -178.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.694 HG23 ' O ' ' A' ' 11' ' ' GLY . 4.9 pt -74.31 -41.63 50.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.66 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.23 -49.36 76.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 0.0 111.146 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.38 -22.56 60.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.743 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.513 ' HA ' ' OE1' ' A' ' 20' ' ' GLN . 5.7 tp60 -68.13 -47.26 68.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.478 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.566 ' HE1' HG12 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -100.93 2.79 41.12 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.765 178.664 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.33 48.92 7.1 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.92 -0.657 . . . . 0.0 114.479 169.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.573 HG22 ' OD1' ' A' ' 27' ' ' ASN . 3.0 p -122.74 162.83 22.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 170.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.0 t -74.94 146.5 41.72 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.853 0.835 . . . . 0.0 111.241 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.681 HG13 HD12 ' A' ' 14' ' ' LEU . 91.2 t -58.91 -35.76 58.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.169 172.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.47 -46.61 69.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.233 -175.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.573 ' OD1' HG22 ' A' ' 23' ' ' VAL . 6.9 p30 -74.87 -43.58 53.64 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.491 -174.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.799 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -68.43 -31.99 71.7 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.834 -178.004 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.644 ' HE ' ' HG ' ' A' ' 14' ' ' LEU . 96.5 mtt180 -66.99 -35.81 80.78 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.887 172.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.6 t -64.38 -45.26 88.48 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -172.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.799 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER -89.02 -2.12 58.43 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.148 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.532 ' HB3' HG12 ' A' ' 34' ' ' ILE . 46.4 m-80 -107.19 -23.53 12.24 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.29 176.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.01 38.61 76.29 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -172.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.532 HG12 ' HB3' ' A' ' 32' ' ' ASN . 15.3 mm -114.42 130.12 69.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.142 0.496 . . . . 0.0 111.815 -171.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.556 ' HB2' HD21 ' A' ' 38' ' ' LEU . 8.2 m -79.06 118.1 20.73 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 169.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.815 ' HA3' ' HB2' ' A' ' 14' ' ' LEU . . . -63.19 -0.88 3.56 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-N 116.229 -0.442 . . . . 0.0 114.151 -175.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -74.59 -37.7 62.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.793 0.33 . . . . 0.0 110.482 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.556 HD21 ' HB2' ' A' ' 35' ' ' SER . 0.4 OUTLIER -96.78 35.56 1.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.034 0.445 . . . . 0.0 111.326 -179.359 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.542 HG23 HG21 ' A' ' 8' ' ' VAL . 14.1 mt -96.47 136.61 26.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 175.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -142.28 171.04 14.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.011 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 61.0 t -64.74 128.63 27.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.59 -10.27 60.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.005 -177.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -61.47 127.99 34.13 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 122.44 0.296 . . . . 0.0 110.427 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -92.73 107.21 19.04 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.746 HD23 HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -124.17 140.61 52.8 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.16 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.515 HD13 ' HB3' ' A' ' 5' ' ' TYR . 49.6 mm -70.3 131.51 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.198 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.754 ' O ' ' HB ' ' A' ' 4' ' ' THR . 11.3 p -136.95 123.49 29.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 122.46 1.124 . . . . 0.0 109.36 173.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -135.64 136.79 41.25 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.705 175.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -79.05 106.22 10.93 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.287 0.565 . . . . 0.0 111.218 -174.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -124.44 20.8 6.9 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 172.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.2 m . . . . . 0 C--O 1.246 0.892 0 CA-C-N 114.561 -0.819 . . . . 0.0 109.097 -178.168 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.933 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.0 m -85.41 68.06 10.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.659 0.742 . . . . 0.0 110.151 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -104.89 113.06 26.43 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.704 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 83.6 m -99.31 157.27 16.51 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -127.42 150.91 49.42 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.621 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.428 ' CE2' ' HA ' ' A' ' 8' ' ' VAL . 55.7 t80 -117.23 120.77 39.26 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.979 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.57 111.82 5.65 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.06 0.457 . . . . 0.0 109.974 170.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 68.7 t -57.34 127.81 16.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.812 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.28 -174.05 2.38 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.9 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.1 m -41.16 -26.47 0.05 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -173.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.662 ' O ' HG23 ' A' ' 17' ' ' ILE . . . -76.79 59.55 3.43 Favored Glycine 0 C--O 1.225 -0.465 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 170.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -59.27 -1.3 0.19 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -171.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.501 ' O ' HG12 ' A' ' 17' ' ' ILE . 2.3 m -112.69 147.98 35.65 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.515 -0.741 . . . . 0.0 110.383 -168.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -54.45 -48.1 72.14 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.875 -169.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -62.32 -36.56 82.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.016 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 29.1 mmmt -73.56 -47.29 41.82 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.283 -173.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 11' ' ' GLY . 6.9 pt -74.69 -41.52 47.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -177.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.72 -49.86 76.1 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.125 0.266 . . . . 0.0 111.196 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.02 -23.71 62.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.077 0.465 . . . . 0.0 110.335 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.503 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 9.7 tt0 -59.96 -46.81 88.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.172 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.476 ' CE1' HG21 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -106.27 13.6 28.59 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.737 179.344 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.19 49.06 17.2 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.645 171.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.682 HG22 ' OD1' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -131.38 175.72 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.208 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.68 ' HB2' HD21 ' A' ' 27' ' ' ASN . 47.7 m -110.86 152.15 27.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.407 0.622 . . . . 0.0 111.699 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.421 HG12 ' HD2' ' A' ' 29' ' ' ARG . 43.8 t -57.73 -40.02 73.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.769 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.31 -47.04 86.87 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.312 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.682 ' OD1' HG22 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -71.7 -41.89 68.04 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -176.044 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.9 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 3.2 pp -69.14 -32.33 71.61 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 118.331 -1.348 . . . . 0.0 111.79 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.421 ' HD2' HG12 ' A' ' 25' ' ' VAL . 32.0 mtp-105 -63.85 -33.7 76.28 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.055 172.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.8 t -68.8 -45.05 72.26 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.35 -174.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.9 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER -90.72 -2.56 57.81 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.096 -178.486 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -95.0 -22.09 18.17 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.825 174.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.61 14.23 77.79 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.766 175.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.97 161.86 28.11 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 CA-C-O 121.286 0.565 . . . . 0.0 111.622 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.4 t -79.48 141.8 36.42 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 171.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.31 51.43 3.28 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.704 -176.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -101.4 -42.21 6.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.195 0.521 . . . . 0.0 109.652 177.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.785 ' H ' HD23 ' A' ' 38' ' ' LEU . 1.4 pt? -96.36 96.96 9.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.088 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.631 HG23 HG21 ' A' ' 8' ' ' VAL . 4.3 mt -139.68 117.39 10.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 171.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.593 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 50.0 p90 -144.41 166.88 23.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.156 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 46.2 t -60.4 129.23 22.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.293 -177.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.77 -15.29 59.78 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.382 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.433 ' OE1' ' HA ' ' A' ' 39' ' ' ILE . 44.2 tt0 -75.28 129.47 37.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.544 0.212 . . . . 0.0 111.076 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -92.11 107.34 19.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.812 0.339 . . . . 0.0 110.237 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.636 HD21 HD12 ' A' ' 17' ' ' ILE . 3.4 pp -109.65 138.58 45.82 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 175.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 46' ' ' ILE . 1.8 mp -65.49 139.35 21.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.063 0.459 . . . . 0.0 110.371 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.704 ' O ' ' HB ' ' A' ' 4' ' ' THR . 11.3 p -149.1 129.13 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 172.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -151.02 155.77 39.73 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.318 0.58 . . . . 0.0 112.223 175.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -112.5 131.25 55.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.795 172.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 136.85 -112.77 0.97 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.128 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.4 t . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.607 -0.711 . . . . 0.0 109.669 -178.862 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.635 0 N-CA-C 111.876 -0.49 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.8 m -131.15 125.09 32.15 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.647 0.261 . . . . 0.0 110.451 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -74.04 149.55 41.14 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.72 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 58.0 m -109.54 155.54 21.26 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.628 ' HB3' HD13 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -131.31 139.68 49.62 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.184 0.516 . . . . 0.0 110.674 173.435 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.437 ' HD2' HD11 ' A' ' 45' ' ' LEU . 36.1 t80 -121.0 141.53 50.65 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.113 -173.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.49 ' O ' ' HG2' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -87.87 120.75 29.5 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.979 171.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.73 HG21 HG23 ' A' ' 39' ' ' ILE . 57.5 t -57.35 127.25 16.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.135 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 7' ' ' THR . 66.1 mmtt -129.72 -178.07 4.54 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.5 m -42.95 125.55 3.55 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.357 0.599 . . . . 0.0 110.11 177.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.609 ' O ' HG23 ' A' ' 17' ' ' ILE . . . 104.52 29.58 5.29 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 108.561 -1.816 . . . . 0.0 108.561 -158.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.546 ' O ' HG22 ' A' ' 39' ' ' ILE . 4.3 p30 -59.84 0.09 0.17 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.454 1.502 . . . . 0.0 114.675 -169.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.531 ' O ' HG12 ' A' ' 17' ' ' ILE . 5.8 m -112.22 145.36 40.05 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 121.571 -0.705 . . . . 0.0 110.19 -172.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.518 ' HG ' HD12 ' A' ' 39' ' ' ILE . 7.0 mp -53.99 -46.48 71.72 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.04 -166.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -61.72 -36.37 80.75 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.929 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 68.5 mttm -73.79 -47.17 40.78 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.851 -176.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 11' ' ' GLY . 2.4 pt -73.28 -42.92 57.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.537 -178.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.561 ' HA ' ' CE1' ' A' ' 21' ' ' TYR . . . -58.45 -49.02 78.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.039 0.447 . . . . 0.0 111.23 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.83 -22.25 60.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.683 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 35.8 tt0 -64.54 -47.51 78.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.032 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.561 ' CE1' ' HA ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -96.85 -0.3 48.05 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.456 177.45 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.58 48.44 7.28 Favored Glycine 0 N--CA 1.453 -0.17 0 C-N-CA 120.894 -0.67 . . . . 0.0 114.062 171.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.661 HG22 ' OD1' ' A' ' 27' ' ' ASN . 1.1 p -126.82 164.36 27.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 172.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.636 ' HB2' ' ND2' ' A' ' 27' ' ' ASN . 4.4 m -91.35 145.34 24.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.237 0.542 . . . . 0.0 111.338 -175.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.527 HG12 ' HD3' ' A' ' 29' ' ' ARG . 38.4 t -55.68 -34.73 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.458 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.54 -47.64 78.06 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -177.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.661 ' OD1' HG22 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -71.93 -46.35 57.91 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -176.094 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.837 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -66.27 -31.21 71.88 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.722 -177.214 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.527 ' HD3' HG12 ' A' ' 25' ' ' VAL . 27.9 mtp180 -66.44 -38.73 88.04 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.239 -0.288 . . . . 0.0 111.315 172.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 66.9 m -67.5 -45.43 75.83 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -171.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.837 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -81.74 -6.42 59.03 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.287 -176.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -94.74 -21.48 18.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.914 0.387 . . . . 0.0 109.958 174.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.76 43.5 99.07 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.09 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.508 ' H ' HD12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -104.94 146.56 11.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.529 177.284 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.7 m -101.78 109.55 21.34 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.179 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.38 -164.29 12.06 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.154 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -116.94 32.86 5.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.963 0.411 . . . . 0.0 110.736 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.33 101.87 4.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.779 0.8 . . . . 0.0 111.419 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.73 HG23 HG21 ' A' ' 8' ' ' VAL . 4.7 mt -139.94 123.57 18.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.46 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.484 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 51.5 p90 -136.38 159.8 40.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.713 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 50.2 t -62.73 129.62 26.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.071 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.89 -20.54 40.86 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.603 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.469 ' NE2' ' HA ' ' A' ' 39' ' ' ILE . 29.4 tt0 -71.78 127.74 33.55 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -94.42 107.63 19.59 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.437 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -115.8 140.55 49.11 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -176.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.628 HD13 ' HB3' ' A' ' 5' ' ' TYR . 49.7 mm -66.17 135.53 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.798 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.72 ' O ' ' HB ' ' A' ' 4' ' ' THR . 13.9 p -147.33 124.63 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 122.072 0.939 . . . . 0.0 110.017 173.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.448 ' O ' ' HH2' ' A' ' 31' ' ' TRP . 57.8 tptt -136.07 124.57 23.53 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.669 171.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -72.56 107.55 5.14 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.254 0.55 . . . . 0.0 110.796 -173.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -117.18 31.21 5.93 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.173 176.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.4 m . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.701 -0.666 . . . . 0.0 109.51 -178.785 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.602 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.6 m -75.24 -57.14 4.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.967 0.413 . . . . 0.0 110.29 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.701 ' HA ' ' HD2' ' A' ' 48' ' ' LYS . 12.6 m120 -83.9 177.47 8.3 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.799 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 34.9 m -115.54 153.51 31.05 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 171.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -131.65 150.04 52.29 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.542 170.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -138.53 139.91 38.9 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.175 -171.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.72 123.67 29.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 173.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.635 HG21 HG23 ' A' ' 39' ' ' ILE . 58.8 t -56.74 116.2 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 123.717 0.635 . . . . 0.0 110.036 -177.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.677 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -103.36 -177.71 3.45 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.331 -177.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.3 p -42.98 112.7 0.39 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.495 0.664 . . . . 0.0 109.819 172.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.714 ' O ' HG23 ' A' ' 17' ' ' ILE . . . 123.14 34.44 0.77 Allowed Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -164.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.446 ' O ' HG22 ' A' ' 39' ' ' ILE . 10.4 p-10 -52.93 -2.64 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -170.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.437 ' OG1' ' HE2' ' A' ' 16' ' ' LYS . 2.6 m -114.13 154.31 28.02 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 121.156 -0.965 . . . . 0.0 109.99 -171.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.718 HD11 ' HA3' ' A' ' 36' ' ' GLY . 48.4 mt -53.39 -48.16 68.88 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 123.573 0.545 . . . . 0.0 111.755 -170.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -62.26 -37.07 84.06 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.24 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.437 ' HE2' ' OG1' ' A' ' 13' ' ' THR . 59.7 mtmt -74.3 -47.69 33.16 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.085 -174.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.714 HG23 ' O ' ' A' ' 11' ' ' GLY . 12.1 pt -72.88 -45.22 56.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.467 -177.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.465 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -58.54 -49.59 76.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.784 0.325 . . . . 0.0 111.578 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.16 -22.78 63.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.658 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.433 HE21 ' CA ' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -61.95 -47.12 86.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.935 177.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.621 ' CE1' HG21 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -107.38 13.56 26.87 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.209 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.523 ' O ' ' HE2' ' A' ' 49' ' ' LYS . . . 78.44 31.48 45.87 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.988 -0.625 . . . . 0.0 114.43 168.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.482 ' CG1' HD23 ' A' ' 28' ' ' LEU . 10.9 p -114.68 159.84 14.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.499 ' HB2' ' OD1' ' A' ' 27' ' ' ASN . 19.2 m -93.69 153.33 18.41 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-O 121.59 0.71 . . . . 0.0 110.735 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.414 HG12 ' CD ' ' A' ' 29' ' ' ARG . 76.8 t -56.86 -38.92 61.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.862 178.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.86 -48.32 81.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -175.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.499 ' OD1' ' HB2' ' A' ' 24' ' ' SER . 1.6 p-10 -75.55 -34.34 60.72 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -175.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.89 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 3.9 pp -71.69 -31.75 67.11 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 118.221 -1.392 . . . . 0.0 111.107 177.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.495 ' N ' HD12 ' A' ' 28' ' ' LEU . 75.0 mtp180 -64.37 -34.68 78.72 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.636 173.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 52.0 m -71.22 -44.91 64.44 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -173.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.89 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -84.55 -2.53 57.5 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.137 -178.411 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.489 ' HB3' ' CG1' ' A' ' 34' ' ' ILE . 26.7 m-80 -100.04 -22.32 15.27 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.475 174.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.08 33.97 81.78 Favored Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -169.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.489 ' CG1' ' HB3' ' A' ' 32' ' ' ASN . 19.3 mm -119.18 126.54 75.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.327 -0.436 . . . . 0.0 111.543 -170.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -72.66 113.47 9.73 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 166.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.718 ' HA3' HD11 ' A' ' 14' ' ' LEU . . . -68.01 6.97 2.61 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 114.552 0.581 . . . . 0.0 114.552 -170.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.1 -33.92 75.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.148 0.499 . . . . 0.0 110.155 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.447 HD11 HG23 ' A' ' 34' ' ' ILE . 1.9 pp -96.24 38.44 1.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.149 -176.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.635 HG23 HG21 ' A' ' 8' ' ' VAL . 5.2 mt -92.95 132.49 37.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.974 0.416 . . . . 0.0 110.166 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -149.35 161.36 42.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.488 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 97.1 t -61.41 129.98 24.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.318 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.36 -20.8 36.67 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.979 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.507 ' OE1' ' HA ' ' A' ' 39' ' ' ILE . 27.4 tt0 -70.28 132.45 45.72 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.425 -0.388 . . . . 0.0 110.508 177.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.588 ' NZ ' ' HB3' ' A' ' 44' ' ' LYS . 2.4 ttpm? -97.15 107.36 19.87 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.82 143.34 45.54 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 -178.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.8 mp -67.42 136.28 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.952 0.406 . . . . 0.0 110.718 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.799 ' O ' ' HB ' ' A' ' 4' ' ' THR . 7.9 p -150.58 129.31 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-O 121.606 0.717 . . . . 0.0 109.266 173.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.701 ' HD2' ' HA ' ' A' ' 3' ' ' ASN . 54.8 tttm -139.93 121.76 15.48 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.584 -0.697 . . . . 0.0 110.861 171.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.523 ' HE2' ' O ' ' A' ' 22' ' ' GLY . 5.4 tmtt? -82.95 108.79 16.53 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.18 83.43 1.71 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.786 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.7 m . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.645 177.872 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.717 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.6 p -80.68 73.33 7.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.71 0.766 . . . . 0.0 109.886 174.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -84.56 162.84 19.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.082 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.548 ' H ' ' HB2' ' A' ' 48' ' ' LYS . 49.4 m -99.51 155.79 17.38 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.704 ' HB3' HD13 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -130.18 139.28 50.87 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.136 0.493 . . . . 0.0 109.859 173.111 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CE2' ' HA ' ' A' ' 8' ' ' VAL . 10.1 t80 -123.11 137.42 54.92 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.329 -172.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.446 ' O ' ' HG2' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -83.9 119.7 25.2 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.08 172.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.695 HG21 HG23 ' A' ' 39' ' ' ILE . 61.3 t -56.68 123.15 7.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.426 -176.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 7' ' ' THR . 28.0 mmtp -116.93 -176.05 2.9 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.646 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.4 m -41.12 113.47 0.39 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.61 0.719 . . . . 0.0 110.341 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.664 ' O ' HG23 ' A' ' 17' ' ' ILE . . . 119.02 37.81 0.79 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 -163.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.47 ' O ' HG22 ' A' ' 39' ' ' ILE . 4.1 p30 -53.79 -1.88 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.578 1.551 . . . . 0.0 114.998 -172.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 m -114.12 152.59 30.88 Favored 'General case' 0 C--N 1.309 -1.152 0 O-C-N 121.439 -0.788 . . . . 0.0 110.01 -169.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.634 HD22 HG13 ' A' ' 25' ' ' VAL . 52.9 mt -53.11 -46.61 68.8 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.977 -171.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -62.11 -36.94 83.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -73.87 -48.88 27.89 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.718 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.664 HG23 ' O ' ' A' ' 11' ' ' GLY . 14.3 pt -74.37 -44.68 48.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.762 -176.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.462 ' HA ' ' CE1' ' A' ' 21' ' ' TYR . . . -59.79 -48.84 80.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.891 0.377 . . . . 0.0 111.189 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.06 -21.88 62.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.851 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -63.38 -46.71 85.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.262 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.462 ' CE1' ' HA ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -99.71 6.05 45.62 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.101 0.477 . . . . 0.0 111.221 176.192 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.28 48.33 11.17 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.854 -0.612 . . . . 0.0 114.125 170.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.11 168.43 23.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 173.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.465 ' HB3' ' OD1' ' A' ' 27' ' ' ASN . 47.6 t -91.59 146.86 23.44 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 122.368 1.08 . . . . 0.0 112.032 -176.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.634 HG13 HD22 ' A' ' 14' ' ' LEU . 60.7 t -59.29 -32.11 47.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.341 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.06 83.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.44 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.49 ' HB2' ' CH2' ' A' ' 31' ' ' TRP . 1.3 p-10 -68.4 -45.1 73.58 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.666 -177.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.776 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 2.8 pp -67.92 -32.13 72.38 Favored 'General case' 0 C--O 1.227 -0.12 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.404 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.532 ' HD2' HG12 ' A' ' 25' ' ' VAL . 36.0 mtt-85 -61.81 -34.6 76.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.77 0.319 . . . . 0.0 110.97 172.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.7 t -71.28 -45.49 63.02 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.776 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 1.0 OUTLIER -89.2 -1.78 58.23 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -176.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.404 ' O ' HG13 ' A' ' 34' ' ' ILE . 22.8 m-80 -95.15 -21.58 18.41 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.414 174.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.51 21.79 72.79 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.113 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 32' ' ' ASN . 20.5 mt -130.09 146.31 34.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.4 m -68.21 108.79 3.3 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 166.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.419 ' O ' HG13 ' A' ' 39' ' ' ILE . . . -69.17 10.54 1.73 Allowed Glycine 0 C--O 1.228 -0.253 0 C-N-CA 121.395 -0.431 . . . . 0.0 113.928 -173.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -60.7 -36.79 79.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.939 0.399 . . . . 0.0 110.437 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.652 ' H ' HD23 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -96.72 90.51 5.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.744 176.416 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.695 HG23 HG21 ' A' ' 8' ' ' VAL . 5.7 mt -123.0 134.31 66.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.0 176.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -137.14 160.9 37.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.563 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 61.9 t -65.04 128.78 28.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.488 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.75 -15.49 48.72 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.204 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.489 ' NE2' HG12 ' A' ' 39' ' ' ILE . 24.5 tt0 -75.45 127.85 34.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.758 0.313 . . . . 0.0 110.265 177.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -89.6 107.18 18.94 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.416 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -114.99 140.88 48.68 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.704 HD13 ' HB3' ' A' ' 5' ' ' TYR . 42.8 mm -68.23 137.45 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.281 -176.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.518 ' O ' ' HB ' ' A' ' 4' ' ' THR . 8.5 p -146.76 112.68 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.625 0.726 . . . . 0.0 110.48 173.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.548 ' HB2' ' H ' ' A' ' 4' ' ' THR . 58.3 tptt 178.51 118.21 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.955 169.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -88.85 112.73 23.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.365 -176.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.62 114.99 3.46 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.353 172.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.343 -0.837 . . . . 0.0 109.482 173.151 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.469 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 89.5 m -82.98 110.78 18.25 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.847 0.356 . . . . 0.0 110.657 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.48 ' HA ' ' HB3' ' A' ' 48' ' ' LYS . 3.6 p-10 -57.68 119.78 7.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.858 176.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.649 ' HB ' ' O ' ' A' ' 47' ' ' VAL . 57.1 m -108.62 157.91 18.07 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -175.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.459 ' HB2' ' HG3' ' A' ' 44' ' ' LYS . 0.9 OUTLIER -130.85 150.0 52.22 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.101 0.476 . . . . 0.0 109.906 171.048 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.455 ' HD2' HD11 ' A' ' 45' ' ' LEU . 1.2 t80 -129.31 139.92 51.59 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.833 -175.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.465 HG23 ' HD3' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -82.99 120.94 26.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.142 173.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.73 HG21 HG23 ' A' ' 39' ' ' ILE . 57.8 t -56.14 124.92 10.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.132 -177.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.691 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -95.23 -175.09 3.4 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.498 -178.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.7 m -57.56 68.41 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.918 0.866 . . . . 0.0 110.849 171.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.618 ' O ' HG23 ' A' ' 17' ' ' ILE . . . -175.03 45.66 0.13 Allowed Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 107.847 -2.101 . . . . 0.0 107.847 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -52.58 -0.26 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.57 1.948 . . . . 0.0 115.406 -170.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.8 m -113.13 147.22 37.79 Favored 'General case' 0 C--N 1.311 -1.081 0 O-C-N 121.364 -0.835 . . . . 0.0 109.694 -171.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.718 HD11 ' HA3' ' A' ' 36' ' ' GLY . 54.6 mt -53.74 -47.33 70.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.116 -168.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -66.64 -30.25 70.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.968 -176.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -74.13 -47.8 33.68 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.013 0.435 . . . . 0.0 111.05 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.618 HG23 ' O ' ' A' ' 11' ' ' GLY . 11.3 pt -74.61 -40.35 47.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.605 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.442 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -58.02 -49.26 77.47 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.0 0.429 . . . . 0.0 111.232 177.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.93 -23.03 63.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.758 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -60.81 -41.82 96.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.502 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.486 ' CE1' HG21 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -107.19 8.17 29.87 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.697 177.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.4 48.16 11.3 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.726 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -133.11 172.58 16.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -97.34 147.32 24.29 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-O 122.297 1.046 . . . . 0.0 111.574 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.586 HG12 ' HD2' ' A' ' 29' ' ' ARG . 88.2 t -56.74 -35.92 47.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.361 176.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.12 -45.66 87.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.141 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -64.67 -46.17 83.59 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.978 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.836 ' HA ' ' NE1' ' A' ' 31' ' ' TRP . 3.4 pp -69.02 -29.49 67.67 Favored 'General case' 0 CA--C 1.523 -0.083 0 C-N-CA 118.719 -1.192 . . . . 0.0 110.853 178.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.586 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -54.54 -41.43 69.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.034 0.445 . . . . 0.0 110.443 171.117 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.6 m -75.9 -44.01 42.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.883 -170.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.836 ' NE1' ' HA ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -91.38 -1.5 57.58 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -173.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.485 ' HB3' HG13 ' A' ' 34' ' ' ILE . 17.3 m-80 -94.81 -24.19 17.17 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.319 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.86 24.77 71.63 Favored Glycine 0 C--N 1.329 0.144 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.98 176.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.485 HG13 ' HB3' ' A' ' 32' ' ' ASN . 0.1 OUTLIER -130.01 161.91 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-O 121.003 0.43 . . . . 0.0 111.629 179.25 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.2 m -68.35 164.28 21.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.558 167.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.718 ' HA3' HD11 ' A' ' 14' ' ' LEU . . . -98.48 3.46 59.51 Favored Glycine 0 C--N 1.319 -0.399 0 C-N-CA 120.802 -0.714 . . . . 0.0 113.415 -172.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -79.93 -29.02 39.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.717 0.294 . . . . 0.0 110.553 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.742 ' H ' HD23 ' A' ' 38' ' ' LEU . 1.4 pt? -96.51 77.06 2.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.699 0.762 . . . . 0.0 111.201 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.73 HG23 HG21 ' A' ' 8' ' ' VAL . 4.9 mt -133.68 121.37 40.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 170.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.544 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 42.4 p90 -141.94 160.75 39.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.719 -176.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 54.0 t -56.56 128.87 17.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.935 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.76 -16.44 58.61 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.896 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.482 ' NE2' ' HA ' ' A' ' 39' ' ' ILE . 27.5 tt0 -74.96 137.94 41.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.852 0.326 . . . . 0.0 110.877 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.465 ' HD3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -95.32 107.72 19.86 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.834 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.455 HD11 ' HD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -117.0 147.08 42.62 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 46' ' ' ILE . 2.5 mp -70.41 137.93 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.967 0.413 . . . . 0.0 111.271 -174.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.649 ' O ' ' HB ' ' A' ' 4' ' ' THR . 8.8 p -151.67 124.72 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.735 0.779 . . . . 0.0 109.302 171.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.48 ' HB3' ' HA ' ' A' ' 3' ' ' ASN . 21.6 pttp -140.69 119.67 12.71 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.57 0.7 . . . . 0.0 111.411 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.15 158.04 33.68 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.158 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.36 43.86 60.97 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.47 177.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.52 -0.752 . . . . 0.0 109.913 177.195 . . . . . . . . 0 0 . 1 stop_ save_